A study of growth and development in the distal radius using the metaphyseal index by Adams, Judith et al.
 
 
 
 
 
 
 
 
 
A STUDY OF GROWTH AND 
DEVELOPMENT IN THE DISTAL RADIUS 
USING THE  
METAPHYSEAL INDEX 
 
 
 
 
A thesis submitted to the University of Manchester for the degree of  
 
Doctor of Philosophy 
 
in the Faculty of Medical and Human Sciences 
 
 
 
 
 
2011 
 
 
 
 
LIANNE CATHERINE ROSE REDDIE 
 
 
 
 
SCHOOL OF MEDICINE 
 
 
 
 
 
 
 2
Table of Contents 
 
Table of Contents ……………………………………………………….. 2 
 
List of Figures and Tables ……………………………………………….. 6 
 
Abstract ……………………………………………………………….. 10 
 
Declaration ……………………………………………………………….. 11 
 
Copyright Statement ……………………………………………….. 11
  
Dedication ……………………………………………………………….. 12 
 
Acknowledgements ……………………………………………………….. 12 
 
The Author ……………………………………………………………….. 12 
 
List of Abbreviations  ……………………………………………….. 13 
 
1.  Overview ……………………………………………………………….. 15 
 
 1.1 Introduction ……………………………………………….. 15 
 1.2 Motivations ……………………………………………….. 15 
 1.3 Approach ……………………………………………….. 17 
 1.4 Aims, Objectives and Hypotheses ……………………….. 18 
 1.5 Structure of Thesis ……………………………………….. 20 
 
2.  Bone Structure, Growth and Development ……………………….. 22 
 
 2.1 Introduction ……………………………………………….. 22 
2.2 The Anatomy of Bone ……………………………….. 22 
2.3 Bone Types and Organisation  ……………………….. 24 
2.4 Relevant Cells and Functions  ……………………….. 24 
2.5 The Origins of Bone Cells and Tissues ……………….. 29 
2.6 Ossification ……………………………………………….. 29 
2.7 Mineralisation ……………………………………………….. 31 
2.8 Bone Modelling and Remodelling ……………………….. 33 
2.8.1 The Remodelling Cycle ……………………………….. 35 
2.9 The Utah Paradigm of Skeletal Physiology and the Mechanostat 36 
2.10 The Functional Muscle-Bone Unit  ……………………….. 37 
2.11 Biomechanics of the Human Skeletal System ……………… 38 
2.12 Distal Radial Fractures ……………………………….. 40 
2.13 Summary ……………………………………………….. 41 
 
 
 3
3.  Quantitative Assessment of the Skeleton ………………………… 42 
 
3.1 Introduction ………………………………………………… 42 
3.2 X-Rays and Radiographs ………………………………… 42 
3.2.1 Introduction to X-Rays and the Production of Radiographs  … 42 
3.2.2 How X-Rays Produce an Image ………………………… 43 
3.2.3 Resolution, Dose and Contrast ………………………… 44 
3.3 Radiogrammetry & Digital X-Ray Radiogrammetry (DXR)  .. 44 
3.4 Bone-Age Assessment ………………………………... 46 
3.5 Peripheral Quantitative Computed Tomography (pQCT)   ….. 48 
3.6 Dual Energy X-Ray Absorptiometry (DXA) ………………... 51 
3.7 The Metaphyseal Index (MI)  ………………………………... 54 
3.8 Puberty and Tanner Pubertal Stages ………………………... 56 
 3.9 Summary ………………………………………………... 58 
 
 
4.  Factors Affecting the Growth Plate ………………………………... 59 
 
 4.1 Introduction ………………………………………………... 59 
4.2 Genetic and Hormonal Actions in a Normal Growth Plate  …. 59 
 4.3 Genetic and Hormonal Disorders ………………………... 62 
 4.3.1 Constitutional Delay of Growth and Puberty ………………... 62 
 4.3.2 Neurofibromatosis Type I ………………………………... 64 
 4.3.3 Other Disorders  ……………………………………………... 65 
 4.3.4 Hormonal Disorders ……………………………………….. 70 
 4.4   Nutrition ………………………………………………... 71 
 4.4.1 Minerals – Calcium and Phosphorus/Phosphate ………... 72 
 4.4.2 Other Minerals ………………………………………... 74 
4.4.3 Vitamins ………………………………………………... 77 
 4.5 Exercise ………………………………………………... 86 
 4.6 Bisphosphonates ………………………………………... 87 
4.7 Summary  ………………………………………………... 89 
 
 
5.  Methods – Original Study Groups ………………………………... 91 
 
5.1 Introduction  ………………………………………………... 91 
5.2 The B16N2 Normal Children Study ………………………... 91 
5.3 The Gymnast Study ………………………………………... 93 
5.4 The NF1 Study ………………………………………... 94 
5.5 The CDGP Study ………………………………………... 95 
 
6.  Methods – Study Groups, Subjects and Quantitative Assessment ……        96 
 
6.1 Introduction ………………………………………………... 96 
6.2 Normal Group Data ………………………………………... 96 
 4
6.3 Gymnast Group Data ………………………………………... 97 
6.4 NF1 Group Data ………………………………………… 97 
6.5 CDGP Group Data  ………………………………………… 98 
6.6 DXA Bone-Age Data ………………………………………… 98 
6.7 Data and Methods Summary ………………………………… 99 
6.8 Quantitative Assessment ………………………………… 99 
6.8.1 Image Acquisition – Radiographs  ………………………… 101 
6.8.2 Digitising Radiographs ………………………………… 102 
6.8.3 Image/Data Acquisition – pQCT  ………………………… 104 
6.8.4 Image Acquisition – DXA  ………………………………… 106 
6.9 Anthropometric Data ………………………………………… 107 
6.10 Calculating the Metaphyseal Index ………………………… 107 
6.10.1 Assessing the Metaphyseal Index ………………………… 111 
6.11 TW3 Bone-Age Assessment Using Hand Radiographs  ……... 112 
6.12 GP Bone-Age Assessment Using Radiographs and DXA Hand Images 
 ………………………………………………………………… 114 
6.13 DXR Measures ………………………………………… 115 
 
7.  Methods – Analysis ………………………………………………… 116 
 
7.1 Statistical Analyses and Data Handling ………………… 116 
7.2 Precision ………………………………………………… 116 
7.3 Normal Group ………………………………………………… 116 
7.3.1 TW3 Bone-Age Assessment ………………………………… 118 
7.3.2 40% and 60% MI ………………………………………… 118 
7.3.3 Longitudinal Analysis………………………………………… 118 
7.4 Gymnast Group ………………………………………… 119 
7.4.1 Longitudinal Analysis ………………………………………… 119 
7.5 NF1 Group ………………………………………………… 119 
7.6 CDGP Group ………………………………………………… 120 
7.6.1 Longitudinal Analysis ………………………………………… 121 
7.7 Comparison of All Groups ………………………………… 121 
7.8 DXA Bone-Age Study ………………………………… 122 
 
8.  Results ………………………………………………………………… 123 
 
8.1 Introduction ………………………………………………… 123 
8.2 Precision ………………………………………………… 123 
8.3 Normal Group ………………………………………………… 125 
8.3.1 TW3 Bone-Age Assessment ………………………………… 137 
8.3.2 40% and 60% MI ………………………………………… 138 
8.3.3 Longitudinal Analysis ………………………………………… 140 
8.4 Gymnast Group ………………………………………… 142 
8.4.1 Longitudinal Analysis ………………………………………… 148 
8.5 NF1 Group ………………………………………………… 150 
8.6 CDGP Group ………………………………………………… 156 
 5
8.6.1 Longitudinal Analysis ………………………………………… 162 
8.7 Comparison of All Groups ………………………………….. 164 
8.8 DXA Bone-Age Study ………………………………….. 170 
 
9.  Discussion ………………………………………………………………….. 172 
 
9.1 Introduction ………………………………………………….. 172 
9.2 Precision ………………………………………………….. 172 
9.3 Normal Group ………………………………………………….. 173 
9.3.1 TW3 Bone-Age Assessment ………………………………….. 180 
9.3.2 40% and 60% MI ………………………………………….. 180 
9.3.3 Longitudinal Analysis ………………………………………….. 181 
9.4 Gymnast Group ………………………………………….. 183 
9.4.1 Longitudinal Analysis ………………………………………….. 189 
9.5 NF1 Group ………………………………………………….. 190 
9.6 CDGP Group ………………………………………………….. 196 
9.6.1 Longitudinal Analysis ………………………………………….. 201 
9.7 Comparison of All Groups ………………………………….. 202 
9.8 DXA Bone-Age Study ………………………………….. 204 
9.9 Challenges ………………………………………………….. 206 
9.10 Limitations ………………………………………………….. 208 
9.11 Comparisons with the Literature ………………………….. 209 
9.12 Future Work ………………………………………………….. 211 
 
10.  Conclusion ………………………………………………………….. 213 
  
 10.1 Summary ………………………………………………….. 219 
 
11.  References ………………………………………………………….. 220 
12.  Appendices ………………………………………………………….. 244 
 
12.1 Appendix 1 – Abstracts and Posters ………………………….. 244 
 
 Abstract 12.1A ………………………………………….. 244 
 Abstract 12.1B ………………………………………….. 246 
 Abstract 12.1C ………………………………………….. 248 
 
12.2 Appendix 2 – Further Information regarding X-rays   ….. 250 
 
 12.2.1 – X-Rays and How They are Generated  ………….. 250 
 12.2.2 – X-Rays and Their Interaction with Tissue ………….. 251 
 
12.3 Appendix 3 – Tanner Pubertal Stage Self-Assessment Sheets  ... 253 
 
 12.4 Appendix 4 - Figures from Chapter 8 Results  …………………. 257 
 
Word Count: 61,689 
 6
List of Figures 
 
(Figures with asterisks * denote figures that have been placed in Section 12.4 - 
Appendix 4). 
 
Figure 1.1 ………………………………………………………………… 16 
 
Figure 2.1 ………………………………………………………………… 23 
Figure 2.2 ………………………………………………………………… 24 
Figure 2.3 ………………………………………………………………… 26 
Figure 2.4 ………………………………………………………………… 26 
Figure 2.5 ………………………………………………………………… 31 
Figure 2.6 ………………………………………………………………… 35 
Figure 2.7 ………………………………………………………………… 38 
Figure 2.8 ………………………………………………………………… 40 
 
Figure 3.1 ………………………………………………………………… 47 
Figure 3.2 ………………………………………………………………… 49 
Figure 3.3 ………………………………………………………………… 49 
Figure 3.4 ………………………………………………………………… 52 
Figure 3.5 ………………………………………………………………… 54 
 
Figure 4.1 ………………………………………………………………… 66 
Figure 4.2 ………………………………………………………………… 69 
Figure 4.3 ………………………………………………………………… 74 
Figure 4.4 ………………………………………………………………… 79 
Figure 4.5 ………………………………………………………………… 89 
 
Figure 6.1 ………………………………………………………………… 104 
Figure 6.2 ………………………………………………………………… 105 
Figure 6.3 ………………………………………………………………… 106 
Figure 6.4 ………………………………………………………………… 108 
Figure 6.5 ………………………………………………………………… 110 
Figure 6.6 ………………………………………………………………… 111 
Figure 6.7 ………………………………………………………………… 113 
Figure 6.8 ………………………………………………………………… 115 
 
Figure 8.3A ………………………………………………………………… 126 
Figure 8.3B ………………………………………………………………… 126 
Figure 8.3C ………………………………………………………………… 127 
Figure 8.3D ………………………………………………………………… 127 
Figure 8.3E ………………………………………………………………… 129 
Figure 8.3F ………………………………………………………………… 129 
Figure 8.3G ………………………………………………………………… 130 
Figure 8.3H ………………………………………………………………… 130 
Figure 8.3I* ………………………………………………………………… 256 
 7
Figure 8.3J* ………………………………………………………………… 256 
Figure 8.3K* ………………………………………………………………… 257 
Figure 8.3L ………………………………………………………………… 135 
Figure 8.3M ………………………………………………………………… 136 
 
Figure 8.3.1A ………………………………………………………………… 137 
 
Figure 8.3.2A ………………………………………………………………… 138 
Figure 8.3.2B ………………………………………………………………… 139 
Figure 8.3.2C*………………………………………………………………… 257 
Figure 8.3.2D*………………………………………………………………… 258 
Figure 8.3.2E*…………………………………………………………………. 258 
Figure 8.3.2F*…………………………………………………………………. 259 
Figure 8.3.2G*………………………………………………………………… 259 
 
Figure 8.3.3A …………………………………………………………………. 140 
Figure 8.3.3B …………………………………………………………………. 141 
 
Figure 8.4A …………………………………………………………………. 142 
Figure 8.4B …………………………………………………………………. 143 
Figure 8.4C* …………………………………………………………………. 260 
Figure 8.4D* …………………………………………………………………. 260 
Figure 8.4E* …………………………………………………………………. 261 
Figure 8.4F* …………………………………………………………………. 261 
Figure 8.4G* …………………………………………………………………. 262 
Figure 8.4H* …………………………………………………………………. 262 
Figure 8.4I …………………………………………………………………. 147 
 
Figure 8.4.1A ………………………………………………………………….. 148 
Figure 8.4.1B ………………………………………………………………….. 149 
Figure 8.4.1C ………………………………………………………………….. 149 
 
Figure 8.5A ………………………………………………………………….. 151 
Figure 8.5B ………………………………………………………………….. 151 
Figure 8.5C* ………………………………………………………………….. 264 
Figure 8.5D* ………………………………………………………………….. 264 
Figure 8.5E* ………………………………………………………………….. 265 
Figure 8.5F* ………………………………………………………………….. 265 
Figure 8.5G* ………………………………………………………………….. 266 
Figure 8.5H* ………………………………………………………………….. 266 
Figure 8.5I ………………………………………………………………….. 155 
 
 
Figure 8.6A ………………………………………………………………….. 156 
Figure 8.6B ………………………………………………………………….. 157 
Figure 8.6C* ………………………………………………………………….. 267 
 8
Figure 8.6D* ………………………………………………………………….. 267 
Figure 8.6E* ………………………………………………………………….. 268 
Figure 8.6F* ………………………………………………………………….. 268 
Figure 8.6G* ………………………………………………………………….. 269 
Figure 8.6H* …………………………………………………………………… 269 
Figure 8.6I …………………………………………………………………… 160 
Figure 8.6J …………………………………………………………………… 161 
Figure 8.6K …………………………………………………………………… 162 
 
Figure 8.6.1A …………………………………………………………………… 163 
Figure 8.6.1B …………………………………………………………………… 163 
 
Figure 8.7A* …………………………………………………………………… 270 
Figure 8.7B* …………………………………………………………………… 270 
Figure 8.7C* …………………………………………………………………… 271 
Figure 8.7D …………………………………………………………………… 165 
Figure 8.7E …………………………………………………………………… 167 
Figure 8.7F …………………………………………………………………… 168 
Figure 8.7G …………………………………………………………………… 169 
 
Figure 8.8A …………………………………………………………………… 170 
Figure 8.8B …………………………………………………………………… 171 
 
Figure 9.3A …………………………………………………………………… 175 
Figure 9.3B …………………………………………………………………… 177 
 
Figure 9.3.2A …………………………………………………………………… 181 
 
Figure 9.4A …………………………………………………………………… 184 
Figure 9.4B …………………………………………………………………… 184 
Figure 9.4C …………………………………………………………………… 187 
 
Figure 9.12A & B …………………………………………………………… 210 
 
Figure 12.1A …………………………………………………………………… 245 
Figure 12.1B …………………………………………………………………… 247 
Figure 12.1C …………………………………………………………………… 249 
 
Figure 12.2A …………………………………………………………………… 250 
Figure 12.3A …………………………………………………………………… 253 
Figure 12.3B …………………………………………………………………… 254 
Figure 12.3C …………………………………………………………………… 255 
Figure 12.3D …………………………………………………………………… 256 
 
 
 
 9
List of Tables 
 
Table 3.1 …………………………………………………………………… 57 
Table 3.2 …………………………………………………………………… 57 
 
Table 4.1 …………………………………………………………………… 80 
Table 4.2 …………………………………………………………………… 90 
 
Table 6.1 …………………………………………………………………… 100 
Table 6.2 …………………………………………………………………… 101 
Table 6.3 …………………………………………………………………… 110 
 
Table 8.2A …………………………………………………………………… 123 
Table 8.2B …………………………………………………………………… 124 
 
Table 8.3A …………………………………………………………………… 131 
Table 8.3B …………………………………………………………………… 132 
Table 8.3C …………………………………………………………………… 132 
Table 8.3D …………………………………………………………………… 133 
Table 8.3E …………………………………………………………………… 133 
Table 8.3F …………………………………………………………………… 134 
 
Table 8.4A …………………………………………………………………… 144 
Table 8.4B …………………………………………………………………… 145 
Table 8.4C …………………………………………………………………… 146 
 
Table 8.5A …………………………………………………………………… 153 
Table 8.5B …………………………………………………………………… 154 
Table 8.5C …………………………………………………………………… 154 
 
Table 8.6A …………………………………………………………………… 158 
Table 8.6B …………………………………………………………………… 159 
Table 8.6C …………………………………………………………………… 159 
 
Table 8.7A …………………………………………………………………… 164 
Table 8.7B …………………………………………………………………… 166 
Table 8.7C …………………………………………………………………… 166 
Table 8.7D …………………………………………………………………… 168 
 
Table 8.8A …………………………………………………………………… 170 
 
Table 12.2.2A …………………………………………………………………… 252 
 
 
 
 
 10
Abstract 
 
Introduction: Metaphyseal inwaisting is a process that occurs during long bone growth 
and remodelling of epiphyses and results in a proportional increase in growth plate width 
(GPW) and a decrease in metaphyseal width (MW).  The Metaphyseal Index (MI) 
compares GPW to MW, usually in the distal femur.  However, due to bone-age 
assessments, the most commonly performed radiograph in children is that of the 
hand/forearm.  Previous work showed that gymnasts have a more widened growth plate 
at the distal radius than normal children, but these studies did not quantify the 
morphological changes using the MI and pQCT measures.  Previous studies have shown 
that the use of DXA hand/forearm images for the purposes of bone-age assessment were 
unreliable for children aged 11 and under. 
Aims: Examine distal radius morphology of 378 Normal subjects (155 male), 36 
Gymnast subjects (15 male), 17 NF1 subjects (7 male) and 108 CDGP subjects (83 
male) to calculate the precision of MI, MW and GPW measurements, to determine a 
normal reference range for the MI in Normal subjects and use this to compare to the 
other 3 groups, and to compare longitudinal measurements.  Also, to investigate whether 
DXA software upgrades have improved the ability to make TW3 bone-age assessments, 
to investigate how closely DXA compares with standard radiographs using 98 (38 male) 
DXA hand images and radiographs, and calculate the precision (CV%) of the GP and 
TW3 bone-age assessment methods. 
Methods: Anthropometric data, Tanner stage, posterior-anterior hand radiographs and 
pQCT scans of the non-dominant hand/forearm were obtained.  MI was measured using 
a semi-automated computer-assisted method.  Statistical analyses were used to compare 
males and females, and compare the Normal group to other groups.  Also, DXA images 
and radiographs were assessed by the same assessor and the TW3 and GP bone-ageing 
methods were compared.  A CV% was calculated for both comparisons.  
Results: The CV% of MI, MW and GPW = 1.05%, 0.92% and 1.28% respectively.  MI 
of males and females was not statistically different in any group.  The MI of Gymnasts 
was significantly lower than the Normal group (p = 0.008).  The NF1 and CDGP groups 
were not significantly different from the Normal group.  Longitudinal measurements 
indicated those with a low/high MI at the first visit were likely to have a low/high MI at 
the second visit, though occasionally the MI would decrease between visits.  DXA bone-
age assessments proved to be reliable in subjects of all ages assessed in this study and 
showed a CV% only slightly higher than standard radiographs (CV = 2.95% DXA vs 
2.68% radiograph).  The CV% of GP and TW3 methods = 2.68% & 1.61% respectively.  
Discussion: The CV% of MI, MW and GPW shows these methods to be very precise.  
The mean MI of gymnasts is significantly lower than in normal children due to a 
widening of the growth plate and not due to a reduction in metaphyseal width.  
Insufficient subject numbers and smaller age ranges, particularly in the Gymnast and 
NF1 groups may play a part in the non-significant differences between them and the 
Normal group. DXA CV% shows that DXA is almost interchangeable with standard 
radiographs.  The TW3 and GP CVs% show that TW3 bone-age assessment is more 
precise than the GP method.  This confirms the tight control that the MW and GPW have 
in proportion to each other. This is the first study to quantify changes in distal radius 
morphology in normal, athlete and disease groups, and create a range of normal 
reference values, which could be useful for future work in this area.   
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List of Abbreviations 
 
Arm Length: refers to forearm length, measured by a radiographer from the ulnar 
styloid process to the olecranon.  
 
BMC (Bone mineral content): the amount of mineral present in a bone (g). 
 
BMD (Bone mineral density): the amount of mineral present per unit of volume (g/cm3). 
 
BMDa (Areal bone mineral density): a 2-dimensional estimate of BMD measured by 
DXA (g/cm2), calculated by dividing bone mineral content over bone area (BMC/BA). 
 
BMDaDXR (Areal bone mineral density measured by DXR): same as BMDa but 
measured in the 2nd, 3rd and 4th metcarpals by DXR.  The volume per projected area is 
calculated using the metacarpal cortical thickness and bone width, then the volume is 
multiplied by a density constant, which produces an estimate of BMDa in g/cm2 (Barnett 
and Nordin, 1960). 
 
BMAD (Bone mineral apparent density): an attempt to compensate for the 2-
dimensional nature of the BMDa measurement by using a 3-dimensional shape, such as 
a cube to represent a vertebral body, to improve the accuracy of the measurement.   
 
CrtThickDXR (Cortical Bone Thickness Measured by DXR): this is a DXR measure 
calculated by the Sectra Pronosco system (Linköping, Sweden).  A plain film radiograph 
is placed on a flatbed scanner and using specialised software, it calculates the average 
cortical thickness of the 2nd, 3rd and 4th metacarpals.  Metacarpal cortical bone thickness 
can also be calculated manually by using callipers and a light-box to measure a plain 
film radiograph directly. 
 
CDGP (Constitutional Delay of Growth and Puberty): one of the groups assessed in the 
current study. 
 
CSMA (Cross-Sectional Muscle Area): this is a QCT measure calculated by removing 
voxels of certain thresholds (bone and fat) so that only muscle area is left. 
 
CV (Co-efficient of Variation): this is the repeatability of a technique.  It is calculated 
by taking repeat measurements of the same subjects using the same technique, all 
performed by the same researcher.  The results of the two analyses are compared and the 
results are expressed as a percentage.  Also known as intra-observer error or precision. 
 
DXR (Digital X-ray Radiogrammetry): radiogrammetry measures, such as MCI, 
BMDaDXR and CrtThickDXR, calculated by a computer program such as the Sectra 
Pronosco system (Linköping, Sweden).   
 
GPW (Growth plate width): a term used in calculating the metaphyseal index (MI) 
whereby the widest part of the distal radial growth plate is measured. 
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MCI (Metacarpal Index): this is a DXR measure calculated by the Sectra Pronosco 
system (Linköping, Sweden).  A plain film radiograph is placed on a flatbed scanner and 
using specialised software, it calculates the average cortical thicknesses and bone widths 
of the 2nd, 3rd and 4th metacarpals.  MCI is the sum of the cortical thicknesses divided by 
the bone width.  MCI can also be calculated manually by using callipers and a light-box 
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bone. 
 
MW (Metaphyseal width): a term used in calculating the metaphyseal index (MI) 
whereby half of the metaphyseal width is measured, 0.5MW, and divided by the distal 
radial growth plate width (GPW). 
 
NF1 (Neurofibromatosis Type 1): one of the groups assessed in the current study. 
 
OI (Osteogenesis imperfecta): a genetic disorder manifesting at birth.  OI types I, II, III 
and IV are the result of a dominant mutation in the genes controlling type I collagen 
manufacture.  There is either too little collagen produced or the collagen quality is poor 
causing an increased risk of fracture from minor trauma throughout life.  OI types VII 
and VIII are the result of recessive mutations in collagen associated genes, specifically 
the genes controlling cartilage-associated-protein (CRTAP) and prolyl 3-hydroxylase 1 
(P3H1) respectively.  The specific causes of OI types V and VI have not as yet been 
identified. 
 
pSSI (Polar Strength-strain index): an estimate of torsional and bending strength 
measured by pQCT and calculated using the section modulus and cortical BMD. 
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1. Overview 
1.1 Introduction 
Bone geometry can provide important information about the health of an individual, and 
in the case of children, bone geometry can provide information about development.  
Bone geometry can be measured in a number of different ways.  The current study sets 
out to create a database of normal reference values for children aged 5-20 (155 male) 
years using a bone geometry measurement technique called the Metaphyseal Index (MI), 
and use these reference values to compare with values obtained from other disease and 
exercise groups.  The only two papers published using the MI technique have dealt with 
the distal femur (Land et al., 2006, Ward et al., 2005a), however the most common 
radiograph taken clinically is that of the hand/forearm for fracture assessment (Cooper et 
al., 2004, Landin, 1983) and bone-ageing.  Therefore the current study aims to use the 
MI to examine the distal radius.  An additional study was performed to determine 
whether bone-age could be assessed successfully using an image obtained by a DXA 
scanner as opposed to the gold-standard of Radiographs.  Having obtained reference 
data, its utility in a number of different groups/conditions can be determined.   
 
1.2 Motivations 
The current study was inspired by a paper entitled Quantification of Metaphyseal 
Modeling in Children Treated with Bisphosphonates (Ward et al., 2005a).  The paper 
outlines a novel method for quantifying the metaphyseal growth and morphology of the 
distal femur called the MI.  The MI is a ratio of two measurements: growth plate width 
(GPW) and metaphyseal width (MW), specifically 0.5MW/GPW (Fig 1.1).  The MI was 
developed to examine metaphyseal modelling of the distal femur by creating a normal 
reference database and comparing these values to values obtained from children that had 
been treated with bisphosphonates for localised conditions.   
The distal femur, which was examined in the previous two studies (Land et al., 2006, 
Ward et al., 2005a) is a weight bearing bone.  Therefore the distal radius may be a more 
appropriate site to study in terms of morphology changes.  Also, the most common 
fracture site in children is at the distal radius (Khosla et al., 2003) and radiographs are 
often  taken of   the  hand  and  forearm  for  fracture  assessment.  Once  a  database  of 
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Figure 1.1: How to calculate the MI: Measure GPW at its widest point.  Take half that measurement 
and measure in a proximal direction towards the metaphysis.  Measure the MW at that point.  
./5.0 GPWMWMI   
 
normal reference values for the distal radius was created, the MI was used to compare 
the morphology of the distal radius in other groups of children with diseases, nutrient 
deficiencies or taking medications that could alter the shape of the metaphysis.  Given a 
baseline measurement, further follow-up measurements could be taken at appropriate 
intervals to monitor growth and treatment.  In the case of bisphosphonate treatment, 
monitoring the morphology of the metaphysis can be used to avoid accidental overdose.  
It could also serve to further our understanding of growth and adaptation of long bones 
in various conditions. 
The motivation behind the DXA bone-age study was a previous study that showed DXA 
could be used as an alternative to Radiographs when imaging the hand for bone-ageing, 
but only for children aged 12 and over (Ashby et al., 2002b).  Since this original study 
was performed, the DXA software in our institution was upgraded.  It was hypothesised 
that an increase in spatial resolution would allow a more accurate determination of bone-
age in children, including those aged below 12 years. 
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1.3 Approach 
The work began with the examination of a large group of normal children.  The first step 
was determining inclusion and exclusion criteria and retrospectively taking images and 
information that met these criteria from an ongoing larger study.  This was also done for 
the subsequent groups obtained: gymnast children, children with Neurofibromatosis type 
1 (NF1) and Constitutional Delay of Growth and Puberty (CDGP).  A precision study 
was undertaken that showed the computerised MI measurement technique was more 
repeatable than the manual one.  Bone-age was assessed in all normal and CDGP cases 
and was used instead of chronological age to compare those 2 specific groups because of 
the delay in growth compared to chronological age experienced in CDGP.  MI was 
assessed in all groups and in all longitudinal images and compared to age.  An 
assessment was also used to determine if there were any correlations between MI and 
pQCT measures.  Also, because the MI is an arbitrary ratio that was designed as a 
method of measuring the same site of the metaphysis regardless of the subject age or 
size of bone, there is a question as to whether or not this is necessarily the best site to 
measure the metaphysis.  The formula for calculating the MI is 0.5MW/GPW.   The site 
of the metaphysis at which the MW is measured is the result of taking 50% of the GPW.  
However, using 50% of the GPW is an arbitrary measure and it is possible that taking 
40% or 60% of the GPW would result in a statistically more useful area of the 
metaphysis being measured.  This was investigated, although the choice to measure at 
40% and 60% were also arbitrary.  
The approach for the DXA bone-age study also involved taking images retrospectively 
from a larger study of normal children that met certain criteria: the children must have 
had a viable Radiograph and DXA hand scan taken on the same day.  The bone-age 
assessment was performed on all Radiographs first and subsequently all DXA scans 
using the GP method (Greulich and Pyle, 1959) and was blinded to the subject’s age.  
Repeat MI measurements were performed approximately three months after the original 
assessment to assess repeatability. 
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1.4 Aims, Objectives and Hypotheses 
 
The aims and objectives of this PhD are as follows: 
 
1. To describe normal bone growth and development, and how diseases, 
deficiencies, and lifestyle choices may disturb these, with an emphasis on the 
metaphysis of long bones – specifically the distal radius.   
2. To measure the MI, MW and GPW of the distal radius in normal children, young 
gymnasts, children with neurofibromatosis type I (NF1), and children with 
congenital delay of growth and puberty (CDGP). 
3. To analyse and compare MI, MW and GPW measurements in the various groups 
of children to determine a normal range of MI, and investigate how the MI in 
disease groups may differ from normal. 
4. To perform bone-age assessments in the normal children and CDGP children 
using the TW3 method.  (Chronological age is an inappropriate method by which 
to compare CDGP to normal children due to the nature of CDGP). 
5. To investigate whether there is any correlation between pQCT measurements of 
the radius [e.g. total bone mineral density (toBMD), cross-sectional muscle area 
(CSMA), polar strength-strain index (pSSI), radius cortical area at the 50% site 
and cortical bone density at the 50% site], with the MI, MW and GPW values 
using both parametric and non-parametric statistical methods. 
6. To assess the MI by altering the original ratio (0.5MW/GPW) to determine 
whether 40% of the MW or 60% of the MW would result in a statistically more 
useful MW site being measured. 
7. To compare bone-age assessments performed on DXA images of the hand 
(Hologic DXA scanner software version 12.4) to that performed conventionally 
from hand radiographs. 
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The hypotheses investigated are as follows: 
 
1. MI should not be influenced by weight because the distal radius is not a weight 
bearing bone.  The possible exception to this is in the gymnasts, in whom loading 
of the distal radius may present. 
2. MI should be dependent on age: MI is lower in the younger age range (5-6 
years), until it comes to a plateau in mid and late teenage years. 
i) The children with pubertal delay should have a very similar MI development 
pattern to normal children, except that the increase and plateau will occur 
later. 
3. MI should not be dependent on sex.  Although the GPW and MW of males may 
be larger than in females, they should be in proportion, giving a similar ratio. 
4. MI should not be dependent on height: bones of different lengths should still be 
in proportion. 
5. MI should always be dependent on cross-sectional bone area at the metaphysis 
because the metaphyseal width is part of the MI ratio. 
6. Increases in BMD and pSSI should not alter the MI because BMD and pSSI are 
not geometric measurements (i.e. will not influence the shape of the bone). 
7. MI should be altered in the case of NF1 due to metaphyseal dysplasia being one 
of the possible features of this disease in relation to the distal radius.  However 
the literature concentrates on this dysplasia presenting in the femur and tibia, 
which are weight-bearing bones.  Therefore although a change in the MI is 
possible due to the distal radius not being a weight bearing bone, the change may 
be small.   
8. MI should be related to cross-sectional muscle area (CSMA) as muscle causes 
the most stress placed on bone. 
9. MI should not be altered in the case of CDGP as the main feature of this 
condition is a delay in growth (smaller bones) rather than a change in the 
morphology, which should not affect a measurement. 
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1.5 Structure of Thesis 
Chapter 2 – Bone Structure, Growth and Development: background information on how 
bone grows, important cell types and actions, modelling, remodelling, biomechanics and 
fractures. 
Chapter 3 – Factors Affecting the Growth Plate: Genetic, hormonal, nutritional, lifestyle 
and medication factors that could affect the growth plate area and the MI are discussed. 
Chapter 4 – Quantitative Assessment of the Skeleton: X-rays, radiogrammetry, bone-
age, pQCT, DXA, MI and Tanner Pubertal Stages are discussed. 
Chapter 5 – Methods, Original Study Groups: Outlines the original studies from which 
parts of the data for the current study were obtained, including original inclusion and 
exclusion criteria. 
Chapter 6 – Methods, Current Study Groups, Subjects and Quantitative Assessment: 
Outlines the MI, how it is calculated and image acquisition.  There is a separate section 
outlining the methodology of bone-ageing using DXA images. 
Chapter 7 – Methods, Statistical Analyses: Outlines the statistical analyses conducted in 
each group for the current study.  
Chapter 8 - Results: Outlines the MI and pQCT results of each group, the TW3 bone-age 
results for the Normal and CDGP group, and the DXA GP bone-age results for the 
Normal group. 
Chapter 9 – Discussion: Interpretation of results, challenges, study limitations and future 
work. 
Chapter 10 – Conclusions: Summarises the results and discussion, and relates them back 
to the aims, objectives and hypotheses. 
Chapter 11 – References 
Chapter 12 – Appendices: Outlines published abstracts and posters, further information 
regarding X-rays and Tanner Pubertal stage self-assessment sheets. 
 
Published Abstracts:  
 
1. Reddie, L., Ashby, R., Adams, J. & Ward, K. (2007) Assessment of the 
Metaphyseal Index to Study Bone Development of the Distal Radius in Healthy 
Children. Osteoporosis International, 18, S324. 
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2. Reddie, L., Ward, K., Mughal, M., Astley, S. & Adams, J. (2009) The 
Metaphyseal Index for Assessing Development of the Distal Radius. Calcified 
Tissue International, 85, 181-182. 
 
3. Reddie, L., Ward, K., Mughal, M., Astley, S. & Adams, J. (2010) The 
Metaphyseal Index of the Distal Radius: a comparison between gymnasts and 
normal children. Bone, 47, S103. 
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2. Bone Structure, Growth and Development 
2.1 Introduction 
Bone is an extremely resilient tissue that undergoes a variety of biochemical processes 
during growth and development.  Bone provides the structural support for the human 
body in the form of an endoskeleton, i.e. an internal skeleton with other surrounding 
tissues.  The skeleton has three main functions:  
1. to provide structural support and a base for muscle and ligament attachment  
(allowing locomotion to occur). 
2. to protect vital organs i.e. the ribs protecting the lungs.  
3. to serve as a store for ions, which help regulate homeostasis.   
This chapter will discuss bone anatomy, bone types and organisation, relevant cells and 
their functions as well as growth and adaptation. 
 
2.2 The Anatomy of Bone 
Bone composition includes collagen, other non-collagenous proteins, and minerals such 
as calcium and phosphorus in the form of hydroxyapatite - Ca5(PO4)3OH.  The growth 
and development of bone allows it to maintain strength whilst being adequately 
functional to resist damage from everyday stresses.   
 
A long bone e.g. humerus or radius, has epiphyses located at each end, the diaphysis or 
shaft comprising the middle section and the metaphyses, which are located in between 
the epiphyses and diaphysis at each end.  The metaphysis of a long bone is the area 
where most of the trabecular bone is located.  During growth, the epiphyses and 
diaphyses are separate, but at skeletal maturity they fuse together.  A diagram of an adult 
human femur is illustrated in Figure 2.1 and typical stages of radial growth are 
illustrated in Figure 2.2.  The periosteum is a two-layered fibrous connective tissue 
located on the outer surfaces of bone, except at the joints and ligament attachments.  The 
endosteum is a vascular connective tissue that lines the inner bone surface adjacent to 
the marrow cavity.  The undifferentiated cells present in these structures are important as 
following an injury, they can differentiate into specific cells to repair the bone 
(Slomianka, 2006). 
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Figure 2.1: Diagram of an adult human femur, adapted from (Mature Long Bone - Femur, 2002). 
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Figure 2.2: Developmental stages of a human radius from birth to 15 years, adapted from (Bass, 
1995). 
 
2.3 Bone Types and Organisation 
There are two types of bone tissue; lamellar and woven bone.  Woven bone is formed 
quickly during ossification and contains irregularly arranged collagen fibres, therefore 
making it relatively weak.  Woven bone is typically found in foetal bones, recent 
fracture sites that have started to heal (fracture calluses), and in some diseases such as 
osteogenesis imperfecta, Paget’s disease and certain bone tumours (Einhorn, 1996).  
Woven bone resembles the weave of a fabric when viewed using polarised-light 
microscopy, from which the name is derived.  Lamellar bone is a more mature bone that 
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results from the remodelling of woven bone or pre-existing bone tissue.  In a typical 
adult bone, the lamellar bone is organised in two different ways; cortical or compact 
bone, which forms the outer shell and is more dense, and cancellous, spongy or 
trabecular bone, which is found in the interior of bones.   
Cortical bone has a complex structure based on osteons, which are formed when the 
vascular spaces in woven bone are filled in by osteoblasts depositing concentric rings of 
lamellar bone along the inner surface of the space in a tree-ring like structure until only 
the Haversian canal remains.  The Haversian canal consists of a small tunnel with a 
blood vessel.  Another type of canal called a Volkmann’s canal is responsible for 
connecting Haversian canals at right angles so that the blood vessels can connect with 
each other.  The lacunae are oblong-shaped spaces where osteocytes reside and are 
connected to one another by small canals called canaliculi.  The main components of an 
osteon are illustrated in Figure 2.3.  Primary osteons are formed during the modelling 
process.  They are eventually replaced by secondary osteons when bone remodelling 
occurs.  Trabecular bone forms an interconnecting mesh structure known as trabeculae.  
Flat bones (e.g. ilium) and small bones (e.g. phalanges) have interiors filled with 
trabecular bone, whereas long bones have their greatest concentrations of trabecular 
bone at the metaphyses and epiphyses.  The trabecular structure in the metaphysis of an 
adult human femur is illustrated in Figure 2.4.  Trabecular bone is organised into parallel 
lamellae, and concentric lamellae are found in the Haversian systems of cortical bone 
(Baron, 1999).  Interstitial lamellae remnants remain after bone remodelling occurs.  
 
2.4 Relevant Cells and Functions 
There are four main types of bone cells involved in the modelling and remodelling of 
bone; osteoblasts, osteocytes, osteoclasts and bone lining cells.   
Osteoblasts: are the bone forming cells and are approximately cube-shaped.  They 
secrete the elements of an extracellular bone matrix, which are mainly collagen and non-
collagenous proteins including osteopontin, osteocalcin, osteonectin and bone 
sialoprotein (Aguila and Rowe, 2005, Rosen, 2004, Young et al., 1992), all of which 
have important functions in bone formation.  Osteoblasts also aid in the bone 
mineralisation process by producing matrix vesicles.  Here, the enzyme alkaline phosph- 
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Figure 2.3: Photomicrograph of a human osteon.  Reproduced and adapted with permission and 
copyright © of the British Editorial Society of Bone and Joint Surgery (Smith, 1960). 
 
 
Figure 2.4: Photograph of an archaeological specimen of an adult human femur with a post-mortem 
break in the distal metaphysis showing the trabecular structure. 
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atase allows phosphate to be transported into the vesicle where it combines with calcium 
and crystallizes.  This enzyme and the newly created bone crystal are released when the 
vesicle ruptures, making levels of alkaline phosphatase in the blood stream an important 
bone formation indicator (Faerk et al., 2002).  Osteoblast membranes contain    alkaline 
phosphatase which is important because the presence of this enzyme creates an alkaline 
environment.  Calcium crystallises in an alkaline environment, thereby aiding the 
osteoblast to produce new bone (Corathers, 2006).   Osteoblasts play an important role 
in haematopoiesis in bone marrow and function as regulators in the haematopoietic 
environment (Aguila and Rowe, 2005).  Much of the activity of osteoblasts occurs at 
ossification centres and along bone growth plates during childhood and adolescence, but 
they continue to function to produce new bone throughout life by forming new layers of 
bone after osteoclasts have removed older bone. 
Osteocytes: derive from osteoblasts that have become caught up in the matrix they 
produce.  This matrix consists mainly of unmineralised osteoid, collagen and other 
proteins mentioned previously.  The space in which osteocytes become trapped are 
known as lacunae and the miniscule canals that extend out between osteocytes for 
removal of waste and the entry of nutrients are known as canaliculi.  Osteocytes are also 
thought to be the major participant in the mechanosensory function of bone, and 
therefore make a large contribution to the way in which bone adaptation occurs (Aarden 
et al., 1994, Cowin et al., 1991, Cowin, 2002).  Current research suggests that the 
movement of fluid through the canaliculi and lacunae creates a force strong enough for 
the osteocytes to sense, and this is the way in which bone is able to sense the mechanical 
load to which it is subjected (Burger and Klein-Nulend, 1999, Cowin, 2002, Klein-
Nulend et al., 2003, You et al., 2001).  Osteocytes could then aid in signalling 
microdamage, disuse and strains to other cells on bone surfaces (Skerry et al., 1989, 
Marotti et al., 1996, Martin, 2003).     
Osteoclasts: are bone resorbing cells.  They are multinucleated and secrete acids and 
enzymes that can dissolve the inorganic components of bone, i.e. hydroxyapatite, and 
the organic components, such as collagen and other proteins.  To begin bone resorption, 
an osteoclast must land, attach and seal to an area of bone.  The adhesion of osteoclasts 
and their progenitor cells are assisted by several attachment proteins called integrins, 
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which facilitate substrate recognition and allow the formation of a closed 
microenvironment between the osteoclast and the bone surface called the sealed zone.  
When the sealed zone is created, a ‘ruffled border’ is formed inside the sealed zone 
allowing the bone resorption process to begin (Kölliker, 1889).  The ruffled border 
consists of long tentacle-like projections that permeate the bone matrix.  Several 
biochemical processes essential to bone resorption occur in the sealed zone, such as the 
formation of hydrochloric acid (Abu-Amer, 2005) and acid hydrolases including 
protease (Blair et al., 1986).  Vesicles transport hydrochloric acid and proteases to the 
resorption lacuna, which is the area between the bone surface and the ruffled border 
within the sealed zone where the bone resorption occurs (Vaananen et al., 2000).  
Osteoclasts are not always active; they must receive a signal indicating how much bone 
to resorb and from where to resorb it.  After an osteoclast has completed resorption, it 
will either undergo apoptosis or return to an inactive state (Vaananen et al., 2000). 
Bone lining cells: are present on bone surface areas not undergoing apposition or 
resorption.  Bone lining cells line the medullary cavity on the endosteal surface, line the 
vascular canals within osteons, and also appear on the periosteal surface.  It is believed 
that they derive from osteoblasts, but are metabolically less active in this terminally 
differentiated form (Rosen, 2004).  Bone lining cells have the ability to secrete 
collagenases (Meikle et al., 1992), which are necessary to initiate bone resorption.  
Collagenases are enzymes that digest the endosteal membrane and expose bone mineral, 
thereby allowing osteoclast attachment (Hill and Orth, 1998, Parfitt, 1994).  Bone lining 
cells can also resorb collagen fibrils protruding from Howship's lacunae, which are left 
behind by osteoclastic resorption (Everts et al., 2002).  The canaliculi allow bone lining 
cells to deliver signals to and from osteocytes and they also have contact with other 
types of cells such as those in neighbouring soft tissues and more distant cells through 
the body’s circulation system (Parfitt, 1994).  Their location and ability to communicate 
with a variety of other cells enables them to remain informed of remodelling needs and 
bring together the necessary components for this process and/or stimulate their 
activation.  It is therefore believed that lining cells are able to signal or ‘home’ 
osteoclasts (Khan and Partridge, 1991, Parfitt, 1994, Rosen, 2004). 
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Fibroblasts are the most common cell type present in connective tissue and they are 
worth noting because they secrete the elements of the extracellular matrix, including 
collagen, while also playing a large role in wound healing.  
 
2.5 The Origins of Bone Cells and Tissues 
Human bone begins as embryonic tissue called mesoderm.  The mesoderm is where the 
majority of the specialised cells of the musculoskeletal system are derived, including red 
blood cells and cartilage.  In the third week of embryonic development, masses of 
mesenchymal tissue form adjacent to the notochord (the early developmental stage of 
the structure that will eventually become the spinal cord) called somites (Müller and 
O'Rahilly, 2003).  Over forty pairs of somites and mesenchymal tissue give rise to 
different elements i.e. skin, muscle and bone, depending on their position.  For example, 
somites thirteen to twenty-four correspond to the thoracic vertebrae (Müller and 
O'Rahilly, 1986), located adjacent to the central part of the notochord.  Certain skeletal 
structures derive from pharyngeal arches (pouches that develop in utero adjacent to the 
pharynx).  Some develop in cartilage, which later ossifies, and others develop directly 
from mesenchymal tissue.  Most of the appendicular skeleton develops from the 
mesenchyme, although muscle cells of the limb have a separate lineage and migrate 
from somites into limb buds (Wolpert, 1999).  Upper limb buds develop slightly before 
the lower limb buds, around twenty-four to twenty-eight days gestation respectively 
(O'Rahilly and Gardner, 1975), but they are evident by the end of the third week 
(Bardeen and Lewis, 1901).   
                                                                                                               
2.6 Ossification 
There are two types of bone ossification; intramembranous ossification and 
endochondral ossification.   
 
Intramembranous ossification is defined as the direct mineralisation of a highly 
vascular connective tissue.  This process occurs in the flat bones of the skeleton, such as 
the facio-maxillary bones.  In summary, intramembranous ossification can be considered 
a four step process:  
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1. An ossification centre forms. 
2. Osteoblasts secrete osteoid elements and the subsequent mineralisation of the 
osteoid matrix begins working outward from the ossification centre. 
3. The early trabeculae form. 
4. The periosteum develops.  This is the process that creates woven bone.  
 
Endochondral ossification is different from intramembranous ossification in that a 
cartilage precursor (template) to the bone is initially laid down, then the bone begins to 
take shape in this template.  In summary, endochondral ossification can be considered a 
ten step process:  
1. The hyaline cartilage model or template grows and develops.  This occurs when 
chondroblasts (the cartilage equivalent of the osteoblast) begin to secrete collagen 
and other proteins forming the cartilage matrix.  Chondroblasts that become caught 
in the matrix are subsequently known as chondrocytes.  A membrane 
(perichondrium) surrounds the cartilage model.   
2. Blood vessels form in and around the cartilage matrix to bring nutrients and 
allow the removal of waste.   
3. A bone collar and the periosteum form around the diaphysis of the cartilage 
precursor when the perichondrium develops osteogenic cells.   
4. Hypertrophic chondrocytes located at the edges of the primary ossification 
centres enlarge.  The cells eventually degenerate, the matrix becomes compressed 
and subsequently mineralises.  This area is known as the proliferative zone.  A 
representation of the growth plate and adjacent metaphysis during growth is 
illustrated in Figure 2.5.   
5. The original cartilage model is then gradually replaced by woven bone in a 
complex system of bone apposition, resorption and elongation.  This process occurs 
in the zone of cartilage transformation and the resulting trabeculae form the primary 
spongiosa.   
6.  Osteoclasts begin to resorb the woven bone and cartilage remnants, osteoblasts 
begin to deposit bone matrix and the crystals produced inside the matrix vesicles 
become organised into the matrix,  producing  lamellar bone.   This process occurs in  
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Figure 2.5: A summary of the major features of a diaphyseal growth plate adapted from 
(Scheuer and Black, 2000). 
 
the zone of ossification and the resulting mature trabeculae form the secondary 
spongiosa. 
7.  More blood vessels form during growth because of the constant need to bring 
nutrients to the newly developing bone.   
8.  Secondary ossification centres appear at the epiphyses of long bones and more 
blood vessels form to bring nutrients to these areas.  In bones such as the carpals and 
tarsals, there is a variation in the number and location of secondary ossification 
centres.   
9.  The development of a medullary cavity occurs through osteoclastic resorption and 
the endosteum begins to form.  Then bone marrow begins to develop in the newly 
created cavity.  The epiphyses do not have separate medullary cavities.  The smaller 
bones do not develop medullary cavities but all bones have some degree of marrow 
within their trabecular structure. 
10.  The articular cartilage forms and remains to form the joint margins.  
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When the epiphysis and diaphysis of a growing long bone become adjacent to one 
another, the diaphysis will gradually fuse with the epiphysis via the creation of 
mineralised bridges until the hyaline-cartilaginous growth plate has been completely 
replaced by bone and bone marrow (Haines, 1975), making a complete bone.  Todd 
has separated this union process into a nine stage process (Todd, 1930).  The 
articular cartilage remains at joint surfaces to form the joints and prevent attrition.   
 
Long bones must also have a mechanism for increasing their diaphyseal circumference 
and their length.  They do this by subperiosteal addition of bone combined with 
endosteal resorption.  This mechanism ensures that the cortical bone layer does not 
become too thick, which would therefore make the bone much heavier and mechanically 
disadvantaged.  The size, shape and density of the cortical and trabecular bone will 
generally develop to a stage at which they are sufficiently strong and light to 
accommodate loading and activity to which the skeleton is normally exposed.  
 
2.7 Mineralisation 
Once the matrix vesicles are produced by osteoblasts and/or chondroblasts, normal 
mineralisation requires the enzyme alkaline phosphatase, normal pH, calcium and 
phosphate ions and the active metabolite of vitamin D 1,25(OH)2D to enable 
mineralisation of osteoid and crystal formation.  The formation of matrix vesicles is 
aided by vitamin D and its metabolites and alkaline phosphatase.  As the crystals grow 
and proliferate, the matrix vesicles break down and the crystals are exposed to the 
matrix.  During that process, collagen fibrils and other non-collagenous proteins such as 
osteopontin and osteonectin help to determine the organisation and orientation of the 
crystal (Christoffersen and Landis, 1991, Sommerfeldt and Rubin, 2001).     
Mineralisation can also occur as the result of crystals forming at sites on collagen fibrils.  
Although the mechanism for the formation of these crystals outside the vesicle 
microenvironment is not completely understood, there may be an association of mineral 
in the collagen matrix with the mineral in vesicles, such as minerals in vesicles serving 
as a calcium and phosphate ion source to assist early collagen-based mineralisation 
(Lian et al., 1999, p25).  However, one feature the two mineralisation processes have in 
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common is the need for calcium and phosphate ions (Christoffersen and Landis, 1991, 
Mundy, 1999). 
Vitamin D deficiency reduces the mineral-osteoid ratio and particularly affects 
endochondral ossification (Mughal, 2002).  If the vitamin D deficiency is sufficiently 
severe it is referred to as rickets in childhood and osteomalacia in adulthood.  It results 
in growth plate expansion and non-mineralised bone matrix, leading to bone deformities 
(Mundy, 1999) such as abnormal curvature of the spine or bowed legs.  Further 
information regarding vitamin D deficiency and the effects of vitamin D on the growth 
plate are discussed in Chapter 4. 
 
2.8 Bone Modelling and Remodelling 
Modelling is the process by which many bodily tissues, including bone, are grown, 
developed and organised into an optimally functional structure, which takes place both 
before and after the birth of an organism (Frost, 2004b).  The growth rate of tissues and 
their elements are genetically determined and highly regulated processes.  Remodelling 
refers to tissue turnover in small areas and this process continues throughout life (Frost, 
1966b).  Remodelling begins in childhood while bone is still being modelled to change 
the physical dimensions of bones from those of a child to those of an adult.  The 
mechanism that performs this remodelling/bone turnover is called the Basic 
Multicellular Unit (BMU) (Frost, 1966a, Frost, 1966b).  Osteoclasts, osteoblasts and 
bone-lining cells are present in a cylindrical structure that is able to burrow through 
cortical bone or erode a trench in trabecular bone and remodel as it advances.  
Osteoclasts are located at the burrowing end, osteoblasts are in the middle section and 
bone-lining cells are at the rear.  The end result of each cortical BMU is one new osteon 
(Parfitt, 1994) and in trabecular bone the end result is a partially remodelled trabecula 
(Frost, 2004b).  The lifespan of a BMU can be from six to twelve months (Parfitt, 1994).  
The movement of BMUs and the amounts of bone resorbed and formed are directed to 
achieve an optimum structure.  The initial appearance, location and then subsequent 
disappearance of BMUs, are precisely controlled activities (Frost, 1966b).  In order for 
new BMUs to appear and maintain their activities, new bone cells must form and other 
elements such as nerves, blood vessels and connective tissue must grow and remodel 
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alongside (Parfitt, 1994).  The main function of remodelling after growth has ceased is 
to replace older bone that may be fatigued or damaged.  On a microscopic level these 
signs of fatigue are collectively known as microdamage, which was first documented by 
Frost (Frost, 1960).   
Bone remodels due to increased or decreased mechanical loading as demonstrated in 
experiments performed by Rubin and Lanyon (Rubin and Lanyon, 1984) and explained 
by the Mechanostat theory introduced by Frost (Frost, 1996).  That is, adequate muscle 
function and normal weight-bearing leads to normal bone development, geometry and 
mineral content, all of which are constantly evolving to optimise the overall structure of 
bone to prevent fractures (Frost, 1996).  Mechanical loading causes strains on bones, 
which generate signals detected by osteocytes and to which many other cells respond.  
These signals have genetically determined threshold ranges that help to regulate 
modelling and remodelling.  Modelling is activated to strengthen load-bearing bones 
when strains exceed the threshold range and disuse-mode remodelling is activated to 
reduce bone strength by removing cortical bone adjacent to the marrow cavity 
(endocortical) and trabecular bone when strains are constantly below the threshold range 
(Frost, 2004a).  This then reduces the amount of trabecular bone by expanding the 
marrow cavity and thinning cortical bone, which can eventually result in disuse-pattern 
osteopenia, for example, in those without the use of one or more limbs (Schoenau and 
Frost, 2002).       
During growth, the modelling process dominates, but remodelling begins to dominate 
when skeletal maturation is reached (Frost, 1966b).  An imbalance in the bone 
formation-resorption cycle can lead to certain disease states due to the fact that as people 
age, the newly deposited bone is not able to completely replace the amount of resorbed 
bone.  An example of this is post-menopausal and age-related osteoporosis.  
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2.8.1 The Remodelling Cycle 
The remodelling cycle has five main phases: activation, resorption, reversal, formation 
and resting (Fig 2.6).   
1. Activation: Pre-osteoclasts appear as a result of a signal to activate the 
remodelling cycle and fuse to create large multinucleated osteoclasts.   
2. Resorption: Osteoclasts resorb bone, leave behind resorption pits, then undergo 
apoptosis.   
3. Reversal: Mesenchymal osteoblast pre-cursors appear near the recently created 
resorption pit.  They proliferate and differentiate into pre-osteoblasts and finally 
mature osteoblasts, which are then ready to fill in the resorption pit by creating new 
bone.   
4. Formation: The osteoblasts begin forming osteoid matrix.   
5. Resting: The newly deposited matrix gradually becomes mineralised and the site 
then lies dormant (the resting phase), pending the next cycle of bone remodelling.   
Through the remodelling sequence, the human skeleton is able to renew and repair itself 
and therefore maintain the ability to perform its three primary functions.  
 
 
Figure 2.6: Illustration of the stages of trabecular bone remodelling adapted from (Parfitt, 1994).  
Key: OCL-osteoclasts beginning to resorb bone that was just previously in a resting state.  MON-
mesenchymal cells appear.  POB-osteoblast pre-cursors appear during the reversal phase.  OB-
Matrix formation by osteoblasts before and during the onset of mineralisation.  The last stage shows 
the completed new ‘hemi-osteon’, using Parfitt’s terminology, covered by bone lining cells.      
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2.9 The Utah Paradigm of Skeletal Physiology and the Mechanostat 
The Utah Paradigm of skeletal physiology is an all encompassing theory that attempts to 
explain, to the best of current knowledge, how bones grow, develop and adapt.  The 
Paradigm in its initial form was introduced in the 1950’s and 1960’s over several books 
and articles (Weinmann and Sicher, 1955, Snapper, 1957, McLean and Urist, 1961), but 
has since undergone major redevelopments in the 1990’s and the millennium by Frost 
(Frost, 1998, Frost, 2000b, Frost, 2000a, Frost, 2001a, Frost, 2001b, Frost, 2004b, Frost, 
2004c).  To summarise, the Utah Paradigm states: 
1. Bone geometry and strength are partially determined by mechanical forces acting 
upon bones. 
2. Bones can endure normal mechanical usage (levels of ‘normal’ usage will 
change throughout life) without failing (fractures). 
3. These mechanisms require non-mechanical factors such as vitamins, minerals, 
hormones, genetic factors and other factors to function appropriately. 
4. Mechanical factors guide the non-mechanical factors in terms of generating 
signals that control the activity (including the activity of bone cells) and levels of 
non-mechanical factors. 
5. These factors together determine bone health.  Abnormalities can contribute to 
bone and associated tissue, such as cartilage, tendon and ligament disorders (Frost, 
1997). 
The Mechanostat theory is a large part of the Utah Paradigm as it deals with the 
adaptation of load-bearing bones in response to mechanical forces (Frost, 1987).  The 
Mechanostat consists of four key areas: 
1. Genetically determined conditions at baseline. 
2. Mechanotransducers (loads that generate signals), which activate or de-activate 
biologic pathways or mechanisms at tissue level. 
3. Minimum effective strain (MES) thresholds for modelling, remodelling, fracture, 
adaptation and pathology, which are genetically determined. 
4. Feedback loops for the MES thresholds (Jee, 2006).   
The Mechanostat is important to the current study because loading and strain are 
important in determining bone shape. 
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2.10 The Functional Muscle-Bone Unit 
The Muscle-Bone Unit or Functional Muscle-Bone Unit is an index that uses bone 
mineral content (BMC) per unit of cross-sectional muscle area (CSMA) as an index of 
musculoskeletal adaptation (Schoenau et al., 2002a).  Muscle strength and usage have a 
corresponding effect on bone strength.  On average, over 2kg of muscle force is required 
to move 1kg of body weight, but it is not body weight that exerts the largest voluntary 
loads on load-bearing bones, it is muscle forces (Schoenau and Frost, 2002).  Muscle 
strength increases from birth to young adulthood and then declines throughout middle 
and old age until at age 80 years, less than half of the muscle strength present in young 
adulthood remains (Schoenau and Frost, 2002).  Therefore momentary muscle strength 
(i.e. the muscle strength that is present at any given moment during life), has a profound 
influence on bone strength.  In addition to exercise, these factors include Vitamin D, 
growth hormone, androgens and calcium (see Chapter 4). 
Assessment of muscle strength and bone strength in relation to each other is important.  
This can be determined in a clinical situation by a dual-energy X-Ray absorptiometry 
(DXA) scan or a Quantitative Computed Tomography (QCT) / Peripheral Quantitative 
Computed Tomography (pQCT) scan.  Both DXA and QCT/pQCT scans can measure 
lean body mass, which consists mostly of skeletal muscle.  Using algorithms and 
software provided by the manufacturer, a DXA scan can determine if muscle size is 
adequate for height and whether bone mineral content (BMC) is normal.  If both are 
normal then the result of the scan is normal.  If BMC is too low for muscle size, then a 
diagnosis of a primary bone defect is made, such as osteoporosis.  If muscle size is 
inadequate for height, but BMC is normal, a diagnosis of a secondary bone defect is 
made, such as disuse-pattern osteopenia.  If both muscle size and BMC are inadequate, 
then a diagnosis of a mixed bone defect (primary and secondary) is made (Schoenau and 
Frost, 2002, Fricke and Schoenau, 2007).     
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2.11 Biomechanics of the Human Skeletal System 
Biomechanics is the science concerned with forces and their effects, as applied to 
biological systems.  ‘Stress’ is the term used to describe the force or amount of 
mechanical loading put onto a bone.  There are many types of stress including 
compressive, tensile, and shear.  ‘Strain’ is the term used to describe the amount of 
deformation that occurs as a result of the stress.  There are 2 types of strain: elastic strain 
is not permanent.  A bone undergoing elastic strain will return to its original shape after 
the stress is discontinued.  Plastic strain is permanent, and bone undergoing plastic 
deformation will undergo a permanent shape change, or will fail completely (fracture).  
There are several different types of stress or loading that a long bone can undergo.  
These include tension, compression, bending, shear and torsion (Fig. 2.7). 
 
 
Figure 2.7: Types of stress bones can undergo in vivo, adapted from (Frankel and Nordin, 1980). 
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The human skeleton has evolved to deal with the stresses to which it is exposed.  The 
structure of the dense outer shell of cortical bone, with an inner lattice framework of 
trabeculae, is able to adapt to stress in visible patterns.  This was first noted by Julius 
Wolff in 1892 in his First Law: form follows function (Wolff, 1892).  The joints 
connecting long bones are a perfect example of this adaptation.  Loading in humans and 
other vertebrates must be transmitted from one long bone to another through a joint that 
has a larger articular surface area than the diaphysis of either long bone.  The cartilage, 
along with a thin layer of subchondral bone and trabecular bone in the joint area are 
designed to spread the load over a larger surface area without allowing the joint surface 
to undergo large deformations (Curry, 2002).  If there was no trabecular bone, the joint 
surface would undergo large deformations under compression loading, and if the 
epiphysis/metaphysis was solid i.e. without a trabecular network, a severe compression 
impact would destroy the articular cartilage (Curry, 2002) and could cause acute 
microdamage and/or macro-fractures (fractures visible to the naked eye using 
Radiographs).  This is illustrated in Figure 2.8. 
The epiphysis and metaphysis can, under certain disease conditions, expand to abnormal 
dimensions to compensate for a thinner diaphysis; this will be discussed in Chapter 4.  
Frequency (the number of occurrences of an event per unit of time), duration (the total 
amount of time for which the event is undertaken), and intensity (how much work, as a 
percentage of the maximum heart rate, is achieved during the event) will affect bone 
strength.  If frequency, duration and intensity are too high, bone remodelling will not be 
able to adapt sufficiently rapidly to such increased loading and fatigue fractures will 
occur (Frankel and Nordin, 2001).  Weightlifting is a good example of an activity that 
subjects the skeleton to compression, bending and combined loading.  In contrast, 
marathon runners improve muscle strength and cardiovascular ability, but bone strength 
remains more or less unaffected because of the different type of load (intermittent and 
less intense than weight-lifting) that running places on the skeleton (Schoenau and Frost, 
2002). 
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Figure 2.8: Examples of metaphyseal design.  (A) represents a load being placed on a bone.  (B) 
represents a bone with only a thin cortical shell for support, and when this design undergoes loading 
(C), there are large bone deformations.  (D) represents a metaphysis with a thick cortical shell to 
prevent large deformations, but when this undergoes loading (E), it produces high local stress on 
impact, which could damage the articular cartilage.  (F) represents a metaphysis with a thin cortical 
shell and a network of trabeculae.  When this design undergoes loading (G), only small 
deformations occur because the impact is absorbed by the trabecular network.  Adapted from 
Curry, 2002).   
   
 
2.12 Distal Radial Fractures 
Fractures of the distal forearm are the most common fracture site in children (Cooper et 
al., 2004, Landin, 1983).  Risk factors for fracture in children and adolescents include 
chronic illness, early age of first fracture, endocrine disorders, e.g. Growth Hormone 
Deficiency (GHD), family history of fractures, genetic disorders e.g. OI, high intake of 
carbonated drinks, poor overall nutrition with particular emphasis on low calcium, 
Vitamin D and protein intake, low birth weight, low BMD and/or BMC levels, low 
levels of physical activity, intake of bone thinning medications e.g. corticosteroids, 
being overweight or obese and smoking (Goulding, 2007).  However, most children 
presenting with distal forearm fractures are healthy with very few children taking bone-
thinning medications such as glucocorticoids, having chronic illness, or being diagnosed 
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with endocrine/genetic disorders (Goulding, 2007).  Why then do apparently healthy 
children have such a high incidence of fracture around the age of puberty?  One pQCT 
study found that in the metaphysis of younger subjects, although there was an increase in 
total BMD, there was a much greater increase in cross-sectional area (CSA), leading to 
an overall decrease in BMC (Rauch et al., 2001b).  Therefore the radius was not able to 
widen sufficiently compared to the rapid longitudinal growth.  Ferrari and colleagues did 
not find significant differences in the BMDa and BMAD levels between fracture and 
non-fracture groups but they did find lower BMC levels (Ferrari et al., 2006).  Numerous 
other DXA studies have found lower BMC and BMD levels in fracture groups (Black et 
al., 2002, Davidson et al., 2003, Goulding et al., 1998, Goulding et al., 2000, Goulding 
et al., 2001, Goulding et al., 2003, Goulding et al., 2004, Jones et al., 2002, Rockell et 
al., 2005).  The increase in strength and mineralisation of the distal radius during growth 
is not as advanced as the increase in mechanical challenges caused by a fall and because 
the rate of endocortical apposition is already very high at that site, it appears that it 
cannot increase further to the levels necessary to keep bone strength adapted to 
mechanical requirements (Rauch et al., 2001a). 
 
2.13 Summary 
Bone functions as part of an adaptive system; bone is able to adapt to the strains or loads 
placed upon it.  Bone does this using a complex interconnected network of cells that are 
able to sense changes in conditions and deposit or resorb bone where required so that it 
has the optimum structure, density and mineral content for purpose.  Ossification, 
mineralisation, remodelling and muscle-loading all work together to achieve a normal 
morphology and are essential parts of the adaptation system.  These factors contribute to 
strain thresholds that allow bone to withstand forces that could cause fracture.  Strain 
thresholds are reduced during puberty at the distal radial metaphysis due to the growth 
spurt and osteoid not being able to mineralise at a rate fast enough to keep up with the 
growth rate.  The optimum morphology and density in a normal individual will be 
different for each person based on his/her daily activities, along with genetic, hormonal 
and nutritional factors, which are discussed in Chapter 4.   
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3.  Imaging and Quantitative Assessment of the Skeleton 
3.1  Introduction 
Bone can be quantitatively assessed in vivo using imaging techniques.  Clinically, the 
techniques available for measuring bone mineral in children are the same as those used 
in adults, but due to the reduced availability of normal values for children, selecting an 
imaging technique and interpreting the results (Petit et al., 2005) becomes more difficult.  
This is because growth is non-linear and children of the same age can have different 
levels of skeletal maturity.  Also, children of different ages, heights, weights and 
ethnicities cannot necessarily be compared to one another easily.  This situation is 
however, beginning to change with the publication of more paediatric reference data 
(Ward et al., 2007a, Ward et al., 2007b, Zemel et al., 2008).   
The beginning of this chapter discusses X-rays in terms of how they form an image and 
the differences between film-based and modern digital radiography systems.  
Subsequently, three imaging techniques will be discussed in terms of what they are, how 
they work and their use in paediatric studies.  First: radiogrammetry and digital X-ray 
radiogrammetry (DXR), second: peripheral quantitative computed tomography (pQCT) 
and third: dual energy X-ray absorptiometry (DXA).  Although not a means of acquiring 
images, an introduction to bone-ageing has also been included in the section on X-ray 
imaging due to its relevance to the current study and due to the necessity of having 
paediatric hand-radiographs in order to carry out a bone-age assessment. 
 
3.2  X-Rays and Radiographs 
3.2.1 Introduction to X-Rays and the Production of Radiographs 
X-rays are a form of high frequency electromagnetic ionising radiation with a range of 
0.01 to 10 nanometres in the electromagnetic spectrum.  X-ray imaging is a widely used 
technique that produces radiographs, which are created by passing X-rays through the 
body to a specially prepared film, or digital receptors, that capture the images.  Different 
tissues attenuate X-rays to different degrees.  Relevant topics include resolution, dose, 
contrast, how radiographs are produced and their use in bone-age assessment, which are 
discussed below.  Further discussion regarding the Photoelectric Effect, the Compton 
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Effect, attenuation co-efficients and X-ray production and detection are discussed in 
Appendix 2 (Section 12.2).   
 
3.2.2 How Radiographs Are Acquired  
There are two methods of acquiring a radiograph: using radiographic film or using 
digital detectors.  The radiographic film method consists of a base of transparent acetate, 
one or two coatings of emulsion and normally an intensifying screen.  The emulsion 
consists of small grains of silver bromide suspended in gelatin.  When the film is 
exposed to radiation, the silver grains are sensitised, forming a latent image.  The 
development process causes a darkening of the sensitised silver grains, which are 
retained and result in the opaque areas seen on a radiograph.  The silver grains that are 
unsensitised are removed, resulting in the transparent areas seen on a radiograph.  
Intensifying screens are used to enhance the resulting image because on its own, 
radiographic film only has a certain amount of sensitivity to X-rays.  These screens 
consist of a fluorescent material placed in proximity to the film.  When the screens are 
exposed to radiation, they interact with the fluorescent material, which then emit 
photons of visible light.  The visible light photons then interact with the emulsion and 
expose the film.  Films are kept in sealed cassettes to prevent accidental exposure to 
ambient light, and are developed in a dark room.   
In digital radiography, the latent X-ray image is captured on an image plate.  An image 
plate contains a screen that consists of phosphor crystals embedded in a binding agent 
and mounted on an underlying layer of plastic (Cowen, 2007).  The most common 
phosphor material is “…barium fluorohalide activated with divalent europium ions 
(BaFX:Eu2+ where X typically represents bromine and iodine atoms)” (Cowen, 2007).  
The image plate is housed in a lightproof container or cassette.  When exposed to X-
rays, the image plate releases electrons.  Over time, the electrons would return to 
ground-state and release light photons.  However that process, if left to occur naturally, 
would take several hours and cause the image to decay.  Instead the image plate and 
cassette are fed into a computed radiography image reader.  Inside the reader, the image 
plate is passed through a laser scanning bed and is exposed to red laser light from a 
solid-state laser diode.  Exposure to the red laser light causes the electrons to return to 
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ground-state and the subsequent release of light photons, referred to as laser-stimulated 
phosphorescence.  The emitted light photons are transported to a high-sensitivity photo-
multiplier tube where they are converted to an electronic current, which is then 
amplified, filtered, and digitised using an analogue to digital converter.  The resulting 
images can then be accessed and viewed using the Picture Archiving and 
Communication System (PACS), which is currently replacing plain film radiography 
(Wiley, 2005).  The image plates themselves are re-usable and can pass through several 
thousand cycles (Cowen, 2007). 
 
3.2.3 Resolution, Dose and Contrast 
In plain film radiography, an advantage of the film-screen method is its high sensitivity, 
which allows radiographic images to be obtained using a very low dose of radiation 
(Kane, 2005).  For example, the Effective Dose Equivalent in the University of 
Manchester Department of Clinical Radiology for a hand radiograph is 0.00017 mSv 
(Ashby, 2007).  A disadvantage of the method is that the high level of spatial resolution 
(approximately 0.02 mm) that can be achieved using the film only method, is lost in the 
film-screen method due to visible photons fanning out when they interact with the film, 
causing the spatial resolution to be reduced to approximately 0.1 mm (Kane, 2005).  The 
contrast of a radiographic image is dependant on many factors including tissue 
attenuation, electron scatter, as well as the recording, processing and displaying 
processes.  This is important to bone-age assessment and measurement of the MI.  If 
blurring of bone detail occurs, an incorrect bone-age might be determined.  If blurring of 
the bone-edge occurs, it can be difficult to accurately measure the GPW and MW, 
therefore giving rise to an incorrect MI.  
   
3.3  Radiogrammetry & Digital X-Ray Radiogrammetry (DXR) 
Radiogrammetry utilises radiographs and is a technique in which the dimensions of 
bones were originally measured with the aid of callipers and a light box.  Virtama and 
Mahonen (Virtama and Mahonen, 1960), and Barnett and Nordin (Barnett and Nordin, 
1960) were the first to use hand radiographs to assess cortical bone width as a criterion 
for bone strength, i.e. if the cortex of a bone thined over time, this would indicate bone 
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loss, and bone strength would subsequently be affected.  Although this technique was 
inexpensive and widely used, it had limited reproducibility (coefficient of variation (CV) 
~10%), requiring longitudinal studies to extend over longer periods (Adams et al., 
1969).  With the advent of other densitometry techniques, such as single energy X-ray 
absorptiometry (SXA) and dual energy X-ray absorptiometry (DXA), radiogrammetry 
was not widely used for many years (Black et al., 2001).  This change was due to the 
ability of DXA especially, to calculate bone mineral content, fat content and muscle 
content without requiring body-part thickness.  Once radiographs became digitised 
however, specialised computer software was able to automatically detect bone and 
quantify bone mineral density and cortical thickness.  An example of this is the Sectra 
Pronosco system (Linköping, Sweden) for evaluating cortical bone thickness in the 
second, third and fourth metacarpals, and also the radius and ulna (Black et al., 2001) 
with improved precision compared to manual radiogrammetry (Ward et al., 2007a).  
Computer-aided radiogrammetry is often referred to as digital X-ray radiogrammetry 
(DXR).  DXR measurements can also be used to help determine whether bone loss is 
due to a decrease of periosteal surface apposition and/or an increase in endosteal 
resorption (Shore and Poznanski, 1999).  While measurements such as these cannot 
diagnose a specific disease, any abnormalities detected can then be assessed by other 
methods.  Radiographs of the hand/wrist have an additional advantage that they are often 
the first diagnostic test taken, in both children and adults, to assess trauma of the 
hand/wrist in a suspected fracture and for bone-ageing purposes.  Another advantage in 
using hand radiographs is the small absorbed radiation dose received, <1μSv (Huda and 
Gkanatsios, 1998).  Even if several radiographs are taken, the dose is unlikely to exceed 
10μSv (Tothill, 1989).  With appropriate computer software, DXR can also measure 
cortical porosity (Nielsen, 2001).  The clustering of osteons can subsequently create 
Haversian canals with excessively large diameters leading to reduced bone strength.  
This has been reported as a possible cause of femoral neck fracture together with cortical 
thinning (Bell et al., 1999, Jordan et al., 2000).  A disadvantage of radiogrammetry is 
that it does not quantify trabecular bone (Shore and Poznanski, 1999). 
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3.4  Bone-Age Assessment 
Bone-age assessment encompasses several methods of determining skeletal maturity.  
Paediatric endocrinologists use bone-age to determine whether skeletal maturity is 
occurring at the same rate as the chronological ageing process and how far apart the 
bone-age is from the chronological age.  It is not unusual for there to be a slight 
difference in the two ages because the ageing process will be different in each 
individual.  However, if there is more than a 2 year difference, further investigation may 
be warranted (Mughal, personal communication).  This is important as extremely 
delayed or advanced bone-age in comparison to chronological age can be a sign of an 
endocrine disorder or genetic disease (Gilsanz and Ratib, 2005). 
There are three well known bone-age assessment methods: Tanner-Whitehouse I, II and 
III (Tanner et al., 1962, Tanner et al., 1983, Tanner et al., 2001), Greulich-Pyle 
(Greulich and Pyle, 1950, Greulich and Pyle, 1959) and the Fels (Roche et al., 1988).  
There is also a relatively new method called the Gilsanz-Ratib method (Gilsanz and 
Ratib, 2005).  All of these methods use hand radiographs to estimate bone-age (which 
may differ from chronological age) and compare with controls of the same chronological 
age.  The bones used in all of these methods include the distal radius and ulna, the 
carpals, metacarpals and phalanges (Fig. 3.1).  As bone-age assessment involves 
comparing skeletal age with chronological age, any of the above methods could help to 
identify whether children are growing and developing normally.  The advantage of the 
Greulich and Pyle (GP) method is that it takes relatively little time in comparison with 
the Fels method, as the GP method requires comparing one whole hand radiograph with 
those in an atlas of hand radiographs of American Caucasian males and females ranging 
in age from birth to middle age (Greulich and Pyle, 1959).  The Fels method is 
computer-assisted and uses 98 statistically weighted age and sex-specific maturity 
markers of the hand and wrist, to obtain an overall bone age assessment (Roche et al., 
1988).  This is a very time consuming process, which involves taking numerous 
measurements.  The Tanner-Whitehouse 3 (TW3) method is the most recent 
development, leading on from the original TW1 and subsequent TW2 methods.  In the 
original method, the bones of the hand and wrist were given ratings with a numerical 
score.   All the scores were summed to give a final score that related to a specific age or  
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Figure 3.1: Paediatric left hand radiograph illustrating the groups of bones used in TW3 bone-
ageing.  The RUS group is shown in red and the CAR group is shown in black/white.  Note the 
epiphyses of the bones in the RUS group have not fused; their sizes, shapes and degree of fusion to 
the diaphysis is a large part of bone-age assessment using any method. 
 
 
age range.  In the TW2 and TW3 methods, new reference data were added and slight 
changes in the scoring methods took place.  Also in the TW3, instead of having a single 
score relating to a single age, the radius, ulna and short bones (RUS) and the carpal 
bones (CAR) each have separate scores.  Therefore, an age range is the more common 
outcome in the TW3 method rather than a single age.  The TW methods are more 
involved than the GP method, but not as time consuming as the Fels method.  TW3 also 
has the advantage that it was based on a population from Britain, which has been 
updated from the original TW1 to include more modern population data from a more 
ethnically diverse background, whereas the Fels method is based on an American 
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Caucasian population gathered over several decades beginning in the 1930’s.  There 
remains a question as to whether the Fels method can be used successfully outside of 
America on a more ethnically diverse and modern population.  TW3 has another 
advantage in that separate RUS and CAR scores can be useful because the carpal bones 
often mature earlier than the RUS bones.  There is also evidence that the TW method is 
more reliable than the GP method (Dhar et al., 1993) and that RUS scores correlated 
more closely with radiograph standards (Wenzel et al., 1984), which is important to the 
methodology of the current study (see Chapter 5.4.8).  
 
3.5  Peripheral Quantitative Computed Tomography (pQCT) 
A pQCT system like the XCT-2000 (Stratec, Pforzheim, Germany) contains hardware 
that is controlled by specialist computer software and, in a clinical setting, is operated by 
a radiographer trained in its operation.  It uses an older CT technology of rotate/translate 
radiation beam and detectors to acquire images in x degree segments and back-projects 
to make a whole 360 degree representation of the bone.  Slices are usually 1-2 mm thick 
with a voxel size (resolution) of 0.4mm and take approximately one minute to acquire.  
The newer conventional spiral body CT scanners use more recent CT technology 
(multiple detectors and continuous spiral rotation of the X-ray tube) to acquire 3 
dimensional volume images extremely rapidly, i.e. whole torso in approximately 20 
seconds.  Both pQCT and central Quantitative Computed Tomography, (QCT) have the 
unique advantage of being able to quantify separately cancellous bone and cortical bone 
compartments and can also be used to examine bone size and geometry.  Volumetric 
bone mineral density (BMD g/cm3) is less influenced by bone size (Gilsanz, 1998) than 
a 2-dimensional technique showing areal BMD (BMDa g/cm2) such as DXA.  pQCT has 
more of an advantage over central QCT due to a lower radiation dose to the patient, as 
only the appendicular skeleton is irradiated (Gordon, 2004, Njeh, 2004, Ward et al., 
2007a).  Muller and colleagues estimated the radiation dose for peripheral scans at 0.1 
µSv (Muller et al., 1989).  Because pQCT can measure BMD and bone geometry, this 
allows the determination of other information such as the polar strength strain index 
(pSSI) (Ward et al., 2007a), which describes the strength of a bone in terms of bending 
and torsion and is calculated using the section modulus (the resistance of a bone to 
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stress) and the volumetric cortical BMD (Schiessl et al., 1996).  The axial moment of 
inertia, which is a measure of the distribution of cortical bone mass around the centre of 
a cross-section of a tubular-shaped bone, can also be produced by pQCT (Quick et al., 
2006).  Furthermore, pQCT can be used to examine the cross-sectional area of muscle 
and therefore be used to examine whether bones have adapted well to the amount of 
muscle present, i.e. to mechanical loading (Ward et al., 2007a) in terms of the muscle-
bone unit (Schoenau, 2005).  Figure 3.2  illustrates a  pQCT  scanogram from which an  
 
 
Figure 3.2: Illustration of a pQCT scanogram of the distal radius and ulna.  
 
    
Figure 3.3: Illustration of a pQCT slice through the distal radius and ulna (left) and a close-up of 
the distal radius (right).  The left image illustrates muscle and lean tissue (light grey), intramuscular 
and subcutaneous fat (dark grey), trabecular bone (red), and cortical bone (bluish white).  The 
close-up image on the right illustrates the threshold used to analyse radial trabecular bone only. 
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image of the distal radius is obtained.  From this scanogram, a reference line for 
scanning is determined; the forearm length is measured using a tape measure from the 
olecranon to the ulnar styloid process and then axial sections are measured at selected 
percentages of the forearm length, i.e. 4% distal and 50% midshaft.  Figure 3.3 shows a 
slice through the distal radius and ulna.  It should be noted that the section of the radius 
scanned for the 4% site is not the same in adults (diaphysis and epiphysis fused) as it is 
in children (growth plate and epiphysis unfused): the 4% site of the latter will be slightly 
more proximal, as the upper reference line is placed at the most distal part of the growth 
plate, while in an adult, the reference line will be adjacent to the articular cartilage (Neu 
et al., 2001a).  pQCT has been used in human studies of adults (Guglielmi et al., 2000, 
Murray et al., 2006, Nara-Ashizawa et al., 2002, Roldan et al., 2001, Rauch et al., 
2001c), children (Dyson et al., 1997, Leonard et al., 2004, MacDonald et al., 2006, 
Moyer-Mileur et al., 2001, Wang et al., 2005, Ward et al., 2005b) and combinations of 
adults and children (Neu et al., 2001a, Neu et al., 2001b, Rauch et al., 2001a, Rauch and 
Schoenau, 2005, Rauch et al., 2001b, Schoenau et al., 2002b).  In addition, studies have 
been performed in animals such as rats (Breen et al., 1996, Ferretti et al., 1995), mice 
(Jamsa et al., 1998) and goats (Siu et al., 2003).  These studies have used pQCT to 
examine attributes such as BMD, SSI, cross-sectional moment of inertia (CSMI), which 
is defined as a measure of mass distribution or area of known density, with respect to a 
given point or axis (Brianza et al., 2006).  CSMI is a measure of bone rigidity, cross-
sectional bone area (CSA), cross-sectional muscle area (CSMA), and bone strength 
index (BSI), which is defined as cortical BMD x CSMI (Ferretti, 1995).  pQCT scans are 
performed using a specific threshold.  The threshold refers to a mode that separates and 
disregards all voxels that register below the specified density.  For example, in the case 
of cortical bone, a higher threshold is able to disregard the lower densities of trabecular 
bone, marrow, fat and muscle.  The main advantages of using this technique on both 
humans and animals are the abilities to assess bone geometry and to differentiate 
between cortical and trabecular compartments.  
There remains a question of adequate precision in terms of locating and reproducing the 
same regions of interest between institutions with different equipment and operators 
(Grampp et al., 1995) and the added disadvantage of scan times taking several minutes, 
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making this technique useful only for those who are able to remain still for the duration 
of the scan(s) (Ward et al., 2007a). 
 
3.6 Dual Energy X-Ray Absorptiometry (DXA) 
DXA was originally referred to as Quantitative Digital Radiography when one of the 
original DXA machines (the Hologic model QDR-1000) was first described (Kelly et al., 
1988).  Like pQCT, DXA scans are performed by trained technicians, usually a 
radiographer.  DXA acquires images using beams of two X-ray energies to differentiate 
bone from soft tissues, hence the name ‘dual energy’.  Various tissues in the body 
attenuate these energy beams to different degrees.  Bone, muscle and fat are attenuated 
by high energy photons; muscle and fat are attenuated by low energy photons.  BMC is 
calculated by defining the pixels of bone and multiplying this by the total area of these 
pixels.  Figure 3.4 illustrates how tissues attenuate the beams of energy and how BMC is 
calculated.  
DXA enables measurements of BMD not only at specific sites (i.e. lumbar spine L1-L4, 
proximal femur, femoral neck and forearm), but also for regional sites (i.e. arms and 
legs) and the total body.  DXA also provides body composition parameters (i.e. lean 
muscle, BMC and fat mass) (Njeh and Shepherd, 2004).  An added advantage is that 
DXA can calculate these body composition parameters without requiring body-part 
thickness.  Other advantages include relatively fast scan times (1 minute or less), 
availability of paediatric reference data for > 5 year olds, good precision (CV of 
approximately 1%), and the low ionising radiation doses received (1-6 µSv) (Ward et al., 
2007a).  Depending on the site and also the brand of scanner used, the radiation dose 
will vary (Njeh, 2004).  DXA also has some disadvantages.  One study has shown that 
heterogeneous fat distribution in the soft tissues and bone marrow can affect the results, 
and depending on how the fat is distributed, it can erroneously either increase or 
decrease bone density (Hangartner and Johnston, 1990).  This problem can limit studies 
not only with obese, but also anorexic children (Gilsanz, 1998).    
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Figure 3.4: Bone profile, observed as the X-ray moves linearly across the patient, and the 
corresponding tissue density profiles, adapted from (Crabtree et al., 2007b). 
 
Another disadvantage is that DXA provides a measure of integral BMD and cannot 
distinguish between trabecular and cortical bone (Gilsanz, 1998).  DXA measures 
BMDa in g/cm2, which is a 2-dimensional area measurement of a 3-dimensional 
structure.  The depth of the bone is not taken into account making this measurement 
vulnerable to changes in size (Carter et al., 1992).  This can be a problem in paediatric 
studies (Horlick et al., 2004) in which the size of a bone is always changing and the 
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BMD would be erroneously low in small bones.  An advantage is the low ionising 
radiation doses received (1-6 µSv) (Ward et al., 2007a).  There are several methods used 
in an attempt to adjust for this problem, one of which is termed bone mineral apparent 
density (BMAD).  This involves dividing the BMC by the bone volume derived from its 
projected bone area using a 3-dimensional shape as a model for a bone, e.g. a cube as a 
model for a vertebra or a cylinder as a model for the femoral neck (Carter et al., 1992, 
Kroger et al., 1992).  Other methods include size adjusted BMC, the Molgaard method 
(Molgaard et al., 1997), correction using regression models (Prentice et al., 1994) and 
correction using lean tissue mass (Hagler et al., 2003, Schiessl et al., 1998).  There is 
currently no consensus as to which method is the best, and a comparison of these 
methods in children showed no significant difference in the abilities of each method to 
detect children with bone densities that were falsely reported as low using standard adult 
algorithms (Fewtrell et al., 2005).  It is likely that certain methods may be more or less 
appropriate to individual patients and research hypotheses, however the authors 
recommend the use of BMC adjusted for height and bone area, and BMAD because the 
calculations are easier to implement and the results are more straightforward to interpret 
(Fewtrell et al., 2005).  
Other limitations include software that has been specifically developed to help detect 
low density bone in young children and adults (Crabtree et al., 2007a).  Although this 
development in itself is advantageous, any results obtained using this software must be 
compared to reference data collected using the same type of software and scanner or the 
BMD will be artefactually over-estimated.  Scanners vary by manufacturer (Njeh and 
Shepherd, 2004), and although there have been attempts to adjust for this by publishing 
standardised reference data in adults (Zemel and Petit, 2007), studies involving children 
and adults must take this into account before comparing results from different scanners.  
There is also a lack of reference data for ethnic groups (Zemel and Petit, 2007).  People 
of Black African descent generally have larger and stronger bones than Caucasians but 
reference data exist mainly for Caucasians (Zemel and Petit, 2007). 
DXA is currently the most widely used bone densitometry method applied to children in 
clinical diagnosis (Adams and Shaw, 2004).  It has been used in original studies that 
examine levels of BMC and BMAD in children with relation to fractures (Bailey et al., 
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1996, Beck, 2003, Clark et al., 2006, Ferrari et al., 2006), and other fracture risk factors, 
which include reduced calcium intake, obesity or previous fracture (Goulding et al., 
1998, Goulding et al., 2000, Goulding et al., 2001, Goulding et al., 2005, Jones et al., 
2002).   
 
3.7 The Metaphyseal Index (MI) 
Metaphyseal inwaisting is a process of rapid reshaping and remodelling that occurs 
during growth.  Figure 3.5 illustrates the resorption/formation activities that occur.  
Endocortical drift and periosteal resorption drift serve to both expand the medullary 
cavity and move the constantly remodelling metaphysis towards its final length during 
the longitudinal growth of a long bone (Frost, 2004b).  One of the aims of this study is to 
quantify this process by performing a measurement of the distal radial metaphysis called 
the metaphyseal index (MI).  A research group based in Australia has recently published 
a paper detailing the measurement of the MI of the distal femur (Ward et al., 2005a).  
Their aim was to quantify the metaphyseal inwaisting process of the distal femur in 
children being treated with bisphosphonates, for localised disorders not directly affecting 
the distal  femur  metaphysis,  and  compare them to  a larger database  of  age-matched 
 
 
Figure 3.5: Resorption and formation during the growth of long bones, adapted from (Jee, 1983). 
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controls.  Their results show that all twenty children who were being treated with 
bisphosphonates for localised disorders experienced normal inwaisting of the distal 
femur when compared with normal controls (Ward et al., 2005a).  This was critical to 
their study as they were investigating whether bisphosphonates could be safely 
administered to children, and at appropriate doses, without disturbing bone growth and 
development.  Their efforts have also produced a reference range of normal values for 
the metaphyseal index of the distal femur of children between the ages of five and 
fifteen (Ward et al., 2005a).  They state specifically that although they “…chose to study 
the femur, similar methodology could be applied to the distal radius once a normative 
database is known” (Ward et al., 2005a, p1002).  The main advantages in examining the 
distal radius are that it is the most common fracture site in children (Cooper et al., 2004, 
Landin, 1983) and hand radiographs are easily performed and taken regularly in children 
for a variety of reasons (i.e. bone-ageing), making it a good choice for study.  
Activity levels also have a significant effect on bones.  Young gymnasts have a much 
greater activity level and therefore a larger amount of repetitive stress placed on their 
bones compared to the average person.  There is evidence that the size, shape and 
density of bone can all be altered due to increased stresses (Haapasalo et al., 2000, 
Kontulainen et al., 2003, Pettersson et al., 2000, Ward et al., 2005b).  Certain diseases 
such as cerebral palsy (CP) can limit physical activity levels and this in turn has a 
detrimental effect on bone modelling/remodelling.  Studies have shown that increasing 
physical activity levels can aid in altering bone architecture, thereby reducing bone 
fragility (Ward et al., 2006).  
CP inhibits muscle function, making bone fragility a secondary consequence.  But other 
diseases such as OI (Land et al., 2006), hypophosphatemic rickets (Rauch, 2006), 
mucopolysaccharidosis (Field et al., 1994), neurofibromatosis (Gupta et al., 1985) as 
well as drugs/treatments (Ward et al., 2005a) can have a direct effect on bone 
architecture and remodelling in children, including that of the metaphysis.  Although 
some metaphyseal abnormalities will be obvious upon radiographic analysis (such as the 
popcorn metaphysis of an OI patient), this method is a way to quantify the results, 
therefore making it much easier to detect small changes and compare them 
longitudinally. 
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To this end, Land and colleagues (Land et al., 2006), have published a more recent study 
examining children with OI using the same technique.  Children with OI can often 
experience less physical activity than normal children due to the risk of fracture in even 
the simplest of everyday activities.  They found that pamidronate affects metaphyseal 
inwaisting by decreasing its speed, therefore resulting in an increased metaphyseal width 
(Land et al., 2006).  The difference in results between the Land and Ward studies may be 
due to the fact that bones with abnormal inwaisting may be more sensitive to the effects 
of bisphosphonates than bones with normal inwaisting levels, or because the dosage and 
amount of time over which treatment occurred was higher in the Land study; 9 
mg/kg/year over 2 or more years (Land et al., 2006) than in the Ward study, average 3.7 
mg/kg/year over a mean of 1.35 years (Ward et al., 2005a). 
 
3.8  Puberty and Tanner Pubertal Stages 
The Tanner Pubertal Stages are commonly used to assess the progression through 
adolescence and puberty for both males and females (Davison et al., 2003).  The system 
rates, over five stages, the development of genitalia and pubic hair in males and pubic 
hair and breast development in females (Tanner, 1962).   Tables 3.1 and 3.2 define these 
stages.  Adolescents are often asked to rate themselves, or self-report, using the Tanner 
stages for their sex.  Black and white drawings of the stages of genital, breast and pubic 
hair development for females, or genital and pubic hair development combined with an   
orchidometer (a string of 12 wooden beads approximating the size, shape and volume of 
the testes) for males are used.  The sheets used for self-assessment can be seen in 
Appendix 12.3.  It is important to note that there will always be a certain amount of error 
in every self-reporting system, however self-assessment is often preferable to being 
examined by a study investigator (Duke et al., 1980). 
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Table 3.1: Descriptions of Tanner Stages for Males 
Stage 1 Pre-adolescent.  Testes, scrotum and penis are about the same size and 
proportion as early childhood.  The vellus over the pubes is not further 
developed than that over the abdominal wall, i.e. no pubic hair. 
Stage 2 Enlargement of scrotum and of testes.  The skin of the scrotum reddens and 
changes in texture.  Little or no enlargement of the penis at this stage.  
Sparse growth of long, slightly pigmented downy hair, straight or only 
slightly curled, appearing chiefly at the base of the penis. 
Stage 3 Enlargement of penis, which occurs at first mainly in length.  Further growth 
of testes and scrotum.  Pubic hair is considerably darker, coarser and more 
curled.  The hair spreads sparsely over the pubes.  
Stage 4 Increased size of penis with growth in breadth and development of glands.  
Further enlargement of testes and scrotum; increased darkening of scrotal 
skin.  Hair now resembles adult in type, but the area covered by it is still 
considerably smaller than in the adult.  No spread to the medial surface of 
the thighs. 
Stage 5 Genitalia adult in size and shape.  No further enlargement takes place after 
stage 5 is reached.  Pubic hair is adult in quantity and type with distribution 
of the horizontal pattern.  Spread to medial surface of thighs but not up linea 
alba or elsewhere above the base of the inverse triangle.  
 
Table 3.1: Tanner Stage descriptions of male genital and pubic hair development (Tanner, 1962). 
 
Table 3.2: Descriptions of Tanner Stages for Females 
Stage 1 Pre-adolescent: elevation of papilla only.  The vellus over the pubes is not 
further developed than that over the abdominal wall, i.e. no pubic hair.   
Stage 2 Breast bud stage: elevation of breast and papilla as small mound.  
Enlargement of areolar diameter.  Sparse growth of long, slightly 
pigmented downy hair, straight or only slightly curled, appearing chiefly 
along the labia.   
Stage 3 Further enlargement and elevation of breast and areola, with separation of 
their contours.  Pubic hair is considerably darker, coarser and more 
curled.  The hair spreads sparsely over the pubes.      
Stage 4 Projection of areola and papilla to form a secondary mound above the 
level of the breast.  Hair now resembles adult in type, but the area covered 
by it is still considerably smaller than in the adult.  No spread to the 
medial surface of the thighs.   
Stage 5 Mature stage: projection of papilla only, due to recession of the areola to 
the general contour of the breast.  Pubic hair is adult in quantity and type 
with distribution of the horizontal pattern.  Spread to medial surface of 
thighs but not up linea alba or elsewhere above the base of the inverse 
triangle.    
 
Table 3.2: Tanner Stage descriptions of female breast and pubic hair development (Tanner, 1962). 
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Epiphyseal fusion occurs earlier in girls than in boys.  This is due to females being 
physically more mature at birth, in utero and throughout the growth period (Tanner, 
1962).  At birth, females are less than 1 month ahead of males, but by the mid-point 
between birth and puberty, females have increased their lead by several months, and by 
puberty the difference is approximately 2 years (Tanner, 1962).  Puberty and skeletal 
maturity are closely related.  In fact, puberty is much more related to skeletal maturation 
than it is to chronological age (Tanner, 1962).  In normal circumstances, children who 
reach maturity faster and begin puberty earlier are often shorter in stature than those who 
mature at a slower rate (Tanner, 1962).  This is because sex-steroids or hormones, which 
play an essential role in puberty, also play an essential role in determining the timing of 
the cessation of bone growth, e.g. epiphyseal fusion (Perry et al., 2008).  This then leads 
back to hormonal actions on the normal growth plate and hormonal disorders discussed 
in Chapter 4. 
 
3.9  Summary 
All of the imaging and assessment techniques discussed here are essential for the study 
of paediatric skeletal and other conditions, both in terms of research and for clinical 
diagnoses.  Radiographs are a front-line imaging technique that can be performed in 
seconds and doses incurred on peripheral imaging are often less than those incurred on 
overseas air travel.  DXA and pQCT require more scan time and more complex 
equipment, but they can both provide invaluable quantitative information such as muscle 
and fat content, as well as bone density and area respectively.  Bone-ageing using 
paediatric hand radiographs are essential for diagnosis of endocrine disorders such as 
Constitutional Delay of Growth and Puberty (CDGP), and along with Tanner Pubertal 
Stages, can provide information on whether children are growing and developing 
properly. 
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4. Factors Affecting the Growth Plate 
4.1 Introduction 
Longitudinal bone growth is a dynamic process, which is prone to disturbance by a 
number of factors.  These factors include genetic mutations, hormonal disorders, 
nutritional deficiencies or excesses and biomechanical forces.  The following section 
will focus on molecular and hormonal actions on bone, followed by a section on how 
disorders in these mechanisms affect bone and, if applicable, how the MI might be 
altered. 
 
4.2 Genetic and Hormonal Actions in a Normal Growth Plate 
For longitudinal bone growth to occur, the cells of the growth plate must differentiate 
and form correctly.  Two genetic factors play a large part in this process; transcription 
factors and signalling molecules.   
Transcription factors (also known as sequence-specific DNA binding factors) are 
proteins that bind to specific parts of DNA through binding domains and are also part of 
the system that controls the transcription of genetic information from DNA to RNA.  
Transcription factors perform their functions alone or by recruiting other proteins by 
increasing (activating) or preventing (repressing) the presence of RNA polymerase, 
which is the enzyme that activates transcription from DNA to RNA (Latchman, 1997).   
One of the more important transcription factors involved in chondrocyte cell 
differentiation in the growth plate is sex reversal Y-related high-mobility group box 
protein 9 (Sox9).  Sox9 is required for the transformation of mesenchymal cells into 
chondrocytes, proliferation of chondrocytes, suppression of premature transformation of 
chondrocytes into hypertrophic chondrocytes, and is responsible for direct regulation of 
the important genes involved in chondrocyte function (de Crombrugghe et al., 2000, 
Kobayashi and Kronenberg, 2005), like Collagen II alpha1 (Col2a1) (Lefebvre et al., 
1997), Collagen XI alpha2 (Col11a2) (Bridgewater et al., 1998), Aggrecan 1 (Agc1) 
(Sekiya et al., 2000), and cartilage-derived retinoic acid-sensitive protein (CD-RAP) 
(Xie et al., 1999).  Related transcription factors L-Sox5 and Sox6 are important in the 
commitment and maintenance of chondrocyte phenotypes (Kobayashi and Kronenberg, 
2005).   
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Runt-related transcription factors 2 and 3 (Runx2/Runx3) play important roles in 
chondrocyte maturation from columnar chondrocytes into hypertrophic chondrocytes 
(Kobayashi and Kronenberg, 2005).  Experiments using mice show that mice lacking 
Runx2 do not have hypertrophic chondrocytes (Inada et al., 1999) and mice lacking both 
Runx2 and Runx3 are missing chondrocytes altogether (Yoshida et al., 2004).  Runx2 
also plays a role in mesenchymal differentiation into pre-osteoblasts (Kobayashi and 
Kronenberg, 2005).   
Osterix (Osx) is a transcription factor that is necessary for osteoblast differentiation 
during both endochondral and intramembranous ossification (Kobayashi and 
Kronenberg, 2005).  Osx acts with the Beta-catenin/T-cell factor/lymphoid enhancer-
binding factor (B-catenin/TCF/LEF) complex aiding pre-osteoblast conversion into 
osteoblasts as well as working with the aforementioned L-Sox5 and Sox6 in chondrocyte 
differentiation (Kobayashi and Kronenberg, 2005).   
Signaling molecules are involved in transmitting information from one cell to another.  
They are released from the cell that is sending the signal, cross between cells, then 
interact with receptors in other cells, which triggers a response.  Important signaling 
molecules include bone morphogenetic proteins (BMP’s), fibroblast growth factors 
(FGF’s), insulin-like growth factor 1 (IGF1), Indian hedgehog (Ihh), and parathyroid 
hormone-related peptide (PTHrP) (de Crombrugghe et al., 2000).  “These secreted 
peptides exert their effects by triggering intracellular signaling pathways and their action 
is likely to be controlled at several levels both extra- and intra-cellularly” (de 
Crombrugghe et al., 2000).  BMP signaling is likely to be required for three stages of 
chondrocyte differentiation; mesenchymal cell to pre-chondrogenic cell, pre-
chondrogenic cell to early chondrocyte and columnar chondrocyte to hypertrophic 
chondrocyte (Kobayashi and Kronenberg, 2005).  FGF signaling plays a part in the 
former two stages, while PTHrP plays a part in the latter stage (Kobayashi and 
Kronenberg, 2005).  FGF’s also increase the expression of Sox9 both in undifferentiated 
mesenchymal cells and chondrocytes, which further aids the differentiation process (de 
Crombrugghe et al., 2000).  Growth hormone (GH), which promotes the synthesis of 
IGF-1 (Venken et al., 2005), and both have critical roles in skeletal growth and 
maturation. Both GH and IGF-1 stimulate the proliferation of chondrocytes and increase 
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serum markers for bone turnover (Sjogren et al., 2002).  Long-term treatment with GH 
has been shown to increase BMDa (Johannsson et al., 1996), and IGF-1 has been shown 
to increase BMD in both mice (Yakar et al., 2002) and human studies (BMDa) (Langlois 
et al., 1998).   
The Hedgehog proteins are a family of secreted intercellular signaling proteins that play 
essential roles in early embryonic patterning of major organs, including bone and many 
other tissues.  Of the three hedgehog proteins that have been identified in mammals, Ihh, 
along with PTHrP, form a negative feedback loop that controls the proliferation and 
hypertrophy of chondrocytes, with Ihh controlling the width of the proliferative zone 
along with proliferation and PTHrP controlling the rate of hypertrophy (van Donkelaar 
and Huiskes, 2007).  Ihh signaling occurs during the conversion of early chondrocytes to 
columnar chondrocytes and mesenchymal cell conversion to pre-osteoblasts (Kobayashi 
and Kronenberg, 2005).  
Parathyroid Hormone (PTH) aids longitudinal bone growth.  One study found that PTH 
administration in rats increased total growth plate thickness and increased the rate of 
longitudinal bone growth by increasing the rate of cell production (Ogawa et al., 2002).  
When serum calcium levels are too low, the parathyroid glands can produce too much 
PTH, which results in secondary hyperparathyroidism.   This causes osteoclastic bone 
re-absorption to increase the level of serum calcium and causes more calcium to be re-
absorbed in the kidneys and intestines.     
The sex steroids androgen and oestrogen play an important role in longitudinal bone 
growth, particularly at puberty.  Oestrogen promotes the pubertal growth spurt and 
subsequent growth plate fusion to the epiphyses (Perry et al., 2008).  This is 
accomplished by oestrogen’s ability to affect GH secretions (Venken et al., 2005).  GH 
secretions are mediated via oestrogen receptors alpha (ER-α) and beta (ER-β), which are 
expressed in the hypothalamus and anterior pituitary gland (Perry et al., 2008).  
Androgens can be placed into two categories: aromatised and non-aromatised, referring 
to the stability of the ring structure of the compound.  The non-aromatised androgens, 
which include dihydrotestosterone and oxandrolone, stimulate bone growth possibly by 
acting directly with the androgen receptor in growth plate cartilage (Vanderschueren et 
al., 2004).  One study showed that dihydrotestosterone regulates differentiation and 
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proliferation of cultured human epiphyseal chondrocytes, most likely by increasing the 
expression of IGF-I receptor and promoting local IGF-I synthesis (Perry et al., 2008).  
Testosterone is also able to stimulate GH secretion when it is converted to oestrogen by 
aromatisation (Perry et al., 2008).   
Both sexes show an increase in BMD during puberty.  The rate of BMD increase in 
females in the lumbar spine and femoral neck is approximately 4-fold before puberty 
and then slows to the stage where BMD changes little thereafter, whereas in males, 
BMD increases approximately 6-fold during puberty with a slower rate of increase at 
other skeletal sites thereafter (Prentice et al., 2006).  As a result, males have a greater 
cortical thickness and a larger bone size after puberty than females, but BMD remains 
similar in both sexes (Prentice et al., 2006).     
 
 4.3 Genetic and Hormonal Disorders   
There are many possible mutations that can occur in the genes affecting the growth 
plate.  There are also many hormone imbalances that affect skeletal growth.  Therefore 
this thesis will concentrate only on a small number of the most relevant disorders that 
affect the metaphyses and can be found in children. 
 
4.3.1 Constitutional Delay of Growth and Puberty (CDGP) 
CDGP for a peripubertal child, and Constitutional Growth Delay (CGD), which is 
diagnosed pre-puberty, are 2 of the most common reasons for children, more often in 
boys, to be referred to a paediatric endocrinologist (Frank, 2003).  Symptoms of CDGP 
include the following: 
1. Short stature with a height below 2 standard deviations for chronological age. 
2. Growth rate below the 25th percentile for chronological age. 
3. Delayed bone-age. 
4. No indications of chronic illness, endocrine disorder or genetic disease. 
5. Onset of puberty at an age greater than 2 standard deviations above average (girls 
>13 years and boys > 14 years) (Frank, 2003). 
When natural puberty occurs in CDGP, both insulin-like growth factor (IGF-1) and GH 
levels increase normally, but final height is often still slightly below average (Frank, 
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2003).  Some CDGP children have been found to have below average levels of GH 
(Bierich and Potthoff, 1979, Clayton et al., 1988, Longas et al., 1996), but while 
treatment with GH can increase the child’s growth rate, it does not improve final height 
(Clayton et al., 1988, Longas et al., 1996).  In one study, the bone-age, rate of 
mineralisation and bone turnover markers such as AP of pre-pubertal children were 
shown to be similar to those in children with CDGP (Doneray and Orbak, 2008).  
Findings in the literature differ regarding whether BMD is altered in adult males with a 
previous history of CDGP.  Some studies have reported reduced radial and lumbar spine 
BMDa in adult males with a history CDGP (Finkelstein et al., 1992, Moreira-Andres et 
al., 1998), but because they used the DXA measurement areal BMD (BMDa), which is 
vulnerable to size bias (because it is a 2-dimensional estimate of a 3-dimensional 
measurement), the results of these studies should be viewed with scepticism.  However, 
Finkelstein and colleagues re-examined their original data using an algorithm to 
determine BMAD, and stated that their original results remained significant (Finkelstein 
et al., 1999).  This is not in agreement with the findings of Bertelloni and colleagues 
who also used BMAD but found that although BMDa was reduced, BMAD was normal 
(Bertelloni et al., 1998).  The difference may be due to the use of different algorithms to 
calculate BMAD, and although QCT would provide more accurate measurements of 
BMD, the higher radiation exposure would be a concern (Bertelloni et al., 1999).  
Finkelstein and colleagues also compared radial width at the 65% site in both men with a 
history of CDGP and controls, and no significant difference was found (Finkelstein et 
al., 1992), though perhaps a width measurement (obtained from total cross-sectional 
area) as well as a BMD measurement using pQCT would have been informative.  In a 
follow-up study to the original, BMDa was measured at the femoral neck and was found 
to be lower in men with a history of CDGP, along with radial and spinal BMDa, 
suggesting that BMDa men with a history of CDGP fails to improve over time and that 
the appropriate timing of puberty is important for bone accrual, BMD levels and fracture 
risk later in life (Finkelstein et al., 1996, Saggese et al., 2001).   
There is nothing in the current literature detailing whether metaphyseal dysplasia in any 
long bone occurs as a result of CDGP, however with reduced mineralisation and BMD it 
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is conceivable that a degree of dysplasia may occur to compensate for loading under 
these conditions.   
 
 4.3.2 Neurofibromatosis Type I (NF1) 
NF1 is an autosomal dominant condition occurring in 1 out of every 3000 births (NIH, 
1988).  It is caused by a mutation in the neurofibromatosis gene located on chromosome 
17 that codes for the neurofibromin protein.  Neurofibromin is a negative regulator of 
RAS; RAS being an important protein subfamily of GTPases controlling intracellular 
signaling and regulation of cell growth and survival (Declue et al., 1992).  Specifically, 
neurofibromin limits cell growth and therefore represses tumour growth (Williams et al., 
2009).  Individuals who have no expression or only partially expressed neurofibromin, 
often exhibit multiple benign dermal tumours, or occasionally malignant peripheral 
nerve sheath tumours (Williams et al., 2009).  An individual is diagnosed with NF1 if 
they present with any 2 of the following features:  
1. Intertriginous freckling (freckles in areas of skin that rub together such as the 
armpit).   
2. Café-au-lait spots (small areas of skin that are light brown in colour; several 
usually clustered in one area). 
3. Neurofibromas (tumours of the nerve sheath, either cutaneous or subcutaneous, 
which are localised tumours affecting only one peripheral nerve, or plexiform, 
which can affect peripheral nerve bundles and more internal nerve bundles). 
4. Lisch nodules (small pigmented benign tumours, specifically hamartomas that 
project from the surface of the iris, but do not typically affect vision). 
5. Optic pathway gliomas (mainly benign tumours affecting the optic nerves, tracts, 
radiations, chiasm or hypothalamus, which collectively form the optic pathway). 
6. Skeletal abnormalities including osteopaenia, long-bone dysplasia and bowing, 
pseudoarthroses, sphenoid wing hypoplasia and fibrous cortical defects. 
7. An immediate family member with a diagnosis of NF1 (Williams et al., 2009). 
 
There are several reports of congenital pseudoarthrosis of the radius and radial dysplasia 
with confirmed or suspected NF1 (Kohler et al., 2005, Ramelli et al., 2001, Sprague and 
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Brown, 1974), but the tibia, fibula and vertebrae are significantly more common sites for 
this to occur (Alwan et al., 2007, Stevenson et al., 1999).  The radius is often shortened 
showing irregular development in these cases (Sprague and Brown, 1974).  It is 
noteworthy that tibiae, fibulae and vertebrae are all weight-bearing bones, but this does 
not explain the lack of lesions in other weight-bearing bones such as calcanei, tali and 
femora (Alwan et al., 2007).  It is possible that the dysplasia in particular is a result of 
neurofibromin-insufficient bone reacting to loading (Alwan et al., 2007).  This would 
not explain dysplasia in non weight-bearing bones, however the combination of irregular 
development including a reduction in chondrocyte proliferation and abnormal collagen 
synthesis, lesions and altered mineralisation (Yu et al., 2005) would explain why the 
growth plate would expand to compensate for these conditions. 
Figure 4.1 is a radiograph of a Caucasian male aged 8 months, exhibiting a congenital 
pseudoarthrosis of the radius (Sprague and Brown, 1974), which is possibly a case of 
NF1.  The father of this patient had NF1 and the patient also exhibited other effects such 
as café-au-lait spots.  This figure also illustrates the grossly expanded growth plate of the 
distal radius, which would result in an altered MI. 
 
4.3.3 Other Disorders   
Chondrodysplasias present with many indicators, some of which are metaphyseal 
defects. They include disorders such as achondroplasia (dwarfism), hypochondroplasia, 
thanatophoric dysplasia type I and II, and the more recently discovered disorder severe 
achondroplasia with developmental delay and acanthosis nigricans (SADDAN) 
dysplasia.  All of these conditions result from a mutation in the fibroblast growth factor 
receptor 3 gene (FGFR3) (Shiang et al., 1994, Tavormina et al., 1995, Bellus et al., 
1995, Tavormina et al., 1999).  FGFR3 mutations are extremely variable (Vajo et al., 
2000), as mutations located in different domains of the FGFR3 receptor can cause 
different phenotypes and various mutations in the same codon can also cause clinically 
distinct disorders. Therefore mutations in what is normally a lysine codon within   the   
cytoplasmic tyrosine kinase activation loop of FGFR3 can result in hypochondroplasia 
when the lysine residue is replaced by asparagine or glutamine, thanatophoric dysplasia 
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occurs when the lysine residue is replaced by glutamic acid or methionine and 
SADDAN when the lysine is replaced by methionine (Zelzer and Olsen, 2003). 
 
 
Figure 4.1: Possible case of NF1 in an 8 month old male with a congenital pseudoarthrosis of the 
distal radius.  Note the expanded radial metaphysis, which would cause a smaller MI than normal.  
Reproduced and adapted with permission and copyright © of the Journal of Bone and Joint 
Surgery (Sprague and Brown, 1974). 
 
Achondroplasia arises from a sporadic (as opposed to inherited) mutation in over 90% of 
affected individuals and is caused by a single nucleotide substitution in more than 95% 
of cases (Ballock and O'Keefe, 2003).  Symptoms include small body size with 
shortened limbs, bowed lower legs, frontal bossing, depressed nasal bridge and lordosis.  
Features of hypochondroplasia are similar to those of achondroplasia but tend to be 
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milder and include rhizomelia (a disproportion in the length of the proximal limbs).  The 
features of SADDAN are more severe and include structural abnormalities of the brain 
that can cause severe developmental delay, seizures and mental retardation. Acanthosis 
nigricans (AN) is a term which describes patches of dark, thick, velvet-like skin 
hyperpigmentation that appear in these patients, although AN can occur separately from 
SADDAN.  Patients with these conditions exhibit varying degrees of metaphyseal 
‘flaring’, therefore the MI may be in the normal range, or may be decreased due to 
expansion of the growth plate. 
The metaphyseal chondro-dysplasias (MCD) include disorders such as cartilage-hair 
hypoplasia (CHH), also known as McKusick type MCD, Schmid type MCD and Jansen 
type MCD0.  All of these conditions are characterised by metaphyseal changes evident 
on radiographs.  McKusick type MCD is the result of a mutation of the ribonuclease 
mitochondrial RNA processing (RMRP) gene, which is the RNA component of the 
RMRP ribonuclease complex (Ridanpaa et al., 2001).  The RMRP complex is involved 
in multiple cellular and mitochondrial processes, but the mechanism of impairment that 
causes the disease remains unknown (Ridanpaa et al., 2003).  Schmid type MCD is the 
result of a mutation of the collagen X gene, specifically the collagen 10 alpha-1 chain 
(COL10A1).  This affects the chondrocytes in the hypertrophic zone: histological 
examination of this area shows thickening and disorganisation (Ho et al., 2007).  Jansen 
type MCD is caused by a mutation in the receptor for PTH or PTHrP.  Genetic studies in 
mice confirm that the primary role of PTHrP is to control the transition between 
chondrocyte proliferation and differentiation (Ballock and O'Keefe, 2003).  Transgenic 
mice that lack either the PTH/PTHrP receptor or PTHrP itself demonstrate dwarfism, 
which results from accelerated differentiation and premature chondrocyte hypertrophy, 
whereas mice in which PTHrP is over-expressed in the growth plate exhibit a dwarfism 
that is due to a distinct slowing of chondrocyte differentiation (Ballock and O'Keefe, 
2003).   
The features of all three MCD’s include dwarfism and the characteristic flared 
metaphysis, but more specifically, the features of McKusick type MCD can also include 
an outward splaying of the lower ribcage, immunodeficiencies, Hirschprung’s disease, 
shortening of the tibia compared to the fibula, light-coloured brittle hair, and an 
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increased risk of developing certain cancers.  The features of Schmid type MCD are very 
similar to McKusick type MCD and can include an outward splaying of the lower 
ribcage, leg pain, bowed legs and hip deformities.  The features of Jansen type MCD are 
the most severe and can include stiffening and swelling of the joints, facial and skull 
deformities that can result in blindness or deafness, benign bone masses, clubbed fingers 
and mental retardation.  Patients with an MCD are far more likely to have a decreased 
MI as metaphyseal flaring is the primary feature of MCD’s.  There is also a group of 
disorders known as the spondylometaphyseal dysplasias (SMD). This group however 
will not be discussed in depth because of the similarities to the MCD’s.  The SMD’s 
have vertebral deformities that can result in scoliosis and/or kyphosis in addition to 
many of the symptoms of MCD’s.   
The following two disorders are characterised by excessive bone formation and can 
result in severe deformities; they are Osteoectasia with Hyperphosphatasia (OwH), 
sometimes referred to as Juvenile Paget’s Disease, and Braun-Tinschert type MCD.  
The latter presents with significantly different radiographic findings than other MCD’s 
and has a similar phenotype to OwH, which is why the Nosology Group of the 
International Skeletal Dysplasia Society have grouped these (among several others) 
disorders together (Superti-Furga et al., 2007).  Braun-Tinschert type MCD was first 
described by Braun and colleagues after studying a German family who exhibited 
expanded metaphyses (without a widened growth plate) due to undermodelling known 
as the Erlenmeyer flask deformity, bowing of the distal radii (often sickle-shaped) 
combined with shortening of the ulnae, flat exostoses in the metaphyses, thin cortices 
and trabecular irregularities (Braun et al., 2001).  Braun and colleagues have done 
extensive genetic testing in an attempt to localise the gene responsible but have not as 
yet been successful, although they have determined that it is an autosomal dominant 
condition, which distinguishes it from the autosomal recessive Pyle’s Disease  (Braun et 
al., 2001).  Until recently this disease had only been observed in Braun’s German cohort, 
but has now been observed in a young Japanese girl, indicating that the disease is not 
restricted to the German population (Takata et al., 2006).  Figure 4.2 illustrates the 
expanded distal radial metaphyses seen in this case (Takata et al., 2006).  The MI in this 
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group would be larger compared to normal as the GPW would not be significantly larger 
than the MW.   
OwH is an inherited autosomal recessive disorder caused by a mutation in the gene that 
encodes for osteoprotegerin (OPG).  OPG is a receptor that is released from osteoblasts 
and pre-osteoblasts to suppress bone resorption (Whyte et al., 2007).  Features of 
hyperphosphatasia include raised serum AP due to increased osteoclastic activity, 
cortical thickening leading to hearing and vision loss, and muscular weakness (Cundy et 
al., 2002).  Osteoectasia refers to the bowing of long bones (Osman and Girdany, 1973).   
 
 
Figure 4.2: Radiograph of a 7 year-old Japanese girl exhibiting the expanded distal radial 
metaphyses characteristic of Braun-Tinschert type MD.  Reproduced and adapted with permission 
and copyright © of the American Journal of Medical Genetics Part A (Takata et al., 2006). 
 
Radiographically, the phalangeal joints are expanded and the trabeculae are thickened 
and distorted.  Although this disease is sometimes referred to as Juvenile Paget’s disease 
(JPD), JPD refers to hyperphosphatasia only.  Juvenile Paget’s is not to be confused with 
Paget’s disease; Paget’s is a metabolic disease resulting in lytic and sclerotic regions 
often affecting many bones of the skeleton (Whitehouse, 2002).  It is caused by a 
mutation in the SQSTM1 gene encoding sequestosome-1 and always begins in middle 
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age (Whyte et al., 2007).  The MI of an OwH or hyperphosphatasia patient would be 
increased because there is reduced remodelling of the metaphyses. 
 
4.3.4 Hormonal Disorders 
Oestrogen promotes the pubertal growth spurt and subsequent epiphyseal fusion by its 
ability to affect GH secretions (Venken et al., 2005).  Precocious puberty results from a 
premature increase in sex steroid production, which leads to a reduced final height due 
to an early growth spurt and epiphyseal fusion (Smith et al., 1994).  A case of a 28 year 
old male with a homozygous mutation of ER-α resulted in continued longitudinal bone 
growth well beyond puberty (Smith et al., 1994).  The mutation resulted in the patient 
having higher than normal serum oestradiol concentrations, but the mutated gene 
contained no binding sites, which made treatment with oestrogen ineffective and only 
served to increase serum estradiol levels (Smith et al., 1994).  This patient had a delayed 
bone age of 15 years, osteoporosis, and an increased serum AP level indicating increased 
bone resorption (Smith et al., 1994).   
Androgens are also important sex steroids, as men who lack androgens often have 
osteoporosis (Foresta et al., 1984) and men who have had CDGP experience low bone 
density and an increased risk of fracture in adulthood (Finkelstein et al., 1992).  
Although the patient with ER-α knockout had normal serum androgen concentrations, 
androgens were not able to compensate for a lack of oestrogen, demonstrating that 
oestrogen has a vital role in normal pubertal growth and bone maturation in both males 
and females (Smith et al., 1994).  A lack of either androgens or oestrogen would not 
affect the MI directly.  The ratio would most likely be in the normal range because it is 
not the fundamental shape of the bone that is being altered, but the growth rates.  
GH deficiency (GHD) results in impaired longitudinal growth while an excess of GH 
results in gigantism (Nilsson et al., 2005).  By examining IGF-1 null mice, Wang and 
colleagues determined that IGF-1 has an impact on chondrocyte size in the hypertrophic 
zone of the metaphysis; mice who lacked IGF-1 still had the same number of 
chondrocytes and columns, the same chondrocyte proliferation rate and the same 
differentiation rate, and an equal proportion of cells in the hypertrophic and proliferative 
zones of the metaphysis (Wang et al., 1999).  Therefore the only feature of growth plate 
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expansion that was clearly disturbed was the extent of chondrocyte hypertrophy;  the 
degree of attenuation of chondrocyte hypertrophy corresponds to the degree of reduction 
in longitudinal growth (Wang et al., 1999).  As with androgen and oestrogen, an excess 
or deficiency of GH/IGF-1 would not affect the MI directly; the ratio would most likely 
be in the normal range because again it is not the fundamental shape of the bone that is 
being altered but the growth rate.  
Thyroid hormone (T3) is one of the major systemic hormones that influence growth 
during childhood.  Left untreated, hypothyroidism (reduced/absent T3) can result in 
delayed skeletal maturation (i.e. younger bone-age) and extreme growth retardation, but 
this condition can be treated with thyroxine (T4) (Williams et al., 1998).  Animals with 
hypothyroidism display a disorganized growth plate with a decreased hypertrophic zone 
that lacks bone resorption in this region resulting in no new metaphyseal bone formation 
and reduced subchondral primary spongiosa in the metaphyseal area (Williams et al., 
1998).  Congenital hypothyroidism, due to hypoplasia or thyroid dysgenesis, is the result 
of mutations in the paired box 8 (PAX8) gene and is inherited as an autosomal recessive 
condition.  Hyperthyroidism or thyrotoxicosis (abnormally high levels of T3) in 
childhood causes growth acceleration and advanced bone age, which can lead to 
craniosynostosis, premature closure of growth plates and shortened stature (Williams et 
al., 1998).  The autosomal dominant condition of hereditary hyperthyroidism is caused 
by a mutation in the thyroid stimulating hormone receptor (TSH-R) gene, though there 
are other causes of hyperthyroidism including cancerous adenomas (Duprez et al., 
1994).  If either hypo- or hyperthyroidism resulted in a change in shape of the 
metaphysis or a change in length of the growth plate then the MI would be altered, but if 
they resulted in smaller bones with no fundamental change in shape, then the MI would 
not be altered, the latter being most likely.  It is important to note that both hyper- and 
hypothyroidism can occur as secondary conditions and in those cases could have other 
factors that affect growth plate architecture. 
 
4.4 Nutrition 
A large number of vitamins and minerals together with proteins, fats and carbohydrates 
play a role in maintaining bone health.  Some of the most important vitamins and 
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minerals for bone health are vitamins A, B, C, D, K and the minerals calcium, 
phosphorus, magnesium, zinc, copper, manganese, potassium and iron (Palacios, 2006, 
Prentice et al., 2006). 
Protein intake aids longitudinal bone growth by increasing levels of IGF-1 and it 
increases calcium absorption (Palacios, 2006, Prentice et al., 2006).  Fat has the potential 
to inhibit calcium absorption but a certain amount of fat intake is necessary to ensure 
overall body health (Prentice et al., 2006).  Fat provides calories for movement and 
exercise, which places a loading force on the skeleton, which in turn ensures normal 
bone growth.  A certain amount of carbohydrates are also necessary to ensure general 
health, although to increase carbohydrate intake at the expense of other nutrients can be 
damaging to general health, including bone health.  For example, a case-control study 
conducted in Greece showed that a high consumption of cola-type drinks was positively 
associated with increased fracture risk in children aged 7 to 14 years (Petridou et al., 
1997).  Several studies have shown how milk and other dairy products have been 
‘replaced’ by nutritionally deficient sugary drinks and foods in the Western diet 
compared to 50 years ago (Kennedy and Goldberg, 1995, Morton and Guthrie, 1998, 
Gerrior et al., 1998), leading to a calcium and phosphorous dietary imbalance (Johnson 
and Frary, 2001).  This in turn has a detrimental effect on bone health which is discussed 
further in the next section. 
 
4.4.1 Minerals – Calcium and Phosphorus/Phosphate 
Calcium is one of, if not the most important mineral for bone growth.  In adults, 99% of 
total body calcium content, which consists of approximately 1000g, exists as 
hydroxyapatite Ca5(PO4)3OH, while the remainder is located in other tissues and extra 
cellular fluid (Favus et al., 2006).  Hydroxyapatite crystals contribute to the mechanical 
weight-bearing properties of bone and also serve as a calcium reservoir for other systems 
that may require calcium (Favus et al., 2006).  Chondrocyte maturation in vitro is 
induced by high concentrations of extracellular calcium (Bonen and Schmid, 1991), by 
increasing phosphate uptake (Mansfield et al., 2003), and by regulating the expression 
of, among other things, collagen type X and PTHrP (Burton et al., 2005, Wu et al., 2003, 
Zuscik et al., 2002).  Calcium concentrations in the fetal growth plate increase from the 
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resting zone to the zone of proliferation, and again from the zone of proliferation to the 
zone of hypertrophy (van Donkelaar et al., 2007).  Calcium concentrations in the growth 
plate increase even further once a secondary ossification centre has developed (van 
Donkelaar et al., 2007) to aid in the mineralisation process.  It has also been shown that 
vesiculation or ectocytosis of the plasma membrane, which occurs during the creation of 
matrix vesicles, is reliant on an influx of calcium into the cytoplasm from several cell 
types including chondrocytes (Wang and Kirsch, 2002).  Proteins called annexins form 
Ca2+ channels in the chondrocytes of the hypertrophic zone in the growth plate and the 
altered Ca2+ homeostasis leads to the release of annexin-containing, mineralisation-
competent matrix vesicles (Wang and Kirsch, 2002).     
Phosphorus and phosphate (PO4) are also very important in the growth plate.  
Hydroxyapatite crystals account for 85% of the total PO4 in the body, and the rest is 
located in other tissues, with a very small amount being contained in extracellular fluids 
(Favus et al., 2006).  Phosphorus aids chondrocyte maturation and subsequent matrix 
mineralisation.  In the cartilage mineralisation area, an increase in local Ca2+ ions and 
PO4 concentrations regulates oxidative metabolism and causes apoptosis of terminally 
differentiated chondrocytes to initiate (Mansfield et al., 2003).  The body of a healthy 
individual can adapt well to a variety of different levels of phosphorus consumption, 
whereas the ability to adjust to a low calcium intake appears to be limited.  Therefore the 
absolute intake of phosphorus seems to be less important for bone health than the ratio 
of calcium to phosphorus intake (Palacios, 2006).  Conditions that cause low serum 
calcium levels (hypocalcemia), or hinder phosphate metabolism or removal, such as 
renal failure, can lead to secondary hyperparathyroidism (Slatopolsky et al., 1999).  The 
increase in PTH secretion leads to an inhibition of vitamin D, specifically 1,25(OH)2D 
synthesis in the kidneys (Hruska, 2006), see Fig 4.3.  The reduction in vitamin D could 
lead to growth plate expansion in the growing skeleton.  Hypophosphataemia can lead to 
rickets/ osteomalacia (Hruska, 2006), which is treatable with oral vitamin D supplements 
or injections.  
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Figure 4.3: Factors involved in the pathogenesis of secondary hyperparathyroidism, adapted from 
(Slatopolsky et al., 1999). 
 
4.4.2 Other Minerals 
The adult body contains approximately 25g of magnesium, about two thirds of which is 
located in the skeleton, one third is intracellular and a minute percentage is located in 
extracellular compartments (Favus et al., 2006).  Around 60% of intracellular 
magnesium is located within the mitochondria, where its function is to act as a cofactor 
in hundreds of enzyme systems relating to use of ATP, transcription and translation, and 
phosphate transport (Favus et al., 2006, Palacios, 2006).  Magnesium also acts to 
decrease hydroxyapatite crystal size, which prevents larger crystals from forming that 
can result in brittle bone (Palacios, 2006).  A study using mice demonstrated that 
magnesium deficiency resulted in osteoporosis, increased skeletal fragility, a decrease in 
growth plate width of 33%, a decrease in metaphyseal trabecular bone volume and 
chondrocyte column decreases in number and length, which all suggested that a 
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magnesium deficiency reduced bone growth (Rude et al., 2003).  Studies in humans 
have also shown that magnesium deficiency is linked to increased bone resorption (New 
et al., 2000). 
The adult body contains approximately 2.3g of zinc (IRCP, 1975).  Zinc is also found in 
other bodily tissues such as the prostate, pituitary, liver, red blood cells and skeletal 
muscle (Aitken, 1976).  Zinc is a fundamental micronutrient for many enzymes both as a 
cofactor and as a stabiliser of their molecular structure (Rossi et al., 2001).  Zinc aids 
chondrocyte activity at the growth plate and has an effect on the synthesis and 
degradation of all types of collagen (Wallwork and Sandstead, 1990).  Zinc is also 
needed for osteoblastic and AP activity (Palacios, 2006).  Zinc deficiency exhibits 
similar manifestations in most animal species; these include alopecia, dermatitis, 
testicular atrophy, ocular lesions, anorexia and growth retardation (Rossi et al., 2001).  A 
study using rats demonstrated that a zinc-deficient diet resulted in reduced activity at the 
growth plate, leading to reduced growth plate width and hypertrophic cartilage 
decreases, lower BMD and a reduced bone growth rate (Rossi et al., 2001). 
The adult body contains approximately 50-120mg (80mg average) of copper, the largest 
amount being contained in the skeleton, but smaller amounts are located in the brain, 
liver, kidneys and heart (Barceloux, 1999).  Copper aids mineralisation of bone, 
influences the integrity of connective tissue (Palacios, 2006) and is an important catalyst 
for iron absorption (Barceloux, 1999).  A copper-containing enzyme, lysyl oxidase, is 
essential for collagen fibril cross-linking, which then increases collagen’s mechanical 
strength to form strong and flexible connective tissue (Palacios, 2006).  Increased levels 
of copper were shown to increase differentiation and proliferation of mesenchymal stem 
cells into both osteoblasts and adipocytes (Rodriguez et al., 2002).  In an in-vitro 
experiment using human mesenchymal stem cells, increased copper levels decreased AP 
activity, and AP reached its maximum value in increasingly shorter culture times, which 
caused deposition of hydroxyapatite crystals to occur earlier than normal (Rodriguez et 
al., 2002).  Copper deficiency has been reported to decrease mineralisation in the 
growing skeleton of animals (Strause et al., 1986) and has been found to significantly 
alter mineralisation in the mature skeleton (Smith et al., 2002).  Copper deficiency can 
result in cortical thinning, growth plate splaying, irregular matrix deposition and 
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osteoporosis associated with reduced osteoblast activity in rats (Parry et al., 1993).  
Osteoporosis leading to fractures is one of the features of Menke’s disease, which is an 
X-linked disorder of copper transport (Danks, 1995).     
An adult human body contains approximately 12-20mg of manganese, most of which is 
located in the skeleton, however there is also a large concentration in mitochondria due 
to the role of manganese in mitochondrial enzyme function (Reynolds et al., 1998).  
Increased levels of manganese in chondrocytes isolated from the growth plates of 6 to 8 
week old hybrid broiler-strain chickens have been shown to inhibit proteoglycan 
synthesis and inhibit mineralisation in cell cultures at levels of 50μm, while double that 
level caused a 50% reduction in protein levels (Litchfield et al., 1998).  There was 
however no affect on AP (Litchfield et al., 1998).  Studies examining manganese 
deficient animals found disproportionate skeletal growth including the shortening of 
long bones and the absence of epiphyses (Hurley et al., 1961).  Inhibition of 
mineralisation has the potential to affect the MI because the undermineralised bone can 
become soft and can expand at the growth plate. 
Potassium is important for bone growth because it promotes an alkaline environment, 
which reduces the demand for skeletal salts to balance endogenous acid generated from 
acid producing food such as meat (New et al., 2000, Palacios, 2006) thereby helping to 
prevent osteoporosis by preserving calcium in the skeleton that might otherwise be 
utilised to maintain normal pH (Palacios, 2006).  Increased intakes of potassium have 
been associated with an increased BMDa in perimenopausal women, while decreased 
intakes were associated with lower BMDa (New et al., 2000).  Potassium is also 
associated with decreased urinary calcium excretion, improved calcium balance, reduced 
bone resorption, and increased bone formation (New et al., 2000).  There is a lack of 
literature as to the effect of potassium on the growth plate. 
The adult human body contains approximately 2-3g of iron, most of which is contained 
in red blood cells with a smaller concentration in the liver as ferritin (Beard, 2001).  Iron 
is an important factor in bone growth because it serves as a cofactor for enzymes 
involved in collagen synthesis (Ilich-Ernst et al., 1998, Palacios, 2006).  Iron also serves 
as a cofactor for 25-hydroxycholcalciferol hydroxylase, which is an enzyme involved in 
transforming vitamin D into its active form, which if deficient would then have 
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repercussions on calcium absorption (Palacios, 2006).  In studies using nephrectomised 
rats (to cause renal failure), increased levels of iron have been shown to inhibit 
endochondral ossification (Mandalunis et al., 2002, Mandalunis and Ubios, 2005).  
Decreased levels of iron can result in anaemia, which has been shown to increase bone 
fragility in rats (Medeiros et al., 1997).  In another study, two groups of rats were fed 
either a control diet or an iron-deficient diet (Katsumata et al., 2009).  They found lower 
BMC and BMDa of the femur, lower trabecular number, a significantly reduced bone 
formation rate and osteoclast surface area in the lumbar vertebrae, and decreased levels 
of serum 1,25(OH)2D, serum total protein, albumin, globulin, IGF-1, C-terminal 
telopeptide of type I collagen (CTx), deoxypyridinoline (DPD) and osteocalcin in the 
iron-deficient group (Katsumata et al., 2009).  CTx and DPD are excreted in urine as a 
by-product of osteoclastic bone resorption and are therefore good markers for bone 
turnover.  These results suggest that severe iron deficiency decreases protein synthesis 
and the conversion of cholecalciferol to 1,25(OH)2D, affecting bone formation and 
inhibiting osteoclast number, which reduces bone resorption (Katsumata et al., 2009).       
Although it would be improbable to have the severe level of iron-deficiency in humans 
as induced in the Katsumata experiment (Katsumata et al., 2009), the results suggest that 
it is possible for the MI to be altered if iron-deficiency is severe and prolonged.   
 
4.4.3 Vitamins 
Vitamins are defined as essential organic compounds with a low molecular weight, 
required in trace amounts for normal growth and metabolic processes, which usually act 
as components of coenzyme systems.  The importance of vitamin D in relation to bone 
growth has already been described in several sections.  However, because vitamin D is 
one of the most important vitamins in relation to bone growth, this section will highlight 
the importance of vitamin D and of vitamins A, C, K and the B vitamins. 
Vitamin D is something of a misnomer, as vitamin D is in fact a steroid hormone that 
exists in two main forms: D3 (also known as cholecalciferol), which is the form of 
vitamin D that is ingested in foods such as cod liver oil and egg yolks, and generated in 
the skin when ultraviolet (UV) light is absorbed by 7-dehydrocholesterol (7-DHC); and 
D2 (also known as ergosterol), which is the form found in plants.  Neither D3 nor D2 are 
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biologically active.  They must be metabolised first in the liver to 25-hydroxy vitamin D 
(25OHD) and then in the kidneys to 1,25-dihydroxy vitamin D (1,25(OH)2D).  Both D3 
and D2 undergo this metabolism, therefore D represents both D3 and D2 (Fig. 4.4).  The 
vitamin D receptor (VDR) binds to several forms of vitamin D, but its affinity for 
25OHD is approximately one thousand times less than for 1,25(OH)2D, therefore 
making 1,25(OH)2D the most biologically active form (Bowen, 2007).  The half-life of 
1,25(OH)2D is less than a day, whereas the half-life of 25OHD is several weeks, 
therefore levels of serum 25OHD are what is measured to determine vitamin D status.  
There has been some question in the literature as to whether D2 is as effective as D3 at 
maintaining the serum levels of calcium and phosphorus at an optimal level.  In a double 
blind trial in which subjects were given either placebo, 1000 IU/day D2 (equivalent to 
25μg), 1000 IU/day D3 or 500 IU D2 combined with 500 IU D3 daily for 11 weeks 
(Holick et al., 2008), all three groups had significant increases in 25OHD levels (Holick 
et al., 2008).  This is in contrast to previous studies in which D2 was less effective than 
D3 in maintaining serum 25OHD levels (Armas et al., 2004, Trang et al., 1998).  
Furthermore, a single dose of 50,000 IU D2 given to healthy adults decreased the serum 
25OHD levels more rapidly than in the placebo group, suggesting D2 was not only less 
effective in maintaining serum 25OHD levels, but also increased the degradation of D3 
(Armas et al., 2004).  Although it is possible that a single dose of 50,000 IU D2 
increased the degradation of D3, D2, and caused a decrease in levels of 25OHD as a 
result, a similar weekly (Malabanan et al., 1998), or twice weekly (Adams et al., 1999) 
dose resulted in an average 100% increase in serum 25OHD levels, and in a significant 
BMDa increase in the spine and hip (Adams et al., 1999).  Possible reasons for these 
discrepancies include the carrier (lactose, ethanol, oil) in which the vitamin D was 
dissolved, that may influence catabolism or bioavailability, but more studies are required 
(Holick et al., 2008).  An important function of vitamin D is mineralisation of the 
skeleton, but vitamin D does not act on the skeleton directly.  Instead vitamin D aids 
bone mineralisation by elevating serum phosphorus and calcium concentrations, the 
levels of which also prevent hypocalcaemic tetany (DeLuca, 1979).  Vitamin D does this 
in two ways: it enables the active transport of both calcium and phosphate in the 
enterocytes, which are intestinal absorptive cells of the small intestine (DeLuca, 1979).   
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Figure 4.4: Illustration of Vitamin D metabolism.  Adapted from (Holick, 2006). 
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Also, when there is insufficient dietary calcium intake, vitamin D, along with PTH, 
stimulates the formation of osteoclasts, and thus bone resorption, to maintain normal 
serum calcium levels  (Garabedian et al., 1974).  These indirect effects are supported by 
the results of Brooks et al., who studied children with vitamin D resistant rickets type II, 
who presented with high circulating levels of 1,25(OH)2D (Brooks et al., 1978).  
Treatment with any form of vitamin D was unsuccessful because there was a genetic 
fault with the VDR; either a complete lack of a VDR, or a defective, or partially 
defective VDR (Brooks et al., 1978).  Effective treatment is available in the form of 
calcium and phosphorus infusions (Brooks et al., 1978), therefore supporting the indirect 
actions of vitamin D on mineralisation.  PTH stimulates osteoclasts to resorb bone in 
order to raise levels of serum calcium.  As this occurs, BMD decreases and as a result, 
the risk of fractures increases (Wagner and Greer, 2008).  In the more severe cases of 
vitamin D deficiency (rickets in children and osteomalacia in adults), the following 
features occur: enlargement of joints, curvature of the spine and femora, general muscle 
weakness and osteopenia (Wagner and Greer, 2008).  The stages of vitamin D deficiency 
are outlined in Table 4.1.  The metaphyses of long bones in children are abnormal in 
severe vitamin D deficiency.  There is also evidence that vitamin D toxicity could also 
cause an altered MI (discussed further in a subsequent section).  
 
Table 4.1: Stages of Vitamin D Deficiency  
 25OHD Levels Ca Levels PO4 Levels PTH Levels 
Stage 1 ↓ ↓ -- -- 
Stage 2 ↓ ↑ ↓ ↑ 
Stage 3 ↓ ↓ ↓ ↑ 
 
Table 4.1:  In the first stage, 25OHD and Ca levels decrease but PO4 and PTH remain unchanged.  
In the second stage, 25OHD levels decrease further but PTH acts to raise Ca levels.  PO4 levels 
decrease.  In the most severe third stage, 25OHD levels continue to decrease but even the raised 
levels of PTH are not able to keep Ca levels normal so they begin to decrease along with PO4.  (‘↑’ = 
Increase, ‘↓’ = Decrease, ‘--’ = Unchanged).  Adapted from Wagner and Greer, 2008.   
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Vitamin A is important in the formation of matrix vesicles and the subsequent 
mineralisation process.  Proteins called annexins facilitate the influx of calcium into 
chondrocyte cytoplasm by creating Ca2+ channels (Wang and Kirsch, 2002).  Growth 
plate chondrocytes treated with retinoic acid (RA) (i.e. vitamin A), result in the 
induction of their terminal differentiation and subsequent mineralisation (Kirsch et al., 
2000).  This initiates an increase that regulates a series of events, which leads to matrix 
mineralisation of growth plate chondrocytes (Wang and Kirsch, 2002).  Vesicles isolated 
from cultures that were not treated with RA, were unable to take up significant amounts 
of Ca2+ (Wang and Kirsch, 2002).  RA negatively regulates longitudinal bone growth by 
inhibiting chondrocyte proliferation, hypertrophy and matrix synthesis at the growth 
plate through retinoic acid receptors (RAR’s) to prevent bone overgrowth (De Luca et 
al., 2000).  The growth-inhibiting effects of RA were completely reversed by an RAR 
antagonist; in the absence of exogenous RA, the RAR antagonist accelerated bone 
growth to an abnormal level (De Luca et al., 2000).  Both excess vitamin A (Pease, 
1962, Standeven et al., 1996, Wolbach, 1947) and vitamin A deficiency (Wolbach, 1947, 
Harris et al., 1978, Fan and Zhu, 1999) have negative effects on the growth plate.  
Excess vitamin A has been associated with premature closure of the growth plate 
(Standeven et al., 1996) while vitamin A deficiency has been associated with incomplete 
skeletal development and reduced body length in rats (Fan and Zhu, 1999) and an 
overgrowth of bone through osteoblast activity, with decreased calcium content in 
guinea pigs (Harris et al., 1978).  There is no published evidence of metaphyseal 
splaying resulting from either a deficiency or excess vitamin A.  Therefore it seems 
unlikely that either of these conditions would cause a significant alteration to the MI 
ratio. 
The water soluble B vitamins, have at various points in time, included approximately 30 
different substances.  However only 8 are currently classified as B vitamins: B1 – 
thiamine, B2 – riboflavin, B3 – niacin, B5 – pantothenic acid, B6 – pyridoxine, B7 – 
biotin, B9 – folic acid and B12 – cobalamin.  This section will concentrate on the effects 
of those that have been studied most in relation to bone: B6, B9 and B12.  
Vitamin B6 (pyridoxine) assists in balancing potassium and sodium levels and promotes 
the production of red blood cells.  In addition, it serves as an important coenzyme in 
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many biochemical reactions including the biosynthesis of dopamine and serotonin 
(neurotransmitters), and is most likely important for normal perinatal development of the 
central nervous system (Spector, 1978).  There are differing opinions as to the effects of 
vitamin B6 on the mineralisation process.  Dodds and colleagues examined the growth 
plate and fracture healing in rat metatarsals and found that rats fed on a B6 deficient diet 
showed metaphyseal, epiphyseal and diaphyseal changes as well as growth plate 
abnormalities that resembled osteoporotic bone (i.e. contained large cavities lined with 
osteoclasts), that were only exacerbated by the presence of a fracture (Dodds et al., 
1986).  The amount of new bone formed in the fracture callus was diminished compared 
to controls, and fractures took longer to unite in the B6 deficient rats (Dodds et al., 
1986).  Abnormalities were also observed by Rodda and colleagues, who described the 
metaphyseal changes as similar to those seen in starvation, including reduced, irregularly 
shaped and degraded trabeculae (Rodda, 1975, Dodds et al., 1986).  A study using tissue 
non-specific alkaline phosphatase (TNAP) null mice examined how vitamin B6 affected 
mineralisation (Narisawa et al., 2001).  The mineralisation of TNAP null mice did not 
improve with administration of vitamin B6, suggesting that vitamin B6 metabolism does 
not affect mineralisation in TNAP null hypophosphatasia (Narisawa et al., 2001).  It is 
possible that the MI could be altered in a vitamin B6 deficient environment, although the 
only evidence for this in the literature are the effects one study observed in rats (Dodds 
et al., 1986).  Because the B vitamins are water soluble, excesses are excreted in urine, 
therefore there is currently a lack of evidence on B vitamin excess and bone. 
Vitamin B9 (folic acid) is an important substance, particularly for expectant mothers, as 
it can prevent birth defects.  Calcification in baby rats whose mothers were chronically 
folic acid deficient, was delayed and disordered (Jaffe and Johnson, 1973).  Studies 
concerning the effects of folic acid on bone growth are relatively rare, however there is 
currently no data to suggest that the MI of long bone would be altered as a result of folic 
acid deficiency. 
Vitamin B12 (cobalamin), acts as a cofactor for osteoblast-related proteins such as 
osteocalcin and AP, and is therefore important for osteoblast function (Palacios, 2006).  
In a study of osteoblast specific proteins, AP and osteocalcin levels were lower in 
cobalamin deficient patients compared to controls, suggesting that osteoblast activity is 
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dependant on cobalamin and that bone metabolism is affected by cobalamin deficiency 
(Carmel et al., 1988).  In children fed a mainly vegetarian diet, cobalamin levels were 
found to be low compared to controls on an omnivorous diet (Dhonukshe-Rutten et al., 
2005).  This deficiency was subsequently found to be associated with low BMC and 
BMDa compared to controls (Dhonukshe-Rutten et al., 2005).  B12 deficiency also 
causes neurological effects (e.g. memory loss and neuropathy) and haematological 
effects (e.g. anaemia) (Carmel et al., 1988).  As with folic acid, there is no information 
in the literature to suggest that the MI would be altered in a case of cobalamin 
deficiency. 
Vitamin C (ascorbic acid) is a water soluble vitamin that is an essential nutrient for 
humans.  A deficiency in vitamin C causes scurvy, which has symptoms that include 
cutaneous bleeding, bleeding from mucous membranes, haemorrhaging from the gums 
and in some cases, tooth loss.  Vitamin C is required for the process of cross-linking 
collagen fibrils in bone by functioning as a cofactor in the hydroxylation of proline and 
lysine (Palacios, 2006).  If vitamin C is not present in sufficient quantities, poor quality 
collagen will be synthesised, which leads to poor quality dentine formation, resulting in 
the dental symptoms listed above (Rajakumar, 2006).  The following events in bone 
formation occur in the metaphyseal area, between the growth plate cartilage and the end 
of the diaphysis:   
 Osteoblasts are unable to form bone matrix, resulting in cessation of 
endochondral ossification. 
 However the calcification of growth plate cartilage in long bones continues, 
leading to a thickening of the growth plate. 
 The typical invasion of capillaries into growth plate cartilage fails to occur. 
 Consequently pre-existing bone becomes brittle because it is undergoing a 
normal rate of resorption. 
 This leads to the formation of microscopic fractures in the spicules between the 
diaphysis and calcified cartilage (Rajakumar, 2006).   
The periosteum becomes loosened because of these fractures, resulting in subperiosteal 
haemorrhage in the metaphyseal area of long bones, however  intra-articular 
haemorrhage is rare because the attachment of the periosteum to the growth plate is very 
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strong (Rajakumar, 2006).  A case study of an infant with both rickets and scurvy 
showed marked under-mineralisation of the skeleton and metaphyses were cupped and 
splayed (Lewis et al., 2007).  Although the metaphyseal splaying could be explained in 
this case by rickets, metaphyseal splaying has also been observed in animals being fed a 
vitamin C deficient diet (Sabin, 1939).  Therefore there is evidence suggesting that the 
MI could be altered in cases of vitamin C deficiency.   
Vitamin K is a fat soluble vitamin with two molecular forms, designated K1 
(phylloquinone) and K2 (menaquinone).  Vitamin K is an important cofactor of γ-
carboxylase, an enzyme necessary for the γ-carboxylation of glutamic acid residues in 
certain proteins such as osteocalcin (Palacios, 2006, Booth, 2003).  The presence of 
glutamic acid residues facilitates the calcium binding of osteocalcin to the 
hydroxyapatite bone matrix (Shearer, 1995).  Vitamin K deficiency increases the amount 
of under-carboxylated osteocalcin, which is a less functional form and found in 
osteoporotic patients (Palacios, 2006).  Also, warfarin, which is a commonly prescribed 
anticoagulant and vitamin K antagonist, has been shown to increase the amount of 
under-carboxylated osteocalcin (Bach et al., 1996).  Studies in both children and adults, 
particularly postmenopausal women, have shown that an increase in vitamin K is 
associated with; increases in BMC (Knapen et al., 2007, van Summeren et al., 2008), 
increased width of the femoral neck (Knapen et al., 2007) and increased BMDa in 
peripubertal children (van Summeren et al., 2008).  There are however conflicting 
results concerning the association of vitamin K with BMD (Cashman, 2005).  Some 
studies have reported no association (Knapen et al., 2007), while others have reported 
that a low intake of vitamin K is associated with decreased BMD (Booth et al., 2003).  
There is speculation that a relative lack of vitamin K in growing children could lead to 
reduced bone strength, quality or suboptimal bone mineralisation, leading to an 
increased fracture risk (van Summeren et al., 2008).  This is in addition to the increased 
fracture risk already present in peripubertal children, due to bone mineralisation not 
being able to keep up with the height increase (van Summeren et al., 2008).  There are 
few studies examining bone geometry in relation to vitamin K in children.  However, an 
intriguing hypothesis has been proposed relating to the interelationship of actions of 
vitamins A, D and K on the growth plate and pathological soft tissue calcification 
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(Masterjohn, 2007).  He proposed that inducing a vitamin K deficiency is the mechanism 
by which vitamin D becomes toxic (Masterjohn, 2007).  In this model he states that 
“…vitamin D up-regulates the expression of certain proteins that must be activated by 
the vitamin K-dependent process of carboxylation” (Masterjohn, 2007), such as 
osteocalcin (Palacios, 2006), and matrix gamma-carboxyglutamic acid protein (MGP) 
(Cancela et al., 1990).  When the amount of vitamin K available to carboxylate these 
proteins has been exhausted, the “…vitamin K-dependent processes that support the 
nervous system, retain minerals in the bone matrix, and protect the soft tissues from 
calcification, cannot be performed” (Masterjohn, 2007).  Warfarin (Bach et al., 1996) 
causes an overabundance of under-carboxylated proteins, which overcome the quantity 
of carboxylated proteins, so the under-carboxylated proteins themselves may assist the 
liberation of calcium from the bone matrix, leading to the accumulation of calcium into 
other soft tissues (Masterjohn, 2007).  He also proposed that the method by which 
vitamin A protects against vitamin D toxicity is the ability of vitamin A to down-
regulate the previously mentioned vitamin K-dependent protein MGP (Masterjohn, 
2007).  It was also noted that the methods in which vitamins A and D alter vitamin K 
concentrations need further study (Fu et al., 2008).  As the demand for carboxylation 
reduces, the resulting effect is the counteraction of (vitamin D-induced) vitamin K 
depletion (Masterjohn, 2007).  There have been studies showing that the consequences 
of overdoses in vitamin D strongly resemble the symptoms of vitamin K deficiency, or a 
deficiency in vitamin K-dependent proteins (e.g. MGP) (Proudfoot and Shanahan, 2006, 
Munroe et al., 1999, Fu et al., 2008, Masterjohn, 2007).  Animals with vitamin D 
toxicity develop soft tissue calcification in the arteries, lungs and trachea, and develop 
growth retardation, bone demineralisation and in severe cases, suffer death due to 
calcification of the aorta and its branches (Masterjohn, 2007).  Similar symptoms, 
though not exactly the same phenotype, have been observed in humans with MGP 
mutations (Keutal Syndrome) (Munroe et al., 1999).  The mechanism by which vitamin 
D is able to cause growth retardation is unknown, however a similar effect is present in 
MGP knockout mice, which exhibit widespread calcification of the proliferative zone 
and zone of provisional calcification in metaphyses (Masterjohn, 2007).  MGP knockout 
mice have disorganised hypertrophic chondrocytes, which are not organised into normal 
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columns, and consequently the scaffolding usually provided for the deposition of bone 
matrix is not present, leading to short stature (Luo et al., 1997).  This indicates that an 
alteration in the MI during growth is certainly possible in cases of vitamin K deficiency.      
 
4.5 Exercise 
Exercise causes muscles to exert stress and strains on long bones, particularly at weight-
bearing sites.  This influences longitudinal bone growth.  Bones must adapt to the stress 
being placed upon them by increasing properties such as BMD and cross-sectional bone 
area in order to prevent exceeding fracture thresholds.  Conversely, if a person is 
immobilised, osteocytes will sense this and facilitate the appearance of osteoclasts, 
which remove bone that is not required due to reduced loading.  Some studies using rats 
have shown that stress increases certain properties such as BMD, BMC and cross-
sectional area (Umemura et al., 1995, Gunter et al., 2008, Isaksson et al., 2009), while 
others have shown that the stress associated with intensive treadmill exercise suppresses 
bone growth (Bourrin et al., 1994, Li et al., 1991).  These differences can most likely be 
explained by various types and magnitudes of stress.  For example, some studies using 
animals have concluded that the stress/strain rate is more significant than the magnitude 
(Judex and Zernicke, 2000b, Judex and Zernicke, 2000a, Skerry and Peet, 1997).  In a 
study of post-menopausal women, BMDa at the hip and lumbar spine was increased 
over a year in participants that undertook a higher level stress/strain exercise program, 
than those who undertook more aerobic low level (walking, running) exercise (Stengel et 
al., 2005).  In a study using pQCT to examine child gymnasts and controls, the gymnasts 
exhibited a higher total BMD at the distal tibia, greater cross-sectional bone and muscle 
area at the 50% radius, higher strength strain index (SSI) at the 50% radius and greater 
total and trabecular BMD at the distal radius (Ward et al., 2005b).  Crucially however, 
the total cross-sectional area of the bone at the 4% distal radius was not significantly 
different between the gymnasts and controls, indicating that although much larger 
amounts of muscle stress were occurring at the 4% distal radius of gymnasts, it was not 
sufficient to cause a significant change in metaphyseal area at this site.  A study of both 
child and adult tennis players showed that children who started playing around the time 
of puberty showed a significant difference in BMC, BMD and bone area differences at 
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the distal radius (Ducher et al., 2006).  This indicates that the irregular stress on the 
playing arm of tennis players was sufficient to cause significant morphological changes 
in the metaphysis.  These results were supported in another study in female tennis 
players who had begun playing before the onset of puberty, in which total cross-
sectional area of the distal radius was significantly different between dominant and non-
dominant forearms, and between athletes and controls (Kontulainen et al., 2003).  
Interestingly, both studies found that the differences between dominant and non-
dominant forearms was much more apparent at the mid-radial diaphysis (Ducher et al., 
2006) and the mid-humerus (Kontulainen et al., 2003) in adult tennis players.  The 
response of the distal radial metaphysis to stress may be limited after epiphyseal fusion, 
and because bone turnover in cortical sites (e.g. mid-diaphysis of a long bone), takes 
longer than in trabecular sites (e.g. metaphysis), this may explain the site-specifc 
differences observed in both studies (Ducher et al., 2006, Kontulainen et al., 2003).  
Both studies also confirm the link between increased high-level intermittent mechanical 
stress and increased bone strength (Ducher et al., 2006, Kontulainen et al., 2003).  Some 
advocate beginning stress-inducing activities such as tennis before puberty to reduce 
fracture risk (Ducher et al., 2006), which is particularly relevant considering fractures of 
the distal radius are the most common type of fracture in peri-pubertal age groups 
(Rauch et al., 2001a).  This evidence indicates that stress and exercise are able, under 
certain circumstances, to alter the MI.   
 
4.6 Bisphosphonates 
Bisphosphonates are a type of drug that inhibits osteoclastic activity.  They do this in 
two ways: clodronate and etidronate, which are older types of bisphosphonate, cause the 
formation of ATP analogues that accumulate in osteoclasts and are cytotoxic, causing 
apoptosis (Shaw and Bishop, 2005).  The newer generation of bisphosphonates, which 
include pamidronate, olpandronate, ibandronate, aledronate, risendronate and 
zoledronate, inhibit the production of farnesyl pyrophosphate and geranylgeranyl 
pyrophosphate (Luckman et al., 1998).  This causes a subsequent prenylation failure of 
several GTP-binding proteins, leading to a failure in the translocation of these proteins 
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into the cell membrane, inducing severe cellular interference and eventually apoptosis 
(Luckman et al., 1998).    
Many studies have been conducted on the use of bisphosphonates (both oral and 
intravenous) for the treatment of a variety of paediatric conditions such as juvenile 
idiopathic osteoporosis (Bachrach and Ward, 2009, Brumsen et al., 1997, Brown and 
Zacharin, 2009), OI (Land et al., 2006, Madenci et al., 2006, Chevrel et al., 2006, 
DiMeglio and Peacock, 2006, Pizones et al., 2005, DiMeglio et al., 2005, Rauch et al., 
2007, Senthilnathan et al., 2008), fibrous dysplasia (Kitagawa et al., 2004, Plotkin et al., 
2003), idiopathic juvenile hyperphosphatasia (Cundy et al., 2004), Menke’s disease 
(Kanumakala et al., 2002) and cerebral palsy (Henderson et al., 2002).  These conditions 
mainly result in metaphyseal splaying, however bisphosphonates could act to reverse 
this effect and over the course of time cause the MI to become closer to normal.  This 
change can proceed too far and eventually cause drug-induced osteopetrosis, such as was 
seen in a case report of a 12 year old male (Fig. 4.5) by Whyte and colleagues (Whyte et 
al., 2003).  Osteopetrosis is an umbrella term that consists of many disorders, both 
autosomal dominant and autosomal recessive, which differ in onset and severity.  It is 
often characterised by increased bone opacity as seen on a radiograph, increased bone 
mass, fractures, and impaired longitudinal bone growth resulting in short stature (Stark 
and Savarirayan, 2009).  The fractures occur because the bone is not remodelled due to 
inhibition of osteoclast differentiation or, in the case of bisphosphonates, function.  
Bisphosphonate use in children has been a widely debated topic due to reports of brittle 
bones and increases in numbers of fractures (Marini, 2003)  Bisphosphonates have a 
half-life of several years in the skeleton, depending on the bone turnover rate, which 
caused the symptoms of the 12 year old male to persist over 18 months after 
bisphosphonate treatment had been discontinued (Whyte et al., 2003).  The ratio of 
GPW to MW in this case appears almost 1 to 1, and since the MI is equal to the 
0.5MW/GPW, a ratio of 1 to 1 would produce an MI of 0.5.  Once osteoclast function 
returned after discontinuation of treatment, the bone would gradually remodel until the 
increased bone mass and radio-opacity disappeared.  Therefore bisphosphonates do have 
an affect on MI. 
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Figure 4.5: Progression from normal femur to bisphosphonate induced osteopetrosis.  A: Normal 
distal femur (age 8 years); B: radio-opaque banding in the distal metaphysis indicating a modelling 
failure (age 9 years – 1.25 years of pamidronate therapy); C: radio-opaque banding expanding 
further into the metaphysis (age 12 years – 1.5 years after last infusion of pamidronate).  
Reproduced with permission and copyright © of the NEJM (Whyte et al., 2003). 
 
 
4.7 Summary 
There are many different types of dysplasias and other conditions that can cause an 
alteration in the MI ratio.  NF1 is such a condition, while CDGP is a possibility.  There 
are also several vitamins, minerals and drugs that have an effect on the MI including 
vitamin C, D, calcium, phosphate, copper, manganese, and bisphosphonates.  Several 
vitamins and minerals could have an effect on the MI including vitamin B6, K, 
magnesium zinc and iron.  Exercise may also affect MI.  Table 4.2 summarises the 
vitamins, minerals, bisphosphonates and exercise effects on the MI.  
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Table 4.2 – Summary of Actions on the Growth Plate 
 
 Could Alter MI? In What Way? Comments 
Vitamin A Unlikely  Negatively affects 
growth plate in terms 
of fusion times but not 
overall morphology 
Vitamin B6 Possibly Deficiency = reduced diaphyseal 
size 
Only 1 reference (from 
1986) to suggest 
possible effects 
Vitamin B9 No evidence in 
literature to support 
an MI effect 
  
Vitamin B12 No evidence in 
literature to support 
an MI effect 
  
Vitamin C Yes Deficiency  = metaphyseal 
splaying 
 
Vitamin D Yes Severe deficiency and toxicity = 
metaphyseal splaying 
 
Vitamin K Possibly Deficiency = metaphyseal splaying  
Calcium Yes Deficiency = metaphyseal splaying Severe deficiency and 
toxicity can result in 
death 
Phosphorus/PO4 Yes Deficiency = metaphyseal splaying  
Magnesium Possibly Deficiency = narrowed growth 
plate height, which may in turn 
cause metaphyseal splaying 
 
Zinc Possibly Deficiency could result in splaying 
or more likely overall reduction in 
bone size meaning MI ratio would 
remain in proportion 
 
Copper Yes Deficiency = metaphyseal splaying  
Manganese Yes Deficiency = metaphyseal splaying  
Potassium No evidence in 
literature to support 
an MI effect 
  
Iron Possibly Deficiency = metaphyseal splaying If severe & prolonged 
Exercise (loading 
of the distal radius)  
Possible  More likely to cause 
changes in BMD and 
BMC rather than 
morphology.  If 
morphology were 
affected, it is more 
likely to be 
proportional, therefore 
the MI ratio would 
remain similar. 
Bisphosphonates 
 
 
 
Yes Will increase MW compared to 
GPW (the opposite effect to 
splaying). 
An overdose can 
mimic osteopetrosis. 
 
Table 4.2: Summary of external forces that could affect the distal radial GPW and MW. 
 91
5. Methods - Original Study Groups 
5.1 Introduction 
The MI study is a retrospective work using the data from two ongoing studies and two 
previously completed studies.  The two ongoing studies are the NF1 and CDGP studies 
and the two completed studies are the B16N2 Normal Children study and the Gymnast 
study.  The bone-age assessment study using DXA hand images and hand radiographs is 
also a retrospective study using data collected as part of the B16N2 Normal Children 
Study.  Sections 5.2 through 5.5 of this chapter outline these four studies and include 
information such as the original inclusion and exclusion criteria, age ranges, what 
techniques were used and what data was collected.  These studies were all carried out in 
accordance with the Declaration of Helsinki (1964).   
 
5.2 The B16N2 Normal Children Study 
The aim of the B16N2 Normal Children study was as follows: to provide a 
comprehensive cross-sectional and longitudinal database of paediatric reference data 
(aged 5 to 20 years) for DXA, pQCT and radiographic examinations, taking into account 
pubertal stage, diet, exercise and lifestyle information (Ashby et al., 2008, Ward et al., 
2007b). 
The justification for generating data from normal children was as follows: paediatric 
studies are more difficult to design and recruit for and although there is a wealth of 
normal adult reference data, there is a paucity of normal paediatric reference data.  It can 
be difficult to assess whether a child is “normal” when comparing him or her to adult 
reference data. 
The B16N2 Normal Children’s Study was originally approved in 1998 by the Central 
Manchester Local Research Ethics Committee (Reference No. CEN/98/036) and was 
later approved by the North West Multi-Centre Research Ethics Committee (Reference 
No. MREC 04/8/006) in 2004.  It was also approved and registered with the University 
of Manchester Ethics Committee (Dr Tim Stibbs, personal communication) and 
recruited from 1998 to 2008.  The data gathered examining bone growth and 
development in normal children included: 
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 DXA hand image for bone-age assessment. 
 BMDa of the proximal femur (total hip and femoral neck) and lumbar spine (L1 
– L4). 
 BMAD of lumbar spine and femoral neck. 
 Whole body total and regional BMC, BMDa and fat and lean muscle mass. 
 pQCT at the 4% forearm and 50% forearm. 
 Radiographs of the hand/forearm (for subjects examined in the Stopford building 
only – mobile units were equipped with DXA and pQCT only). 
 DXR measures (MCI, BMDa and CrtThick) were subsequently obtained 
from hand radiographs. 
 Grip strength. 
 Height. 
 Weight. 
 Tanner pubertal stage. 
 Food and exercise diaries.  
 
Inclusion criteria included being of white Caucasian ancestry and being aged between 5 
and 20 years from baseline and throughout all follow-up scans (follow-up scans refer to 
subjects that returned for additional examinations over the course of several years for the 
purpose of gathering longitudinal data).  Exclusion criteria included being of non-
white/Caucasian ancestry, inability to give informed consent, weight and/or height 
outside the minimum (0.4th centile) or maximum (99.6th centile) weight or height 
reference curves for the UK (Freeman et al., 1995b), fracture within the previous 12 
months, history of recurring low-trauma fractures, presence of systemic disease, any 
periods of prolonged immobilisation within the previous 12 months, undertaking any 
procedure involving ionising radiation within the previous 12 months, the use of drugs 
or presence of any condition known to affect skeletal health, a first-degree relative 
diagnosed with primary osteoporosis, and in the case of females, pregnancy or the 
possibility of pregnancy (Ashby, 2007). 
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5.3 The Gymnast Study 
The aim of the original study was as follows: to examine BMC, BMD, CSMA and bone 
area and the effects of calcium supplementation in young gymnasts using DXA, pQCT 
and anthropometric measurements and compare the data with that of normal controls 
(Ward et al., 2005b). 
The justification for this study was as follows: previous studies have reported beneficial 
effects of gymnastics on the skeleton (Nichols et al., 1994, Nickols-Richardson et al., 
1999), as the amount of stress placed on the skeleton during gymnastics will cause the 
bones to adapt by increasing BMD and or BMC, but bone geometry and the uptake of 
calcium (whether gymnasts will respond differently when supplemented with calcium 
than normal controls), had not been investigated. 
The Gymnast group were part of a 12 month randomised control trial investigating 
calcium supplementation in pre-pubertal children who participated in 6 or more hours of 
competitive gymnastics per week (Ward et al., 2005b).  The study was approved by the 
Central Manchester Local Research Ethics Committee (Reference No. CEN/00/144) and 
the Liverpool Children’s Research Ethics Committee (Reference No. 01/27/E).  Subjects 
were randomised to either calcium supplementation or placebo and examined at baseline 
and at 12 months (Ward et al., 2005b).  A total of 44 gymnasts (17 male, 1 mixed 
ancestry, 1 Chinese ancestry) aged 5 to 12 years (mean age 9 years) were originally 
recruited from schools within the Greater Manchester Area (Ward et al., 2005b).  The 
inclusion and exclusion criteria for the gym study were very similar to the B16N2 
Normal study except that participants were not excluded based on race or ethnic 
background.  The additional exclusion criteria were allergy to dairy products or a 
personal or family history of nephrocalcinosis or kidney stones (Ward et al., 2005b).  All 
subjects were confirmed as pre-pubertal by self-assessment (and parental aid if 
necessary) at baseline using the Tanner criteria and an orchidometer (Tanner, 1962).  
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5.4 The NF1 Study 
The aim of this study is as follows: to investigate spinal abnormalities including spinal 
cord dural ectasia, spinal neurofibromas, and meningoceles with dysplastic osseous 
abnormalities, dystrophic scoliosis and general bone health in individuals aged 6 to 9 
years of age with NF1. 
The justifications behind this study were as follows: 
 Dysplastic radiographic findings may be useful clinical screening tools for 
scoliosis, which would allow preventative strategies for the development and 
progression of scoliosis to be investigated. 
 Changes to vertebral body and canal area lead to rapid progression of 
neurological complications; therefore a screening tool/technique to detect these 
changes would be clinically useful. 
 There may be indications of future complications of the disease when bone 
health (as studied using DXA, pQCT, radiographs and urinary examination of 
pyridinium cross-links) is investigated.  
 
Manchester is one of the centres in the NF1 study, which is a multi-centre and multi-
national (other centres are Cincinnati USA, Utah USA and Vancouver Canada) study 
that was originally approved in 2006 by the South Manchester Research Ethics 
Committee (Reference No. 06/Q1403/107) and continues until 2011.  The original 
inclusion criteria include meeting the National Institute of Health criteria for diagnosing 
NF1 (in subjects aged 6 to 9 years at time of enrolment and Tanner stage not greater than 
1 at time of enrolment).  All subjects were confirmed as pre-pubertal by self-assessment 
(and parental aid if necessary) using the Tanner criteria and an orchidometer (Tanner, 
1962).  The original exclusion criteria include prior surgical repair of the spine, short-
segment (4-6 vertebrae) curve with a Cobb angle of 45° or more, taking hormone 
replacement therapy, chronic glucocorticoid use, presence of tibial pseudoarthrosis, or 
presence of other chronic medical problems known to influence general bone health (i.e. 
diabetes mellitus, cerebral palsy etc).  Subjects are examined once per year over four 
years with a hand radiograph taken at years one and four for bone-age assessment.   
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5.5 The CDGP Study 
The aims of the original study were as follows: 
 To investigate BMD and body mass index (BMI) in CDGP and compare this 
group with normal controls. 
 To investigate whether biochemical markers are useful in identifying children 
with CDGP who have a low BMDa. 
 To investigate genetic polymorphisms associated with lower BMDa in children 
with CDGP. 
The justification for the study was: bone health may be affected in children with CDGP, 
therefore quantitative imaging and biochemical analysis may provide further insight into 
identifying children with CDGP and assess whether any adverse affects to bone health 
may persist into adulthood. 
 
The CDGP study is an ongoing study that began recruiting in 2003 and has been 
ethically approved by the CMMCUH (Reference No. 00137) and the North West 9 
Research Ethics Committee – Greater Manchester West (Reference No. 07/H1009/66).  
The principal investigator is Dr Indraneel Banerjee of the Manchester Royal Children’s 
Hospital.  Subjects were recruited between  ages 5 to 17 years; a diagnosis of CDGP is 
made if there are no signs of puberty by age 12 in girls and 13 in boys and a diagnosis of 
constitutional growth delay (CGD) may be made in girls aged <12 years and boys aged 
<13 years.  Inclusion criteria were a diagnosis of CDGP or CGD.  Subjects were not 
excluded due to race, ethnic origin, other chronic disease(s), systemic diseases or use of 
drugs that could affect bone health.  The exclusion criterion was being unable to give 
informed consent.   
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6. Methods – Study Groups, Subjects and Quantitative Assessment 
6.1 Introduction 
The following chapter describes how the data from the original study groups (described 
in the previous chapter) were used in the MI study.  Sections 6.2 through 6.6 describe 
the subjects, inclusion and exclusion criteria, methods used and information obtained.  
Section 6.7 contains two tables that summarise the methods and information obtained 
from the original study groups, as well as the author contribution.  Sections 6.8 through 
6.13 are in-depth descriptions of the methods used.  As this was a retrospective study, 
the ethics approval was already granted in the ethics approvals of the original studies. 
  
6.2 Normal Group Data 
All subjects in the Normal group, or described as Normal controls, were part of the 
B16N2 Normal Children’s Study discussed in section 5.2.  Inclusion criteria for the 
current study, for examination of the MI and TW3 bone-age assessment, were: subjects 
were required to be aged between 5 and 20 years and have minimum 1 hand radiograph.  
Exclusion criteria for the MI study were as follows: subjects were excluded if, 
subsequent to the original examination, one of the original exclusion criteria for the 
B16N2 study was found to apply, such as low BMD, abnormal bone geometry or 
presence of systemic disease.  There were eight subjects excluded from the original 
B16N2 database, and were therefore excluded from the present study.  Subjects were 
excluded from the MI study if the radiographs were not of sufficient quality or had poor 
positioning so that the MI, MW, GPW or bone-age could not be determined; 1 subject 
was excluded on this basis as only a few millimetres of the distal radius was visible.  
Subjects examined only on the mobile osteoporosis vans for the B16N2 study were 
excluded from the MI study because no hand radiographs were available for these 
participants.  This was due to the lack of mobile radiographic equipment on the vans, 
which were equipped only with a Hologic QDR Discovery (Bedford, USA) and a Stratec 
XCT-2000 pQCT (Phorzeim, Germany), for the period this study was recruiting.  The 
total number of subjects that met the inclusion criteria for the MI study was 378 (155 
male).  Of the 378 subjects, 11 did not have an available baseline pQCT scan due to 
movement artefacts and 17 did not have a follow-up pQCT scan, but did have a follow-
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up hand radiograph.  Of the 378 subjects, 16 refused to complete the self-assessed 
Tanner pubertal stage, leaving 362 subjects that provided at least one (baseline) Tanner 
pubertal stage.  MI, MW, GPW, TW3 and GP bone-age were assessed using hand 
radiographs.  Three DXR measures (MCI, BMDa and metacarpal cortical thickness) 
were assessed using hand radiographs and the Sectra Pronosco DXR system (Linköping, 
Sweden).  Only 159 subjects within this group had DXR results available for 
comparison in the MI study.    Chronological age, height, weight, arm length and pQCT 
values were obtained from the original study and compared to the MI, MW and GPW. 
     
6.3 Gymnast Group Data 
At baseline, 37 (15 male) gymnasts aged 5 to 12 years (mean 9 years) had hand 
radiographs available for examination in the MI study.  Inclusion criteria for the MI 
study included meeting the original inclusion criteria and having a minimum of one hand 
radiograph available for analysis.  Subjects were excluded from the MI study if the 
radiographs were not of sufficient quality or had poor positioning so that the MI, MW, 
GPW or bone-age could not be determined; one subject was excluded for this reason, 
leaving 36 subjects (15 male).  MI, MW and GPW were assessed from hand 
radiographs.  Chronological age, height, weight, arm length and pQCT values were 
obtained from the original study and compared to the MI, MW and GPW values.    
 
6.4 NF1 Group Data 
The inclusion criteria of the MI study included meeting the original inclusion criteria 
and having one hand radiograph minimum available for analysis.  Subjects were 
excluded from the MI study if the radiographs were not of sufficient quality or had poor 
positioning so that the MI, MW, GPW or bone-age could not be determined, however 
neither of these situations occurred.  MI, MW and GPW were assessed using hand 
radiographs.  By September 2008, 23 subjects had been recruited and had a baseline 
radiograph on hard-copy film; when the NF1 study began recruiting, it pre-dated PACS.  
PACS replaced the use of radiograph film after 17 (7 male) subjects were recruited.  
Because the subjects who had PACS hand radiographs could not have calibration 
markers placed on the image retrospectively to determine the absolute GPW and MW 
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values, any subject with a PACS hand radiograph was excluded from the MI study.  
Chronological age, height, weight, arm length and pQCT values were obtained from the 
original study and compared to the MI, MW and GPW.  Two of the 17 subjects did not 
have pQCT scan data and one subject did not have a forearm length measurement.  
 
6.5 CDGP Group Data 
The inclusion criteria of the MI study included meeting the original inclusion criteria 
and having one hand radiograph minimum available for analysis.  Subjects were 
excluded from the MI study if the radiographs were not of sufficient quality or had poor 
positioning so that the MI, MW, GPW or bone-age could not be determined, however 
neither of these situations occurred.  MI, MW, GPW and TW3 bone-age were assessed 
using hand radiographs.  Height, weight and chronological age were obtained from the 
original study.  However, the majority subject case-notes were stored in a secure NHS 
location and were not available to the author for the MI study.  Only 25 subjects (22 
male) were available for the MI study that had a height and weight measurement on the 
same day as their hand radiograph was taken.  It should be noted that some of the 
illnesses suffered by the CDGP subjects included gynecomastia, Hodgkin’s lymphoma, 
Leri-Weill syndrome, congestive heart disease, unspecified allergies, clinical obesity, 
asthma (some subjects taking unspecified steroids, some not), coeliac, anaemia, and 
renal failure.  The author did not have access to case notes, therefore it was not possible 
to associate these conditions with any particular subject.  
 
6.6 DXA Bone-Age Data 
Subjects from the B16N2 database were included in the MI study if they fit the original 
inclusion criteria and had a DXA hand scan and hand radiograph taken at the same visit.  
Ninety-nine children fit the inclusion criteria.  Subjects were excluded if either the hand 
radiograph or DXA hand scan were of insufficient quality or exhibited poor positioning 
such that bone-age could not be determined.  One subject was excluded due to an 
incomplete DXA hand scan in which only half of the hand was visible due to poor 
placement, which meant an accurate bone-age could not be determined.  Therefore 98 
subjects (38 male) aged 6 to 20 (mean 13.27; SD 3.78) years, had a postero-anterior 
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(PA) DXA image and radiograph (96 left, 2 right) of the non-dominant hand, at the same 
visit.  GP bone-age was determined for each radiograph and each corresponding DXA 
hand scan.      
 
6.7 Data and Methods Summary 
The retrospective nature of the MI study and the use of two ongoing and two previously 
completed studies, all with different inclusion and exclusion criteria, age ranges and 
some with follow-up visits, may lead to ambiguity.  Therefore two summary tables 
attempt to clarify what information was obtained from the original studies and how 
many subjects (both total and baseline) were examined (Table 6.1) and what information 
the author collected for the MI study (Table 6.2).  
 
6.8 Quantitative Assessment 
Hand radiographs produced in the B16N2 Normal, Gymnast and the NF1 subjects were 
taken in the University of Manchester Medical School and those obtained in the CDGP 
study were taken at Booth Hall Children’s Hospital, Greater Manchester.   
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Table 6.1 – Subject Summary B16N2 Normal Gymnast NF1 CDGP 
Chronological Age 542 Total  
378 Baseline 
68 Total 
36 Baseline 
17 Total & 
Baseline 
161 Total 
108 Baseline 
TW3 Bone-Age 542 Total 
378 Baseline 
 
N/A 
 
N/A 
161 Total 
108 Baseline 
GP Bone-Age  98 Radiograph 
98 DXA Image 
 
N/A 
 
N/A 
 
N/A 
MW 542 Total 
378 Baseline 
68 Total 
36 Baseline 
17 Total & 
Baseline 
161 Total 
108 Baseline 
GPW 542 Total 
378 Baseline 
68 Total 
36 Baseline 
17 Total & 
Baseline 
161 Total 
108 Baseline 
Height 542 Total 
378 Baseline 
68 Total 
36 Baseline 
17 Total & 
Baseline 
25 Total & 
Baseline 
Weight 542 Total 
378 Baseline 
68 Total 
36 Baseline 
17 Total & 
Baseline 
25 Total & 
Baseline 
Tanner Pubertal Stage 499 Total 
362 Baseline 
68 Total 
36 Baseline 
17 Total & 
Baseline 
Unavailable 
to Author 
Arm Length 541 Total 
377 Baseline 
66 Total 
36 Baseline 
16 Total & 
Baseline 
Less than 10 
subjects had 
pQCT scans 
when the 
analysis was 
being done for 
the MI study.  
Due to subject 
number being 
too small to 
obtain reliable 
statistical 
output, none 
were analysed.  
Total Bone Density 4% 541 Total 
377 Baseline 
66 Total 
36 Baseline 
15 Total & 
Baseline 
Total Bone Area 4% 541 Total 
377 Baseline 
66 Total 
36 Baseline 
15 Total & 
Baseline 
CSMA 50% 538 Total 
374 Baseline 
65 Total 
35 Baseline 
15 Total & 
Baseline 
pSSI 50% 538 Total 
374 Baseline 
65 Total 
35 Baseline 
15 Total & 
Baseline 
Total Bone Area 50% 538 Total 
374 Baseline 
65 Total 
35 Baseline 
15 Total & 
Baseline 
Cortical Bone Density 50% 538 Total 
374 Baseline 
65 Total 
35 Baseline 
15 Total & 
Baseline 
Metacarpal Index DXR 148 Total & 
Baseline 
 
N/A 
 
N/A 
 
N/A 
BMDa DXR 148 Total & 
Baseline 
 
N/A 
 
N/A 
 
N/A 
Cortical Thickness DXR 148 Total & 
Baseline 
 
N/A 
 
N/A 
 
N/A 
 
Table 6.1: Data summary across all four studies outlining number of subjects examined in each 
group and using what technique. 
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Table 6.2 – Data 
Summary 
Data Obtained from Original 
Studies Used for MI Study 
Data Calculated by 
Author for MI Study 
Chronological Age X  
TW3 Bone-Age  X 
GP Bone-Age  X 
Height X  
Weight X  
Hand Radiograph X  
DXA Hand Image X  
40% & 60% MI/MW  X 
MI Z Scores  X 
MW  X 
GPW  X 
Arm Length X  
pQCT Measures X  
DXR Measures X  
Statistical Analyses  X 
 
Table 6.2:  Summary of data obtained from previous studies and data calculated by the author for 
the MI study. 
 
 
6.8.1 Image Acquisition - Radiographs 
Hand radiographs were performed by several radiographers in the department of Clinical 
Radiology at the University of Manchester, using Philips Medical Systems Super 80 CP 
X-ray equipment (Philips, Eindhoven, The Netherlands).  X-ray exposure was 55–60 
kV, 5 mAs, film focus distance 1m, and fine focal spot 0.6 mm.  The radiographic film 
used was either high-resolution Kodak MinR 2000 (Kodak, Rochester, N.Y.) single-
sided emulsion mammography film (SF), with Kodak MinR screens, or Konica MGSR 
fine-grain DF, with Kodak Lanex fine screens (all 24cm by 30cm).  All films were 
processed on a standard processing cycle in a Kodak X-OMAT M35 processor.   
Shortly after the CDGP group hand radiographs were completed at Booth Hall Hospital, 
this hospital was permanently closed and many records were moved to off-site NHS 
storage facilities, to which the author was not able to obtain access.  Therefore the author 
was not able to obtain the specifics of the radiographic processing for this group.   
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6.8.2 Digitising Radiographs 
To obtain the optimum method for digitising the radiographs to make the MI/MW/GPW 
assessments was problematic and required several approaches. 
a) The initial protocol involved using a digital camera (Canon model EOS 20D with 
Canon Macro lens set at medium quality .jpg 2544 x 1696 pixels, file size 1.2MB) 
mounted on a stand at 60cm above the film.  The films were illuminated using a light 
box to which a clear plastic ruler was attached both to give a straight edge with which to 
align the radius for computer analysis, and to give the images calibration markers.  The 
viewfinder of the camera was equipped with square boxes which were used to align the 
camera to the straight edge of the ruler.  The radiographs were then placed underneath 
the ruler with the widest part of the distal radial growth plate aligned to the straight edge 
of the ruler.  This practice ensured that the image of the radial growth plate would be 
horizontal, which was essential to the computer assisted measurement process.  The 
camera was set with a timer so that the camera placement would not be accidentally 
altered when the images were captured. 
The advantages of this protocol were the speed at which the images could be acquired; 
approximately 30 to 45 seconds to place the film and capture the digital image, and the 
resulting digital images did not require alignment alterations.  This protocol was 
discontinued after approximately 60 test images because access to this specific camera 
became difficult.  Another camera of this quality was not easily accessible, therefore the 
protocol was changed and a dedicated radiographic digitiser was used. 
b) The second method of digitising the radiographs involved using the VIDAR 
DiagnosticPro Advantage film digitiser (Vidar, Herndon, USA).  The digitiser was set at 
the following settings: depth 12, resolution 300dpi, pixels 3000 x 3600, scan size 10 x 
12 and the power was set at 5.  Power is the level of light/dark.  Power 1 is the lightest 
and power 10 is the darkest, therefore power 5 is in the midrange.  Although this often 
resulted in the middle and distal phalanges being too dark to distinguish clearly 
(unimportant in an MI assessment), it also kept the background around the radius from 
being too light, which interfered with the ability of the author to judge the edges of the 
bone.  The advantage of this method was that the scan time for a 300dpi image was short 
at approximately 30 seconds.  However, this resolution resulted in an image of 
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significantly reduced quality compared to Method 1 and it was often difficult to judge 
the edges of the bone.  This method was abandoned after approximately 70 test images.  
c) The third protocol also used the VIDAR DiagnosticPro Advantage film digitiser.  
The digitiser was set at the following settings: depth 12, resolution 570dpi, pixels 5700 x 
6840, scan size 10 x 12 and power set at 3 (which is the default power setting).  The 
image quality was excellent at this resolution but the file size was very large.  The Vidar 
has the advantages of being able to scan up to 25 radiographs in one batch and has scan-
settings of up to 570dpi resolution.  The disadvantages are the time it takes to scan one 
radiograph at 570dpi (approximately 4 minutes) and the large file sizes at that resolution 
(approximately 75MB .tiff files for the scan settings in this protocol).  Another 
disadvantage specific to this study is that for the computer-based measurements to be 
accurate, the widest part of the radial growth plate must be a completely straight 
horizontal line.  This meant that to prepare a digitised radiograph for computer-based 
measurement, the image would have to be opened in Adobe Photoshop and rotated until 
the radial growth plate of the image was horizontal.  Unfortunately this process changed 
the size of the image: the more the image had to be rotated, the higher the increase in file 
size, which could have undetermined effects on the image.  This also resulted in the 
image files often exceeding 100MB and the software used to perform the computer-
assisted measurements often experienced difficulties opening the files or would crash 
during the measurement process.  The issues of file size being too large to be 
opened/measured, image rotation file size differences and a malfunction in the VIDAR 
that was causing damage to the films lead to a final change in protocol back to the 
original digital camera method after completing approximately 25 test images. 
d) The final protocol was as described for a) the initial protocol, using the same 
Canon model EOS 20D digital camera and Canon Macro lens.  A 1.2MB file size was 
easily managed by the program used to perform the computer assisted measurements 
(further detail in section 6.10), and provided excellent resolution for bone-edge 
detection.  The final method is illustrated in Figure 6.1. 
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6.8.3 Image/Data Acquisition – pQCT 
All pQCT scans for the original B16N2 study were performed by a radiographer in the 
department of Clinical Radiology at the University of Manchester using a Stratec XCT-
2000  pQCT  scanner  (Phorziem, Germany).   The length of  the forearm to be  scanned 
 
 
Figure 6.1: Photograph of setup used to digitise radiographs, optimised for measurement of MI. 
 
(arm length) was measured by placing the subject’s elbow on a table with the arm 
resting vertically and using a tape-measure to measure from the ulnar styloid process to 
the olecranon, and was performed by a radiographer.   The arm of the subject was placed 
within the bore of the pQCT where their hand rested on a hand-grip.  This allowed the 
subject to keep his/her arm still, thus avoiding movement artefact (Fig 6.2).  Scans were 
taken at the 3.5%, 4% and the 50% midshaft radius.  Generally the 3.5% slice is not used 
but two subjects experienced movement artefacts on the 4% slice, therefore the 3.5% 
was  used  in  those  cases.   The  measurements  used  were  total  bone  mineral  density 
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Figure 6.2: The Stratec XCT-2000 pQCT machine at the Manchester Royal Infirmary (formerly 
housed at the department of Clinical Radiology, University of Manchester).  
 
(toBMD), cross-sectional muscle area (CSMA), polar strength-strain index (pSSI), 
radius cortical area (50%) and radius bone density (50%).    The cortical scans at the 4% 
site were performed using a 710 mg/cm3 threshold.  The cortical scans at the 50% site 
were performed using a 960 mg/cm3 threshold, except the cortical SSI threshold, which 
was performed at 480 mg/cm3.  Contour mode 1 peel mode 1 was the standard loop 
analysis used for bone and contour mode 3 peel mode 1 was used for muscle and bone 
analysis.  The contour mode works by identifying a voxel on the edge of the region of 
interest (e.g. radius) and comparing it to several other voxels surrounding it.  This 
process is repeated around the circumference of the radius until the starting voxel is 
reached.  Voxels not meeting the required threshold are excluded, leaving the region of 
interest.  Peel mode 1 peels away 55% of the outer bone layers (cortical bone) leaving 
45% of trabecular bone.  Bone area is the total cross-sectional area of a bone calculated 
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before the peel mode takes effect.  The standard Phorzeim pQCT phantoms were used to 
perform quality assurance daily.  Although there are no precision calculations for pQCT 
scans of children, the CV for adults in the Department of Clinical Radiology = 1.27% for 
trBMD and 2.1% for toBMD at the 4% distal radius and 1.7% for tBA, 2.4% for csBA, 
and 3.7% for CSMA at the 50% radius (Ashby, 2007). 
  
6.8.4 Image Acquisition – DXA Hand Images 
All DXA scans were performed by a radiographer in the department of Clinical 
Radiology at the University of Manchester using Hologic QDR 4500 Discovery DXA 
scanner, software version 12.4 (Hologic Inc. Bedford, MA) (Fig 6.3), using the lumbar 
spine protocol.  The standard Hologic phantom was used to perform quality assurance 
daily.  During lumbar spine lateral morphology scans, a single-energy scout scan is used 
in order to determine if the patient is in the correct position.  It is this single energy scan  
 
 
Figure 6.3: Hologic QDR 4500 Discovery DXA scanner in the Bone Densitometry suite at the 
Manchester Royal Infirmary (formerly housed in the department of Clinical Radiology, University 
of Manchester). 
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that was used to produce the DXA hand images.  To simulate soft tissue and improve 
image quality, a piece of polystyrene of uniform thickness (PUT), which measured 3 cm 
in thickness, was placed under the hand before the scan commenced.  Subjects placed 
their pronated forearm and hand, with fingers together, on the PUT.  Scanning then 
commenced a few centimetres distal to the finger-tips and stopped after approximately 
1/3 of the distal forearm was scanned.  Data regarding DXA BMDa were disregarded as 
the images obtained were the focus of this study.  Although no studies of precision were 
conducted on DXA hand image scans, the department of Clinical Radiology had a CV = 
1.1% for adult lumbar spine scans, and for whole body and lumbar spine scans 
combined, the maximum estimated dose equivalent was 0.0055 mSv (Ashby, 2007).   
 
6.9 Anthropometric Data 
Height to the nearest 0.1 cm was measured in the B16N2 normal, gymnast and NF1 
studies using a Leicester Height stadiometer (Child Growth Foundation, UK).  Weight to 
the nearest 0.1 kg was measured in all studies using Seca digital scales (Autoweigh 
Scales, UK).  Subjects were clothed but without shoes when height and weight were 
assessed.  Tanner pubertal stage was assessed using the Tanner criteria (Tanner et al., 
1962) and a Prader orchidometer (Pharmacia and Upjohn, Sweden).  Subjects were 
provided with a private changing room and parental assistance was permitted when 
needed.   
 
6.10 Calculating the Metaphyseal Index 
The method for calculating the MI is the same as that originated by Ward and colleagues 
(Ward et al., 2005a).  It is defined as the ratio of half the metaphyseal width (0.5MW) to 
the growth plate width (GPW) (Fig 6.4).  Two measurement techniques were employed: 
manual and computer assisted measurement.  The manual measurement technique was 
performed using a hard copy film radiograph, a Lineartools Electronic Digital Calliper 
(Middlesex, UK), and a light box.   
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Figure 6.4: Method for calculating the MI.   
 
The computer assisted technique used the program Qwin© by Leica Microsystems 
(Milton Keynes, UK).  The Stopford numbers (used to anonymise images) of each 
radiograph were matched with the file name that the camera automatically assigned to 
each image.  Each time the setup was dismantled, the number of images taken was 
recorded in order to ensure that the calibration was checked on the first image of a new 
batch and on other randomly selected images.  The calibration was achieved by selecting 
two points on the image, usually points on the ruler between 10mm and 30mm apart.  
The operator would enter the appropriate distance in millimetres into the calibration 
menu.  After entering the distance, QWin would provide a calibration.  The calibration 
was checked approximately 50 times over the course of analysing the images.  In every 
case the calibration used was 0.0449mm.  This meant that despite the setup being 
dismantled and set up several times, the repeatability was excellent (see section 8.2) as 
the calibration given by QWin was always the same.  The digital images appeared 
approximately quadruple the size of what was visible using a hard-copy film for the 
manual measurements.  The pointer (controlled by the computer’s mouse) combined 
with the size and quality of the image, allowed for a very finely detailed selection of the 
edge of the radial growth plate.  Once the widest edge of the radial growth plate was 
selected (usually beginning with the left edge), the pointer was moved across to the 
opposite edge of the radial growth plate.  As the pointer moved, the distance (in number 
 109
of pixels) would change accordingly and appeared in a function menu at the side of the 
screen.  Once the opposite edge of the radial growth plate was reached, the number of 
pixels was noted.  This number, when converted by the computer to millimetres, was the 
GPW measurement.  GPW was then divided by two to obtain the 0.5GPW measurement.  
Once the GPW was divided by two, the pointer was moved downwards until it reached 
the number of pixels equivalent to 0.5GPW.  The resulting image was a box in the shape 
of a rectangle.  To obtain the 0.5MW measurement, the pointer was used to select the 
edges of the bone and the excess portions of the rectangle were removed.  QWin 
converted the length of these lines from pixels to millimetres and produced information 
for each image.  To make this process faster and more user friendly, a QUIP was written 
within Qwin to automate certain actions.  QUIP is an interactive macro-programming 
facility that allows the operator to create semi-automatic routines for repetitive tasks.  
Once the QUIP was running, the image folder containing the digitised radiographs 
opened.  After the operator selected a radiograph, the calibration toolbar appeared, 
which allowed a calibration check to occur on every image if the operator so chose.  
Once the operator accepted the calibration, a box-drawing toolbar appeared that allowed 
the operator to mark the GPW and MW.  Once the operator accepted the box, the 
‘erasure’ toolbar appeared allowing the user to erase the parts of the box that extended 
beyond the bone edge.  When the operator accepted the bone-edge detection, the 
measurements of the two remaining lines (GPW and MW) appeared (in millimetres) in a 
Microsoft Office compatible table that could easily be copied and pasted into a master 
document or spreadsheet.  Once the operator copied and pasted the values for that image 
into another document and the ‘continue’ button was clicked, the process began again.  
Figure 6.5 is an illustration of the computer assisted measurement method.  Table 6.3 is 
an example of the information produced by QWin.  Feature number 1 is the GPW 
measurement and Feature number 2 is the MW measurement, both given in millimetres.  
The other statistical information (X FCP and Y FCP) is defined as the feature count 
point for the X and Y axes, which are pixel co-ordinates.  This information is currently, 
along with the descriptive statistical information i.e. the mean, standard deviation etc., 
irrelevant for the purposes of this project but has been saved.  By dividing the MW by 2 
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(21.611 / 2 = 10.806) we obtain the 0.5MW measurement.  MI is calculated by 0.5MW / 
GPW.  Therefore the MI for the example in Table 6.3 is 10.806 / 29.289 = 0.369. 
 
 
 
Figure 6.5: An example of the measurement process using Leica QWin.  Bone edge detection was 
performed by the operator.  The green lines were measured and the yellow lines were discarded. 
 
 
Table 6.3 – QWin Data Output
Features 2   
        
 Number  
       X 
FCP 
       Y 
FCP 
Width 
(mm) 
1 1062 469 29.289 
2 992 779 21.611 
    
Total        2054 1248 50.901 
Mean        1027 624 25.45 
Std Dev    35 155 3.839 
Std Err     24.749 109.602 2.714 
Max          1062 779 29.289 
Min          992 469 21.611 
2-s Ran     140 620 15.355 
 
Table 6.3: Example of output produced by Leica QWin.  Width number 1 is the GPW and width 
number 2 is the MW. 
 
 111
6.10.1 Assessing the Metaphyseal Index 
The formula for calculating the MI is 0.5MW/GPW.   The metaphyseal site at which the 
MW is measured is calculated by taking 50% of the GPW.   However, taking 50% of the 
GPW is an arbitrary percentage chosen by Ward and colleagues (Ward et al., 2005a) and 
it is possible that using 40% or 60% of the GPW would result in a statistically more 
useful area of the metaphysis being measured, though the choices to take measurements 
at 40% and 60% of the GPW were also arbitrary.  When 40% of the GPW was chosen, it 
resulted in a slightly more distal site of the metaphysis being measured.  When 60% of 
the GPW was chosen, it resulted in a more proximal site of the metaphysis being 
measured (Fig. 6.6).  This meant the MW would be at a different site and therefore a 
different width depending on how much of the GPW was used to calculate the MW site.  
The term ‘40% MI’ was used to describe an MI where 0.4 GPW was used to determine 
the MW site, and the term ‘60% MI’ was used to describe an MI where 0.6 GPW was 
used to calculate the MW site.  Twenty-five randomly selected males and 25 randomly 
selected females from the normal group were assessed using the 40% MI and the 60% 
MI.  Both the 40% MI and 60% MI were plotted against age and the plots compared to 
the original MI.  The minimum, maximum and mean were calculated and also compared 
with the original MI results.   
 
 
Figure 6.6: An illustration the methods for calculating the 40% and 60% MI. 
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6.11 TW3 Bone-Age Assessment Using Hand Radiographs 
The bone-ageing method chosen for the MI study was the TW3 (Tanner et al., 2001), 
which is the most current of the TW series and all hand radiographs were assessed using 
this method.  This method involves designating each relevant bone with a letter of the 
alphabet along with its corresponding numerical score.  The letters range from B to I; B 
being the most skeletally immature category and I being the most skeletally mature 
category.  Once the bone was assigned a letter based on maturity level, it was assigned a 
corresponding numerical score, which is different for every bone and is sex specific, as 
the female skeleton matures earlier than the male skeleton.  Some bones, such as the 
radius and ulna, are weighted higher in the scoring system than phalanges or 
metacarpals.  Therefore, having a more mature radius ensures a higher overall score than 
having a mature phalanx.  A higher overall score therefore corresponds to a higher bone 
age.  The TW3 method has two scoring systems, one for the radius, ulna and short bones 
(RUS), and one for the carpal bones (CAR).  The specific bones included in the RUS 
group are the radius, ulna and the metacarpals and phalanges of the first, third and fifth 
digits.  The bones included in the CAR group are the capitate, hamate, triquetral, lunate, 
scaphoid, trapezium and trapezoid (Fig. 6.7).  Separating the scores in this way means 
that there is one bone age for the RUS group and one for the CAR group.  The highest 
overall score attainable for both the RUS and CAR groups for both sexes is 1000.  An 
overall score of 1000 for a male RUS is equivalent to a bone age of 16.5 years and an 
overall score of 1000 for a male CAR is equivalent to a bone age of 15+ years.  For 
females, an overall score of 1000 for an RUS is equivalent to a bone age of 15 years and 
an overall score of 1000 for a CAR is equivalent to a bone age of 13+ years.  RUS bones 
are shown in red and CAR bones are shown in black.  Each radiograph was assessed 
using this method.  The RUS scores were then plotted on graphs comparing them to the 
value of the MI.  Only the RUS scores were used because the radius is the most relevant 
bone to compare to the radial MI.  The carpals often have a bone-age that is more 
advanced than both the RUS age and chronological age because they mature at a faster 
rate (Dhar et al., 1993) and a single age rather than an age range is needed for statistical 
comparisons.   
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Figure 6.7: The bones used in TW3 bone-age assessment.  The 1st, 3rd and 5th metacarpals and 
phalanges are used in this method.  Although not visible in this radiograph, the pisiform (one of the 
carpal bones) is also not used in this method. 
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6.12 GP Bone-Age Assessment Using Radiographs and DXA Hand Images 
In the B16N2 Normal study, the Mobile Osteoporosis Research Scanning Units owned 
by the University of Manchester were frequently taken to schools to obtain scans from 
children to improve recruitment.  However, this mobile unit did not contain any X-ray 
equipment (for taking hand radiographs), due to availability and the cost of making such 
devices portable.  In a previous study, a set of images of the left hand made using a 
Hologic 4500 DXA scanner (Hologic Inc., Bedford, MA, USA) were used to investigate 
whether bone-age assessments could be performed by DXA to replace standard 
radiographs (Ashby et al., 2002a).  In 2004 the software for the DXA scanner was 
upgraded to Hologic QDR 4500 Discovery (Bedford, USA) software version 12.4, 
resulting in improved image quality from that obtained in the original study.  Beginning 
in October 2004, DXA hand images of children participating in the B16N2 study were 
taken using the new DXA software.  The aim of this study is to evaluate bone age 
assessment using the GP method from hand radiographs and compare the results with 
hand/wrist images generated by DXA using a cross-sectional approach.  The primary 
hypothesis is that bone-age assessment from hand radiographs will differ significantly 
from those made using DXA hand images.  The inclusion criteria were as follows:  Each 
child was required to have both a hand radiograph and a viable DXA hand scan, which 
were performed on the same day, available for comparison.  Some children had multiple 
hand radiographs and DXA hand scans in the longitudinal study so where there was 
more than one option, the base-line hand radiograph and DXA hand scan were preferred 
for consistency, but not utilised exclusively in order to obtain a more varied age range.  
All scans were performed using the lumbar spine algorithm on software version 12.4.  
Twenty repeat bone-age measurements were performed to calculate bone-age 
assessment precision; 10 males and 10 females, both randomly selected.  Figure 6.8 
illustrates a conventional hand radiograph taken using radiographic film and a DXA 
hand image.  
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Figure 6.8: A comparison of a conventional hand radiograph (A) and a DXA hand image (B).  
 
6.13 DXR Measures 
All DXR measures (BMDa, cortical thickness the Metacarpal Index (MCI)), were 
obtained using baseline hand radiographs of the Normal group by a previous PhD 
student using  the  Sectra Pronosco system (Linköping, Sweden) and have been 
published  previously (Ashby, 2007).  The Sectra Pronosco system consists of a flatbed 
scanner linked to a computer with the Pronosco software.  A hand radiograph is placed 
on the scanner and the system automatically detects the regions of interest, which are the 
diaphyses of the second, third, and fourth metacarpals (Adams, 2010).            
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7. Methods - Analysis 
7.1 Statistical Analyses and Data Handling 
All statistical calculations were performed using SPSS (Statistical Package for the Social 
Sciences) (Chicago, USA) using software version 16.0, StatsDirect software version 
2.6.2 (Altrincham, UK) and Analyse-It (Leeds, UK) attachment for Microsoft Excel 
2003 (Washington, USA).  All subject data were stored in SPSS files (.sav, .spv) and/or 
in Microsoft Excel and Word 2003 spreadsheets in .xls, and .doc files respectively.  
Graphical representations of the data were made using StatsDirect or SPSS.  Digital 
images were analysed using Leica Qwin© (Milton Keynes, UK).  DXA hand images 
were stored using Hologic QDR Discovery software version 12.4.  Data were stored 
securely on password protected hard drives within the University of Manchester’s 
Imaging Science Department.  Stopford numbers were assigned to each subject to ensure 
anonymisation during the analyses. 
 
7.2 Precision 
Precision or co-efficient of variation (CV) was calculated using Equation 7.2:  
 
Equation 7.2:    CV% = (within subject standard deviation / mean) X 100 
 
(Gluer et al., 1995).  The within subject standard deviation equals the square root of the 
within subject variance, or mean square in SPSS, which was calculated using a one-way 
ANOVA.  The CV% was calculated using repeat MI measurements of 30 subjects (9 
male).  Thirty-five subjects (14 male) were used to calculate the precision of the TW3 
bone-age assessment using radiographs and GP bone-age assessment using radiographs.   
 
7.3 Normal Group 
Distributions of variables were examined using histograms to check for normal 
distributions.  The baseline MI, MW and GPW values for the Normal group were 
compared to chronological age, height, weight, arm length, toBMD (4% site), CSMA 
(50% site), radius bone area (50% site), radius cortical density (50% site), MCI, 
BMDaDXR and CrtThickDXR in males and females using simple linear regressions and 
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the relationships were compared using Spearman’s rank correlation.  MI and 
chronological age were compared using a polynomial regression.  MI, MW and GPW 
were plotted against chronological age and height using simple linear and polynomial 
regressions.  Mean MI, MW and GPW values of males and females (adjusted for age) 
were compared using a one-way analysis of variance (ANOVA) with Tukey’s HSD.  
Where statistically significant differences or large differences in minimum and 
maximum values were detected between males and females, Tukey’s HSD and 
descriptive statistics were used to guide the adjustment of values so that the values in 
each category matched or overlapped significantly.  A stepwise multiple linear 
regression was performed to examine the relationships of MI, MW and GPW using the 
anthropometric, pQCT measures and DXR measures as covariates, the results of which 
determined the covariates used in the analysis of co-variance (ANCOVA) analysis.  
ANCOVA was used to compare the slopes of the above data in males and females.  MI 
values were also plotted against Tanner pubertal stage and Tanner group using box and 
whisker plots.  To increase the number of subjects in each group for statistical purposes, 
the Tanner stages were grouped together; Tanner stage 1 comprised Tanner group A 
(136, 67 male) Tanner stages 2 and 3 comprised Tanner group B (100, 48 male), and 
Tanner stages 4 and 5 comprised Tanner group C (127, 36 male).  Tanner stages were 
not available to the author for 15 Normal group subjects.  Tukey’s HSD was used to 
compare the means between the MI, MW and GPW in Tanner groups A, B and C.  To 
visually examine the distribution, the MI values were transformed into Z scores using 
Equation 7.3:  
 
 
Equation 7.3:  MI Z score = (subject MI value - mean MI value for that Tanner group) 
            the SD of the mean MI for that Tanner  group 
 
 
Male and female means and SD’s were calculated separately.   
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7.3.1 TW3 Bone-Age Assessments 
All Normal radiographs, including longitudinal radiographs, had a TW3 bone-age 
assessment.  Repeats were performed to assess precision as discussed in section 7.2.  
Bone-age was used instead of chronological age for the CDGP and to compare them 
with the Normal group as discussed in sections 7.6 and 7.7.  
 
7.3.2 40% and 60% MI and MW 
The 40% and 60% MI and MW were compared to chronological age using 25 randomly 
selected females and 25 randomly selected males.  The 40% MI and MI, the 60% MI 
and MI, the 40% MW and MW, and the 60% MW and MW were plotted against each 
other using simple linear regressions to examine the relationships between these 
variables. 
 
7.3.3 Longitudinal Analysis 
Many subjects in the Normal group attended multiple visits.  In the Normal group, 63 
subjects attended for 2 visits, 36 subjects attended for 3 visits and 9 subjects attended for 
4 or more visits.  The minimum time elapsed between visits was approximately 1 year 
and the maximum was approximately 6 years.  The MI values of all Normal group 
subjects with a visit at Tanner pubertal stage 3 and Tanner pubertal stage 4 (21 subjects, 
7 male), were plotted against each other using both a simple linear regression and a 
grouped linear regression separating males and females.     
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7.4 Gymnast Group 
The baseline MI, MW and GPW values for the Gymnast group were compared with 
chronological age, height, weight, arm length, toBMD, CSMA, radius bone area (50% 
site) and radius cortical density (50% site ) in males and females using Spearman’s rank 
correlations and the relationships were compared using simple linear regressions.  Mean 
MI, MW and GPW values of males and females (not adjusted for age) were compared 
using a one-way ANOVA with Tukey’s HSD.  The regression lines of chronological age 
and height in males and females were compared using grouped multiple linear 
regressions and ANCOVA.  To visually examine the distribution, the MI values were 
transformed into Z scores using Equation 7.3, but male and female means and SDs were 
not calculated separately due to insufficient subject numbers.  
 
7.4.1 Longitudinal Analysis 
Most subjects in the Gymnast group attended multiple visits: 32 (12 male) of 36 subjects 
attended for 2 visits and no subjects attended for more than 2 visits.  The time elapsed 
between visits was approximately 1 year (+ 1 month) in each case.  The data for each 
subject with 2 or more visits was examined.  The MI value from the first visit was 
plotted against the MI value from the second visit using simple and grouped linear 
regressions to examine the relationship between the 2 visits.  
 
7.5 NF1 Group 
The MI, MW and GPW values for the NF1 group were plotted against chronological 
age, height, weight, arm length, toBMD, CSMA, radius bone area (50% site) and radius 
cortical density (50% site) in males and females using Spearman’s rank correlations. 
Where statistically significant differences or large differences in minimum and 
maximum values were detected between males and females, Mann-Whitney U-tests and 
descriptive statistics were used to guide the truncation of values so that the values in 
each category matched or overlapped.  Mean MI, MW and GPW values of males and 
females (not adjusted for age) were compared using a one-way ANOVA with Tukey’s 
HSD.  The relationships of these variables were compared using non-parametric linear 
regressions, where the value of the median slope (ms) is reported in place of an r value.  
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The regression lines of males and females were compared using ANCOVA.  To visually 
examine the distribution, the MI values were transformed into Z scores using Equation 
7.3.  Male and female means and SDs were not calculated separately due to insufficient 
subject numbers.  A Shapiro-Wilk test was used to test for non-normal distribution of the 
MI Z scores. 
 
7.6 CDGP Group 
Shapiro-Wilk tests were used to test for non-normal distribution of the variables.  The 
MI, MW and GPW values for the NF1 group were plotted against TW3 bone-age (using 
a polynomial regression), height and weight in males and females using simple linear 
and polynomial regressions and the relationships were compared using Spearman’s rank 
correlations.  Mean MI, MW and GPW values of males and females (not adjusted for 
age) were compared using a one-way ANOVA with Tukey’s HSD.  The regression lines 
of males and females were compared using ANCOVA.  For the height and weight 
calculations, only 25 subjects (22 male) of the total number of subjects examined (108, 
89 male) were used due to height and weight information only being available to the 
author for those 25 subjects.  Height values were not truncated despite the large 
differences between the minimum and maximum values of male and female heights 
because there were only 3 female heights available for comparison.  To visually examine 
the distribution, the MI values were transformed into Z scores using Equation 7.6.   
 
Equation 7.6: MI Z score = (subject MI value - mean MI value for that bone-age year)  
        SD of the mean MI for that bone-age year 
 
where ‘that bone-age year’ refers to groupings of subjects within 1 bone-age year (e.g. 
6.0 – 6.9 years, 7.0 to 7.9 years etc).  Male and female means and SDs were not 
calculated separately due to an insufficient number of female subjects in this group.  A 
Shapiro-Wilk test was used to test for non-normal distribution of the MI Z scores.  A 
paired t-test and a box and whisker plot were used to illustrate the differences between 
chronological age values and TW3 bone-age values.  All CDGP subjects, including 
longitudinal radiographs, had a TW3 bone-age assessment.  TW3 bone-age was used in 
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place of chronological age in all CDGP assessments and a comparison between MI and 
TW3 bone-age and MI and chronological age using polynomial regressions was made to 
illustrate the purpose of this. 
 
7.6.1 Longitudinal Analysis  
Many subjects in the CDGP group attended multiple visits: 23 subjects attended for 2 
visits, 10 subjects attended for 3 visits and 3 subjects attended for 4 or more visits.  The 
minimum time elapsed between visits was approximately 1 year and the maximum was 
approximately 4 years.  The data for each subject with 2 or more visits was examined for 
visits that were approximately 18 months apart (+ 4 months).  These 2 MI values were 
plotted against each other using simple and grouped linear regressions to examine the 
relationship between the 2 visits (15, 9 male).  
 
7.7 Comparison of All Groups   
Visual comparisons of the MI, MW and GPW were made using box and whisker plots 
illustrating the means, standard deviations and range of all 4 groups.  The differences in 
mean height were analysed by comparing the mean height of the Gymnast group, NF1 
group and CDGP group compared to the Normal group using three unpaired t-tests.  The 
baseline MI values for the Normal, Gymnast and NF1 groups were plotted against age 
using a grouped linear regression plot and the means were compared using a one-way 
ANOVA with a Dunnett’s test.  The baseline values of the Normal, Gymnast and CDGP 
groups were truncated to match the chronological age distribution of the smallest group 
(NF1), therefore all subjects aged between 5.9 years and 9.9 years (or with a TW3 bone-
age of 5.9 to 9-9 years in the case of the CDGP group) were used in the one-way 
ANOVA with Dunnett’s t test (107 Normal, 26 Gymnast, 17 NF1 and 32 CDGP).   As 
the only consistent interval variable throughout all 4 groups was age, the only covariate 
used in the ANCOVA analysis was age (chronological for Normal, Gym and NF1 and 
the equivalent TW3 bone-age for CDGP).  Levene’s test was used to examine the groups 
for homogeneity of variance.  Dunnett’s t test is the only test that specifically requires a 
control group to be chosen so that all other groups are compared only to the chosen 
control, therefore the results section (8.7) concentrated on the results of the Dunnett’s t 
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test.  Each subject in the Gymnast group was matched for height (within 1.5cm) with 
one control from the Normal group.  A paired t-test was performed on both height and 
MI to determine the any mean differences.  The MI Z scores using “chronological age 
groups” were used to compare the Normal, Gymnast and NF1 groups.  The MI Z scores 
using “bone-age groups” were used to compare the Normal and CDGP groups.  
   
7.8 DXA Bone-Age Study 
Statistical analyses were performed using SPSS (Statistical Package for the Social 
Sciences) (Chicago, USA), software version 14.0 and Med-Calc software version 9.5.2.0 
(Mariakerke, Belgium).  The CV% was calculated using the equation 7.3.  The within 
subject standard deviation equals the square root of the within subject variance, or mean 
square in SPSS, which was calculated using one-way ANOVA.  A Bland and Altman 
plot (Bland and Altman, 1986) was used to test the agreement between the two methods 
(radiograph and DXA).  The r2 value was calculated to indicate the correlation between 
DXA bone-age and radiograph bone-age.  Twenty repeat measurements (10 male) each 
were performed to calculate the precision of GP bone-age assessment using DXA hand 
images and GP bone-age assessment using radiographs.  The repeat bone-age 
assessments were performed approximately one month after the original assessments 
and were performed by the same assessor (the author).    
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8. Results 
8.1 Introduction 
This chapter has three parts containing the results of the work presented in this thesis.  
The first part contains the results of the four groups studied and is organised into four 
sections: results within the Normal group, within the Gymnast group, within the NF1 
group and within the CDGP group.  The second part compares the results of each study 
group to the Normal group.  The third part outlines the results of the DXA bone-age 
assessment study.  For abstracts and posters with descriptions of preliminary 
experiments and results of the MI study, see Appendix 12.1.  There are significant 
numbers of figures referred to in this chapter that may impede readability if they were to 
all be placed within this chapter.  Therefore any figures with an asterisk placed next to 
the figure reference in the text (e.g. Fig 8.1A*) are located in Appendix 12.4.   
 
8.2 Precision 
Table 8.2A represents the CVs of the MW, GPW and MI measurements.   
Table 8.2A:  Precision of MI Measurements – Comparison of 
Manual and Computer Assisted Techniques CV % 
Manual MW 1.81% 
Manual GPW 2.35% 
Manual MI 2.91% 
Computer Assisted MW 0.92% 
Computer Assisted GPW 1.28% 
Computer Assisted MI 1.05% 
 
Table 8.2A: CVs of manual compared to computer-assisted measurement techniques.   
 
This table shows that all the computer-assisted measurements (0.92% MW, 1.28% GPW 
and 1.05% MI) have a higher repeatability than the manual measurements (1.81% MW, 
2.35% GPW and 2.91% MI), therefore the computer-assisted measurements were used 
for subsequent work.  
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Table 8.2B: Precision of Bone-Age Assessment  - Comparison of 
TW3 and GP Methods 
CV % 
Radiograph Bone-Age Assessments (TW3) 1.61% 
Radiograph Bone-Age Assessments (GP) 2.68% 
 
Table 8.2B: CVs of bone-age assessment methods comparing the precision of the TW3 method to 
the GP method.  
 
 
Table 8.2B shows the CV of the TW3 bone-age assessment method compared to the CV 
of the GP bone-age assessment method.  This table shows that the CV of TW3 bone-age 
assessments indicate a higher repeatability than the CV of GP bone-age assessments.
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8.3 Normal Group 
Each pQCT and anthropometric variable exhibited normal distribution.  When the 
baseline MI values were compared with the baseline values of each anthropometric 
measure (chronological age, TW3 bone-age, height, weight, Tanner stage and arm 
length), each pQCT measure (toBMD, CSMA, pSSI, radius bone area 50% and cortical 
bone density 50%), and each DXR measure (MCI, BMDaDXR and CrtThickDXR) 
Spearman’s rank and Pearson’s r correlations showed that the MI was not significantly 
correlated with any DXR measures (all p > 0.297) or toBMD (4%) (p = 0.181).  MI was 
significantly correlated with all other variables (all p < 0.0009), with no r values above 
0.305 (Tanner stage).  If one squared the highest significant r value and multiplied it by 
100; (0.3052 = 0.093), (0.093 x 100 = 9.3), this would indicate that although the 
correlation was significant, only 9.3% of variation in the MI could be explained by 
Tanner stage. 
MI was not compared to toBA (4%) because bone width, which is a component of the 
MI, will always be correlated with toBA.  When MI was compared to chronological age 
using baseline values, the MI was lower in early age groups, and increased through the 
pre-teenage and teenage years where it reached a plateau (Fig 8.3A).  A similar result 
occurred when MI was compared to height using baseline values (Fig 8.3B).  Using 
grouped linear regressions to examine the MI in males and females compared with 
chronological age (Fig 8.3C) and height (Fig 8.3D), with age and height values adjusted 
so that the minimum and maximum values were the same for both males and females, 
there were no statistically significant differences in the slopes for either MI compared to 
chronological age (p = 0.240), or MI compared to height (p = 0.092).  
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Figure 8.3A: MI vs chronological age (years) in the Normal group (baseline values).  This cross-
sectional plot illustrates that the MI increases with age. 
 
 
Figure 8.3B: MI vs height (cm) in the Normal group (baseline values).  This cross-sectional plot 
illustrates that the MI increases with height. 
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Figure 8.3C: MI vs chronological age (years) in Normal males and females.  This plot illustrates the 
slightly different regression lines of males and females, but there is no statistically significant 
difference. 
 
 
Figure 8.3D: MI vs height (cm) in Normal males and females.  This plot illustrates the slightly 
different regression lines of males and females, but there is no statistically significant difference. 
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The common slopes were both significantly different from zero (both p < 0.0001).   
 
The MW was compared with the same variables discussed previously and most 
Spearman’s rank and Pearson’s r values were significant (p < 0.0001) except those for 
toBMD, MCI, BMDaDXR and CrtThickDXR, which showed insignificant correlations 
(all p > 0.9).  The lowest significant r value was cortical bone density (50%); r = 0.273 
with a 95% CI of 0.174 to 0.366, and the highest was pSSI; r = 0.815 with a 95% CI of 
0.777 to 0.847.  Therefore cortical bone density explained 7.5% of the variation in MW 
and pSSI explained 66.4% of the variation in MW.  MW was compared to chronological 
age in the Normal group using baseline values. This showed a similar result to the MI, 
but exhibited a tighter concentration of values around the regression line (Fig 8.3E).  
The Spearman’s rank correlation for chronological age compared to MW (baseline 
values) was r = 0.673 (p < 0.0001), with a 95% CI for r = 0.614 to 0.725, which 
indicated a statistically significant positive correlation between MW and chronological 
age.  A similar result occurred when MW was compared to height (baseline values) (Fig 
8.3F); r = 0.763, (p < 0.0001) with a  95% CI of 0.718 to 0.803, indicating that height 
was also significantly positively correlated with MW.     
GPW was compared to all variables discussed previously, and all Spearman’s rank and 
most Pearson’s r values were statistically significantly correlated (all p < 0.007) except 
for toBMD (4%), MCI, BMDaDXR and CrtThickDXR, which were insignificantly 
correlated (all p > 0.1).  The lowest significant r values was cortical bone density (50%); 
r = 0.251 with a 95% CI of 0.151 to 0.345, and the highest r value was CSMA; r = 0.806 
with a 95% CI of 0.767 to 0.840.   Therefore cortical bone density explained 6.3% of the 
variation in GPW and CSMA explained 65.0% of the variation in GPW.  GPW 
compared with chronological age in the Normal group (baseline values) showed a 
similar result to MW vs chronological age; a tight concentration of values around the 
regression line (Fig 8.3G), r = 0.657 (p < 0.0001) with a 95% CI of 0.596 to 0.711, 
indicating a statistically significant correlation between GPW and chronological age.  
GPW compared with height showed a similar result (Fig 8.3H), r = 0.751 (p < 0.0001) 
with a 95% CI of 0.703 to 0.792, also indicating a statistically significant positive 
correlation between GPW and height.  Outliers will be discussed in section 9.3. 
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Figure 8.3E: MW (mm) vs chronological age in the Normal group (baseline values).  This cross-
sectional plot illustrates that the MW increases with age. 
 
 
Figure 8.3F: MW (mm) vs height (cm) in the Normal group (baseline values).  This cross-sectional 
plot illustrates that the MW increases as height increases. 
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Figure 8.3G: GPW (mm) vs chronological age in the Normal group (baseline values).  This cross-
sectional plot illustrates a similar result to the MW plot - that the GPW increases with age. 
 
 
Figure 8.3H: GPW (mm) vs height in the Normal group (baseline values).  This cross-sectional plot 
illustrates a similar result to the MW plot - that the GPW increases as height increases. 
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A comparison of mean MI, MW and GPW values of males and females Tukey’s HSD 
revealed that there were no significant differences between the MIs (p = 0.734) or MWs 
(p = 0.129) of males and females, but there was a significant difference between the 
GPWs of males and females (p = 0.007).    
Tanner pubertal stage was also assessed in the Normal group.  The means of each MI, 
MW and GPW in the 5 Tanner stages (rounded to 3 decimal points) are shown in Table 
8.3A.  The MI in Tanner stages 1 through 5 showed that the MI increased through 
puberty (Fig 8.3I*).  Using Tukey’s HSD test, the only significant differences in the MI 
means were found between Tanner stages 1 and 4 (p = 0.001) and Tanner stages 1 and 5 
(p < 0.0001).  The MW means (Fig 8.3J*) showed significant differences between 
Tanner stages 1 and each other Tanner stage (all p < 0.0001).  There were also 
significant differences between MW Tanner stages 2 and 4 (p < 0.0001) and 2 and 5 (p < 
0.0001).  There were significant differences between the GPW mean at Tanner stage 1 
and each other Tanner stage (1 and 2, p = 0.001; 1 and 3/4/5, p < 0.0001) (Fig 8.3K*).  
As in the MW means, the GPW means showed significant differences between Tanner 
stage 2 and 4 (p = 0.001) and 2 and 5 (p < 0.0001).   
 
 
Table 8.3A – Means of MI, MW and 
GPW in Tanner Stages 1 through 5 Mean MI Mean MW Mean GPW
Tanner Group A Tanner Stage 1 0.347 15.342 22.130 
Tanner Group B Tanner Stage 2 0.352 17.096 24.297 Tanner Stage 3 0.352 18.284 25.997 
Tanner Group C Tanner Stage 4 0.358 19.094 26.705 Tanner Stage 5 0.358 19.442 27.184 
 
Table 8.3A: Means of MI in the Normal group by Tanner pubertal stage and Tanner group.   
 
 
Table 8.3C shows the mean MI + 2SD values (males and females combined) for Tanner 
Groups A, B and C. 
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Table 8.3B – Tukey’s HSD Comparisons of the Mean Values of MI, MW and 
GPW in Tanner Groups A, B and C 
 
Tukey’s HSD Comparison 
MI: TannerA vs. TannerB 
MI: TannerB vs. TannerC 
MI: TannerA vs. TannerC 
 
 
Mean difference (95% CI) 
0.005701  (0.0003  to  0.0111) 
0.006082  (0.0007  to  0.0115) 
0.011783  (0.0067  to  0.0168) 
 
 
S.E. 
3.529327 
3.739872 
7.778573 
 
 
Sig. 
p = 0.0347 
p = 0.0232 
p < 0.0001 
 
 
Tukey’s HSD Comparison 
MW: TannerA vs. TannerB 
MW: TannerB vs. TannerC 
MW: TannerA vs. TannerC 
 
Mean difference (95% CI) 
2.402921  (1.7252  to  3.0806) 
1.55322    (0.8710  to  2.2355) 
3.956141  (3.3206  to  4.5916) 
 
S.E 
11.80238 
7.57744 
20.72048 
 
 
 
p < 0.0001 
p < 0.0001 
p < 0.0001 
 
Tukey’s HSD Comparison 
GPW: TannerA vs. TannerB 
GPW: TannerB vs. TannerC 
GPW: TannerA vs. TannerC 
 
 
Mean difference (95% CI) 
3.080363  (2.1636  to  3.9971) 
1.783681  (0.8607  to  2.7067) 
4.864044  (4.0043  to  5.7238) 
 
 
S.E. 
11.1839 
6.43235 
18.8317 
 
 
Sig 
p < 0.0001 
p < 0.0001 
p < 0.0001 
 
 
Table 8.3B: Tukey’s HSD Comparisons of the Mean Values of MI, MW and GPW in Tanner 
Groups A, B and C.  Note there is a significant difference in MI, MW and GPW between Tanner 
groups indicating that MI, MW and GPW change significantly as puberty develops in the Normal 
group. 
 
 
 
Table 8.3C – Values of the 
Means and SDs for Tanner 
Groups A, B and C 
Mean MI 
-2 SD Mean MI 
Mean MI 
+2 SD 
Tanner Group A 0.313 0.348 0.383 
Tanner Group B 0.320 0.354 0.387 
Tanner Group C 0.316 0.353 0.390 
 
Table 8.3C: Values of the means and standard deviations for Tanner groups A, B and C in the 
Normal group. 
 
A stepwise multiple linear regression was performed to determine the most significant 
covariates to use in an ANCOVA analysis.  Within the Normal group, the most 
significant covariates for the MI were chronological age and toBMD (4%).  This meant 
that chronological age and toBMD were the most important predictors of MI.  This 
model had the highest r2 = 0.120 with an F-ratio of 23.315 (p < 0.00001), meaning that 
chronological age and toBMD (4%) explain 12% of the variance in MI values.  The 
negative β value of toBMD (Table 8.3D) meant the relationship between MI and toBMD 
was a negative one; as MI increased, toBMD decreased.  The results of the ANCOVA 
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analysis for MI indicated that both the male and female slopes as a whole (common 
slope), were not significantly different from zero (p = 0.735) and there was no 
statistically significant difference between the slopes of males and females (p = 0.643), 
meaning that once the covariates were accounted for, the slope of the lines was flat.   
 
 
Table 8.3D 
Covariates for MI Normal r
2  F-ratio p β p 
Chronological Age 0.120 23.315 < 0.00001 0.348 < 0.0001 toBMD (4%) -0.231 < 0.0001 
 
Table 8.3D: Summary of results of the multiple linear regression with MI as the dependent variable 
in the Normal group. 
 
 
Within the Normal group, the most significant covariates for the MW were height, 
chronological age, CSMA, pSSI and toBMD (4%), meaning that these were the most 
important predictors for MW.  This model had the highest r2 = 0.663 with an F-ratio of 
144.911 (p < 0.0001), meaning that height, chronological age, CSMA, pSSI and to BMD 
explain 66.3% of the variance in MW values.  The negative β value of chronological age 
and toBMD (Table 8.3E) meant that the relationship between MW and those variables 
was a negative one; as MW increased, chronological age and toBMD decreased.  In the 
case of chronological age, this is most likely a statistical anomaly and the β value of 
chronological age was not significant (p = 0.070). 
 
Table 8.3E 
Covariates for MW Normal r
2  F-ratio p β p 
Height 
0.663 144.911 < 0.0001 
0.540 < 0.0001 
Chronological Age -0.132 = 0.070 
CSMA 0.274 < 0.0001 
pSSI 0.194 < 0.0001 
toBMD -0.152 = 0.001 
 
Table 8.3E: Summary of results of the multiple linear regression with MW as the dependent 
variable in the Normal group. 
 
 
The results of the ANCOVA analysis for MW indicated that both the male and female 
slopes as a whole (common slope), were significantly different from zero (p < 0.0001) 
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but there was no statistically significant difference between the regression lines of males 
and females (p = 0.134).  This meant that despite the covariates included in the model, 
the common slope was still rising, but there was no statistically significant difference 
between the slopes of males and females.    
Within the Normal group, the most significant covariates for the GPW were height, 
chronological age, CSMA, arm length, pSSI and toBMD (4%), meaning that these were 
the most important predictors for GPW.  This model had the highest r2 = 0.644 with an 
F-ratio of 110.626 (p < 0.0001), meaning that height, chronological age, CSMA, arm 
length, pSSI and toBMD explain 64.4% of the variance in GPW values.  There were 
negative β values (Table 8.3F) for chronological age, CSMA and toBMD but the value 
for CSMA was not significant (p = 0.062).   
 
Table 8.3F 
Covariates for GPW Normal r
2  F-ratio p β p 
Height 
0.644 110.626 < 0.0001 
0.817 < 0.0001 
Chronological Age -0.270 < 0.0001 
Arm Length 0.346 < 0.0001 
CSMA -0.201 = 0.062 
pSSI 0.136 = 0.028 
toBMD -0.085 = 0.018 
 
Table 8.3F: Summary of results of the multiple linear regression with GPW as the dependent 
variable in the Normal group. 
 
 
The results of the ANCOVA analysis for GPW indicated that both the male and female 
slopes as a whole (common slope), were significantly different from zero (p < 0.0001), 
but again there was no statistically significant difference between the regression lines of 
males and females (p = 0.198).  This meant that despite the covariates included in the 
model, the common slope was still rising, but there was no statistically significant 
difference between the slopes of males and females.     
The chronological ages of females extend further than that of males: 15 females were 
recruited from ages 18-20 (baseline values), compared to zero males in the 18-20 age 
categories at baseline.  In order to take this into account, the female age range was 
adjusted when comparing the means of the MI in males and females.  Using an unpaired 
t-test to compare the means of MI in females (0.353) and MI in males (0.350) (p = 
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0.123, 95% CI = -0.007 to 0.00008) showed no significant difference in the MI of 
females and males.  All MI values were transformed into Z scores and the results were 
plotted in two histograms, one for males (Fig 8.3L) and one for females (Fig 8.3M).  The 
MI values of both males and females exhibit a normal distribution around the mean of 
zero, which were both confirmed by Shapiro-Wilk tests; male W = 0.955 (p = 0.927), 
female W = 0.992 (p = 0.404). 
 
     
Figure 8.3L: MI values for males in the Normal group as Z scores illustrating a normal distribution 
around the zero mean. 
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Figure 8.3M: MI values for females in the Normal group as Z scores illustrating a normal 
distribution around the zero mean. 
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8.3.1 TW3 Bone-Age Assessments 
The results of comparing MI with TW3 bone-age in the Normal group (baseline values) 
were similar to those obtained in the comparison of MI and chronological age (Fig 
8.3.1A).  MI was lower in early ages then increased through the pre-teenage and teenage 
years where it reached a plateau.  The concentration of females at age 15 and males from 
15 to 16.5 is due to 15 and 16.5 being the maximum bone-ages for female and males 
respectively using the TW3 technique.   Therefore any females with a bone-age similar 
to, or advanced than their chronological age, will reach the maximum TW3 bone-age in 
their early teens and will remain at the maximum from that point onwards, hence the 
large concentration of females at TW3  bone-age 15.   A TW3 bone-age of 15 includes a 
 
 
Figure 8.3.1A: MI vs chronological age (years) in the Normal group (baseline values).  This cross-
sectional plot illustrates that the MI increases with age.  The large concentration of values at TW3 
bone-age 15 is due to that being the maximum bone-age given to a skeletally mature female. 
 
wide range of female chronological ages from 13 to 20 years.   The same phenomenon 
occurs in males approximately 1.5 years later.  The Spearman’s rank correlation r = 
0.285 (p < 0.0001), with a 95% CI = 0.190 to 0.375, indicating that there is a statistically 
significant positive correlation between MI and TW3 bone-age.  MW and GPW showed 
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a similar relationship to those seen when they were plotted against chronological age 
(results not shown).  
 
8.3.2 40% and 60% MI and MW 
The slopes of the 40% MI, 40% MW, and 60% MW exhibited similar results as 
illustrated using the MI and chronological age.  The 40% MI compared with 
chronological age (Fig 8.3.2A) shows that the 40% MI was lower in younger age groups, 
then  rose  through  pre-teenage  and  teenage  years  where it  reached a plateau.   A 
simple linear regression showed the 40% MI was statistically significantly correlated 
with chronological age, r = 0.785 (p < 0.0001) with a 95% CI of 0.649 to 0.873.  The 
60% MI however showed a completely flat regression line when compared with 
chronological age (Fig 8.3.2B), which is unlike the MI and 40% MI.  A simple linear 
regression showed the 60% MI was not statistically significantly correlated with 
chronological age, r = 0.002 (p = 0.99) with a 95% CI of -0.277 to 0.280.  Outliers will 
be discussed in section 9.3.2. 
 
 
Figure 8.3.2A: 40% MI compared to chronological age using 25 males and 25 females from the 
Normal group (baseline values).  This plot illustrates that the 40% MI increases with age. 
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Figure 8.3.2B: 60% MI vs chronological age (years) using 25 males and 25 females from the Normal 
group (baseline values).  This cross-sectional plot illustrates that the 60% MI appears not to 
increase with age. 
 
The 40% MW (Fig 8.3.2C*) and the 60% MW (Fig 8.3.2D*) both showed a tight 
concentration of values around the regression line, 40% MW r = 0.834 (p < 0.0001) with 
a 95% CI of 0.723 to 0.903, and 60% MW r = 0.809 (p < 0.0001) with a 95% CI of 
0.684 to 0.887, indicating a statistically significant correlation between both the 40% 
and 60% MW’s and chronological age.  Outliers will be discussed in section 9.3.2.  
 
The MI, 40% MI and 60% MI were plotted against each other in 3 simple linear 
regression plots to examine how well these variables correlate with each other.  All 3 
plots showed similar results with values distributed close to the regression lines, had 
high corresponding r values and statistically significant p values.  This indicates each 
variable correlated well with the other variables.  The MI compared to the 40% MI (Fig 
8.3.2E*) had an r = 0.880 (p < 0.0001) with a 95% CI of 0.798 to 0.931.  The MI 
compared with the 60% MI (Fig 8.3.2F*) had an r = 0.883 (p < 0.0001) with a 95% CI 
of 0.802 to 0.932.  The 40% MI compared to the 60% MI (Fig 8.3.2G*) had an r = 0.785 
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(p < 0.0001) with a 95% CI of 0.649 to 0.873.  Outliers will be discussed in section 
9.3.2. 
 
8.3.3 Longitudinal Analysis 
The results of the comparison MI values of Normal group subjects with visits at both 
Tanner stage 3 and Tanner stage 4 (Fig 8.3.3A) were that r = 0.913 (p < 0.0001) with a 
95% CI of 0.795 to 0.965.  This indicates a very high correlation between MI values at 
Tanner stages 3 and 4.  When males and females were examined separately (Fig 8.3.3B),  
there was very little difference between the slopes and this was confirmed by the 
statistical output.  The common slope was statistically significantly different from zero 
(p < 0.0001), but there was no statistically significant difference between the slopes of 
males and females (p = 0.400). 
 
 
 
Figure 8.3.3A: A plot comparing MI values of 21 Normal group subjects with visits at Tanner stage 
3 and Tanner stage 4.  Most subjects have a higher MI at Tanner stage 4 but not all. 
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Figure 8.3.3B: A grouped linear regression plot comparing MI values of 21 Normal group subjects 
(7 male) with visits at Tanner stages 3 and 4.  This plot appears to show a slight difference between 
the slopes of males and females, but there is no statistically significant difference (p = 0.400). 
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8.4 Gymnast Group 
Each pQCT and anthropometric variable exhibited normal distribution.  When the 
baseline MI values were compared with the baseline values of each anthropometric 
measure (chronological age, height, weight and arm length) and each pQCT measure 
(toBMD, CSMA, radius bone area 50% and cortical bone density 50%), Spearman’s 
rank correlations showed that the MI was not significantly correlated with most of the 
variables (all p > 0.300), except for toBMD, r = -0.383 (p = 0.022).  The negative value 
of r denotes an inverse relationship between MI and toBMD, so as toBMD decreases, 
MI increases.  MI was not compared to toBA (4%) because bone width, which is a 
component of the MI, will always be correlated with toBA.  A simple linear regression 
comparing MI  to  chronological  age  using  baseline values  (Fig 8.4A) does  not  show 
a growth curve as it did in the Normal group.  Although the graph appears to show a 
slight decrease in MI as Gymnasts age, this relationship is not statistically significant, r 
= -0.034 (p = 0.843) with a 95% CI of -0.359 to 0.298.  Another simple linear regression 
 
 
Figure 8.4A: MI compared to chronological age in the Gymnast group using baseline values.  This 
cross-sectional plot appears to show a slight decrease in MI values as gymnasts age, but there is no 
statistically significant relationship (p = 0.843). 
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Figure 8.4B: MI compared to height in the Gymnast group (baseline values).  This cross- sectional 
plot shows a slight increase in MI as Gymnast height increases, but it was not significant (p = 0.452). 
 
was used to compare MI to height using baseline values (Fig 8.4B) using adjusted height 
values due to a difference of maximum and minimum heights between males and 
females.  This graph illustrated a slight increase in MI as Gymnasts grew in height, but 
again the relationship was not statistically significant, r = 0.129 (p = 0.452) with a 95% 
CI of -0.208 to 0.439.  Using grouped linear regressions to examine the MI in Gymnast 
males and females compared with chronological age (Fig 8.4C*) and MI compared with 
height (Fig 8.4D*) when the age and height  values  are adjusted so the minimum and 
maximum values were the same for both males and females, there were no statistically 
significant differences in the regression lines for either MI compared to chronological 
age (p = 0.502), or MI compared to height (p = 0.959).  Neither of the common slopes 
was significantly different from zero (both p > 0.225). 
The MW was compared with the same variables discussed previously and showed all 
Spearman’s rank and Pearson’s r values were significant (p < 0.0001) except those of 
toBMD (4%) (Spearman’s r = 0.179, p = 0.295, Pearson’s r = 0.196, p = 0.130).  MW 
compared to chronological age in the Gymnast group using baseline values (Fig 8.4E*) 
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showed a similar result to the same analysis in the Normal group.  The r = 0.833 (p < 
0.0001), with a 95% CI for r = 0.694 to 0.912.  This indicates a statistically significant 
positive correlation between MW and chronological age.  Similar results occurred when 
MW was compared to height.  MW was compared to height using baseline values in the 
Gymnast group (Fig 8.4F*) r = 0.770, (p < 0.0001) with a 95% CI of 0.590 to 0.877, 
indicating that height is also significantly positively correlated with MW. 
GPW was compared to all variables discussed previously, and all Spearman’s rank and 
Pearson’s r values were statistically significantly correlated (all p < 0.05).  GPW 
compared with chronological age in the Gymnast group using baseline values in a 
simple linear regression (Fig 8.4G*), showed a similar result to MW compared to the 
Normal group; r = 0.872 (p < 0.0001) with a 95% CI of 0.761 to 0.933, indicating a 
statistically significant correlation between GPW and chronological age.  GPW 
compared with height showed a similar result (Fig 8.4H*), r = 0.735 (p < 0.0001) with a 
95% CI of 0.535 to 0.857, also indicating a statistically significant positive correlation 
between GPW and height.  Outliers will be discussed in section 9.4. 
A comparison of mean MI, MW and GPW values of males and females Tukey’s HSD 
revealed that there were no significant differences between the MIs, MWs or GPWs of 
males and females (all p > 0.995).    
A stepwise multiple linear regression was performed to determine the most significant 
covariates to use in an ANCOVA analysis.  Within the Gymnast group, the only 
significant covariate for the MI was toBMD (4%).  This meant that toBMD was the most 
important predictor of MI.  This model had the highest r2 = 0.151 with an F-ratio of 
5.847 (p = 0.021), meaning toBMD (4%) explains 15.1% of the variance in MI values.  
The negative β value (Table 8.4A) meant that the relationship between toBMD and MI is 
negative; as MI increased, toBMD decreased.   
 
Table 8.4A 
Covariates for MI Gym r
2  F-ratio p β p 
toBMD (4%) 0.151 5.847 = 0.021 -0.388 = 0.021 
 
Table 8.4A: Summary of results of the multiple linear regression with MI as the dependent variable 
in the Gymnast group. 
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The results of the ANCOVA analysis for MI indicated that both the male and female 
slopes as a whole (common slope), were not significantly different from zero (p = 0.454) 
and there was no statistically significant difference between the slopes of males and 
females (p = 0.989), meaning that once the covariate was accounted for, the slopes of 
both males and females were not significantly different from a flat line.   
Within the Gymnast group, the most significant covariates for the MW were 
chronological age, toBMD (4%) and pSSI, meaning that these were the most important 
predictors for MW.  This model had the highest r2 = 0.858 with an F-ratio of 62.418 (p < 
0.0001), meaning that chronological age, toBMD and pSSI explain 85.8% of the 
variance in MW values.  The negative β value (Table 8.4B) for toBMD indicated that the 
relationship between toBMD and MW was negative; as MW increased, toBMD 
decreased. 
 
Table 8.4B 
Covariates for MW Gym r
2  F-ratio p β p 
Chronological Age 
0.858 62.418 < 0.0001 
0.493 < 0.0001 
toBMD -0.264 = 0.002 
pSSI 0.576 < 0.0001 
 
Table 8.4B: Summary of results of the multiple linear regression with MW as the dependent 
variable in the Gymnast group. 
 
The results of the ANCOVA analysis for MW indicated that both the male and female 
slopes as a whole (common slope), were not significantly different from zero (p = 0.454) 
and there was no statistically significant difference between the regression lines of males 
and females (p = 0.989).  This means that despite the covariates included in the model, 
the common slope is still rising, but there is no statistically significant difference 
between the slopes of males and females.    
Within the Gymnast group, the most significant covariates for the GPW were 
chronological age, arm length and pSSI, meaning that these were the most important 
predictors for GPW.  This model had the highest r2 = 0.882 with an F-ratio of 77.460 (p 
< 0.0001), meaning that height, chronological age, arm length and pSSI explain 88.2% 
of the variance in GPW values.  There are no negative β values (Table 8.4C) in this 
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model meaning that each covariate has a positive relationship with GPW.  Though arm 
length is technically not significant at p = 0.052, it is very close to being significant. 
 
Table 8.4C 
Covariates for GPW Gym r
2  F-ratio p β p 
Chronological Age 
0.882 77.460 < 0.0001 
0.321 = 0.010 
Arm Length 0.237 = 0.052 
pSSI 0.447 = 0.001 
 
Table 8.4C: Summary of results of the multiple linear regression with GPW as the dependent 
variable in the Gymnast group. 
 
The results of the ANCOVA analysis for GPW indicated that both the male and female 
slopes as a whole (common slope), were not significantly different from zero (p = 
0.055), and there was no statistically significant difference between the regression lines 
of males and females (p = 0.856).  This indicates that the common slope is not 
significantly different from zero, though with a p = 0.052 this remains very close to a 
significant relationship.   
Using an unpaired t-test, neither the chronological ages of females and males (baseline 
values) were statistically different (p = 0.241), nor were the means of the MI in Gymnast 
females (0.336) and Gymnast males (0.331) (p = 0.361, 95% CI = -0.015 to 0.006).  A 
Mann-Whitney U-test confirmed these results (not shown).  All MI values were 
transformed into Z scores and shown in a combined histogram (Fig 8.4I) due to an 
insufficient number of subjects in the Gymnast group available to calculate the mean MI 
of each age group in each sex.  This group shows a normal distribution around the zero 
mean.  
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Figure 8.4I: MI Z score values for the Gymnast group.  These Z scores show a normal distribution 
and a mean of zero. 
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8.4.1 Longitudinal Analysis 
The results of the comparison of MI values of the Gymnast group subjects (Fig 8.4.1A) 
with 2 visits at approximately 1 year apart (32, 12 male) were that r = 0.787 (p < 0.0001) 
with a 95% CI of 0.604 to 0.891.  This indicates a very high correlation between MI 
values at visit 1 and visit 2.  When males and females were examined separately (Fig 
8.4.1B), there was very little difference between the slopes and this was confirmed by 
the statistical output.  The common slope was statistically significantly different from 
zero (p < 0.0001), but there was no statistically significant difference between the slopes 
of males and females (p = 0.122).  Fig 8.4.1C shows how the MI changes between visits 
in males and females (male changes are indicated by red lines).  
 
 
 
Figure 8.4.1A: A simple linear regression plot comparing MI values of 32 Gymnast subjects with 
visits approximately 1 year apart.  This plot shows all but 1 value is within the 95% CI.   
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Figure 8.4.1B: A grouped linear regression plot comparing MI values of 32 Gymnast subjects (12 
male) with visits approximately 1 year apart.  This plot appears to show a slight difference between 
the slopes of males and females, but there is no statistically significant difference (p = 0.122). 
 
 
Figure 8.4.1C: A plot comparing MI values of 32 Gymnast subjects (12 male) with visits 
approximately 1 year apart.   
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8.5 NF1 Group 
Unlike the Normal and Gymnast groups, there were only 17 subjects in the NF1 group, 
meaning that not all variables exhibited a normal distribution.  Therefore a combination 
of non-parametric and parametric tests was used.  When the MI values were compared 
with the baseline values of each anthropometric measure (chronological age, height, 
weight and arm length) and each pQCT measure (CSMA, pSSI, radius bone area 50% 
and cortical bone density 50%), Spearman’s rank correlations showed that the MI was 
not significantly correlated with any of these variables (all p > 0.072).  A Spearman’s 
rank correlation comparing MI to toBMD showed an r = -0.513 (p = 0.052) with a 95% 
CI of -0.812 to -0.001, which is on the border of achieving statistical significance.  The 
negative value of r denotes an inverse relationship between MI and toBMD, so as 
toBMD decreases, MI increases, though not significantly in this group.  MI was not 
compared to toBA (4%) because bone width, which is a component of the MI, will 
always be correlated with toBA.  A simple linear regression comparing MI to 
chronological age using baseline values (Fig 8.5A) does not show a growth curve as it 
did in the Normal group.  Although the graph appears to show a slight increase in MI as 
NF1 subjects age, this relationship is not statistically significant; ms = -0.001 (p = 0.868) 
with a 95% CI of -0.010 to -0.013.  Another non-parametric linear regression was used 
to compare MI to height (Fig 8.5B).  This graph illustrated a slightly steeper increase in 
MI as NF1 subjects grew in height, but again the relationship was not statistically 
significant; ms = 0.0005 (p = 0.509) with a 95% CI of -0.001 to 0.002.   
Using grouped linear regressions to examine the MI in NF1 males and females 
compared with chronological age (Fig 8.5C*) and MI compared with height (Fig 8.5D*), 
there were no statistically significant differences in the regression lines for either MI 
compared to chronological age (p = 0.802), or MI compared to height (p = 0.840).  
Neither of the common slopes was significantly different from zero (both p > 0.287).  
The height values for this regression were adjusted due to a statistically significant 
difference between the mean height of males and females (Mann-Whitney U test p = 
0.05). 
The MW was compared with the same variables discussed previously using Spearman’s 
rank correlations.   MW compared with chronological age,  toBMD and cortical density  
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Figure 8.5A: MI compared to chronological age in the NF1 group.  This cross-sectional plot appears 
to show a slight increase in MI values as NF1 subjects age, but there is no statistically significant 
relationship (p = 0.868). 
 
 
 
Figure 8.5B: MI compared to height in the NF1 group.  This plot shows a slightly steeper increase in 
MI than in Fig 8.5A as NF1 height increases, but it was not significant (p = 0.509). 
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(50%) were not significantly correlated (all p > 0.115).  MW compared with height (p = 
0.003), weight, (p = 0.0003), arm length (p = 0.005), CSMA (p = 0.008), pSSI (p = 
0.0002) and radius bone area (50%) (p = 0.001) were all significantly correlated.  MW 
compared to chronological age in the NF1 group (Fig 8.5E*) showed a dissimilar result 
to the same analysis in the Normal group; ms = 0.614 (p = 0.159), with a 95% CI for ms 
= -0.405 to 1.364.  This indicates that MW and chronological age are not significantly 
correlated.  All age values were within the 95% CI.  MW was compared to height in the 
NF1 group (Fig 8.5F*) ms = 0.115, (p = 0.005) with a 95% CI of 0.041 to 0.169, 
indicating that MW increased as height increased.  Outliers will be discussed in section 
9.5. 
GPW was compared to all variables discussed previously using Spearman’s rank 
correlations.  GPW compared with chronological age (p = 0.082), toBMD (4%) (p = 
0.071), CSMA (p = 0.057), pSSI (p = 0.084) and radius cortical density (50%) (p = 
0.928) were not significantly correlated.  GPW compared with height (p = 0.013), 
weight (p = 0.004), arm length (p = 0.018) and radius bone area (50%) (p = 0.013) were 
all significantly correlated.  GPW was compared with chronological age (Fig 8.5G*) in 
the NF1 group using a simple linear regression and this showed a similar result to the 
same comparison in the Normal group; r = 0.872 (p < 0.0001) with a 95% CI of 0.761 to 
0.933, indicating a statistically significant correlation between GPW and chronological 
age.  GPW compared with height showed a similar result to the previous comparison 
(Fig 8.5H*), r = 0.735 (p < 0.0001) with a 95% CI of 0.535 to 0.857, also indicating a 
statistically significant positive correlation between GPW and height.  There are no 
outliers in these plots. 
A comparison of mean MI, MW and GPW values of males and females Tukey’s HSD 
revealed that there were no significant differences between the MIs, MWs or GPWs of 
males and females (all p > 0.492).    
Two linear regressions were performed to determine the most significant covariates to 
use in an ANCOVA analysis.  Within the NF1 group, there were no variables with 
significant Pearson correlations, so due to that and the small number of subjects in the 
NF1 group, only the results of the Spearman’s rank correlations were used.  This meant 
that toBMD (4%) was the only covariate used in the first linear regression.  However, 
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this resulted in a very low r2 value = 0.083, β = -0.288 (p = 0.297).  Therefore a second 
linear regression (multiple) was performed using all of the previously mentioned 
variables.  This regression indicated that the best model was one that included all 
covariates; r2 = 0.839 with an F ratio of 2.314 (p = 0.218, df = 9, 4), meaning that this 
model accounts for 83.9% of variation in the MI values.  Most of the β values did not 
have significant, p values except for toBMD (4%) (p = 0.026), meaning toBMD (4%) 
was the most statistically significant predictor in the model (Table 8.5A).  
Two ANCOVA analyses for MI were performed, one with toBMD (4%) as the only 
covariate, and one with all variables in Table 8.5A used as covariates.  The results were 
very similar in that both indicated that the common slopes were not significantly 
different from zero, and there was no significant difference between male and female 
slopes.   
Table 8.5A 
Covariates for MI NF1 r
2  F-ratio p β p 
toBMD (4%) 
0.839 2.314 = 0.218 
-1.100 = 0.026 
Chronological Age -0.327 = 0.687 
Height 1.530 = 0.197 
Weight 0.145 = 0.814 
Arm Length -0.682 = 0.216 
CSMA -0.590 = 0.573 
pSSI 0.072 = 0.887 
Radius Area (50%) 0.603 = 0.311 
Cortical Density (50%) 0.572 = 0.139 
 
Table 8.5A: Summary of results of the multiple linear regression with MI as the dependent variable 
in the NF1 group. 
 
Using only the p values from the latter ANCOVA, the common slope was not 
significantly different from zero (p = 0.602) and there was no significant difference 
between the slopes of males and females (p = 0.919), meaning that once the covariates 
were accounted for, the slopes of both males and females were not significantly different 
from a flat line.   
Within the NF1 group, the most significant covariates for the MW were pSSI and radius 
bone area (50%), meaning that these were the most important predictors for MW.  
Although a model using all possible covariates resulted in a higher r2 value, the model 
using pSSI and radius bone area (50%) had a much higher and statistically significant F-
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ratio; r2 = 0.857, F ratio = 32.895 (p < 0.0001).  This meant that pSSI and radius bone 
area (50%) explained 85.7% of the variance in MW values (Table 8.5B).  There were no 
negative β values in this model meaning that each covariate had a positive relationship 
with GPW.   
   
Table 8.5B 
Covariates for MW NF1 r
2  F-ratio p β p 
pSSI 0.857 32.895 < 0.0001 0.494 = 0.013 Radius Bone Area (50%) 0.502 = 0.012 
 
Table 8.5B: Summary of results of the multiple linear regression with MW as the dependent 
variable in the NF1 group. 
 
Two ANCOVA analyses for MW were performed, one using pSSI and radius bone area 
(50%) as covariates, and one using all possible covariates.  The former indicated that the 
common slope was statistically significant from zero (p < 0.0001), while the latter 
indicated the common slope was not statistically different from zero (p = 0.508). Neither 
indicated a statistically significant difference between the regression lines of males and 
females (both p ≥ 0.117).  These results will be discussed further in section 9.5. 
Within the NF1 group, the most significant covariate for the GPW was height, meaning 
that height was the most important predictor for GPW variation.  This model had the 
highest r2 = 0.340 with an F-ratio of 6.187 (p = 0.029), meaning that height explained 
2.9% of the variance in GPW values.  There were no negative β values (Table 8.5C) in 
this model meaning that each covariate has a positive relationship with GPW.  Though 
arm length is technically not significant at p = 0.052, it is very close to being significant. 
 
Table 8.5C 
Covariate for GPW NF1 r
2  F-ratio p β p 
Height 0.340 6.187 = 0.029 0.321 = 0.029 
 
Table 8.5C: Summary of results of the multiple linear regression with GPW as the dependent 
variable in the NF1 group. 
 
The results of the ANCOVA analysis for GPW indicated that the common slope was not 
significantly different from zero (p = 0.144), and there was no significant difference 
between the regression lines of males and females (p = 0.917). 
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Using a Mann-Whitney U-test, the chronological ages of females and males were not 
significantly different; U = 20.5 (p = 0.168) with a 95% CI of -2.3 to 0.2, but the MI in 
females (median = 0.349) and males (median = 0.328) were significantly different; U = 
55.5 (p = 0.046) with a 95% CI of 0 to 0.04.  There were not enough subjects to separate 
males and females when transforming  the MI values into  Z  scores.   Therefore they are 
 
 
 
Figure 8.5I: MI Z score values for the NF1 group.  These Z scores show a normal distribution 
around the zero mean. 
 
shown in a combined histogram (Fig 8.5I).  The histogram looks to be fairly normally 
distributed around the zero mean, but in order to determine this statistically, a Shapiro-
Wilk W-test was performed to test for non-normality; W = 0.970 (p = 0.815).  The p 
value was not significant indicating there was no evidence for non-normality.  
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8.6 CDGP Group 
In this group, height and TW3 bone-age exhibited a normal distribution, but weight did 
not; Shapiro-Wilk W = 0.895 (p = 0.015).  When the baseline MI values were compared 
with the baseline values of TW3 bone-age, height and weight using Spearman’s rank 
correlations, they showed that the MI was not significantly correlated with height or 
weight (all p > 0.092), but was significantly correlated with TW3 bone-age; r = 0.242 (p 
= 0.012).  A polynomial regression was used to compare MI with TW3 bone-age (Fig 
8.6A) and revealed that r = 0.238 with a 95% CI of 0.051 to 0.408 (p = 0.013).  This plot 
showed a similar growth curve to the Normal group.  A simple linear regression was 
used to compare MI to height using 25 baseline values (Fig 8.6B).  This plot illustrated a 
slight increase in MI as the CDGP subjects grew in height and the relationship was 
statistically significant, r = 0.396 (p = 0.050) with a 95% CI of 0.0008 to 0.684.   
 
  
Figure 8.6A: MI compared to TW3 bone-age in the CDGP group using all baseline values.  This 
cross-sectional plot shows a similar growth curve to the Normal group.  The MI increases as bone-
age increases. 
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Figure 8.6B: MI compared to height in the CDGP group using 25 baseline values.  This plot shows a 
slight increase in MI as CDGP subject height increases, which was significant (p = 0.050). 
 
 
Grouped linear regressions were used to examine the MI in CDGP males and females 
and compared with TW3 bone-age (Fig 8.6C*) and with height (Fig 8.6D*).  Figure 
8.6C* shows a statistically significant common slope (p = 0.017), but there was no 
significant difference between the regression lines of males and females (p = 0.550).  
Figure 8.6D* appears to show a large difference in the slopes of males and females, but 
the difference was not significant (p = 0.812).  The common slope was also not 
significantly different from zero (p = 0.062).  
The MW was compared to TW3 bone-age, height and weight.  The results showed all 
Spearman’s rank r values were significant; MW compared to TW3 bone-age (p < 
0.0001), MW compared to height (p = 0.0001) and MW compared to weight (p = 
0.0009).  MW compared to TW3 bone-age in the CDGP group using all baseline values 
(Fig 8.6E*) showed a similar result to the same analysis in the Normal group; r = 0.778 
(p < 0.0001), with a 95% CI for r = 0.601 to 0.822.  This indicates a statistically 
significant positive correlation between MW and TW3 bone-age.  A similar result 
occurred when MW was compared to height using baseline values in this group (Fig 
 158
8.6F*) r = 0.751, (p < 0.0001) with a 95% CI of 0.507 to 0.884, indicating that height is 
also significantly positively correlated with MW. 
GPW was compared to all variables discussed previously, and all Spearman’s rank 
values were statistically significantly correlated (all p < 0.003).  When GPW was 
compared to chronological age in the CDGP group using all baseline values in a simple 
linear regression (Fig 8.6G*), this showed a similar result to the same test in the Normal 
group; r = 0.822 (p < 0.0001) with a 95% CI of 0.749 to 0.875, indicating a statistically 
significant correlation between GPW and TW3 bone-age.  GPW compared with height 
showed a similar result (Fig 8.6H*), r = 0.714 (p < 0.0001) with a 95% CI of 0.444 to 
0.865, also indicating a statistically significant positive correlation between GPW and 
height.  Outliers will be discussed in section 9.6. 
In a comparison of mean MI, MW and GPW values of males and females Tukey’s HSD 
revealed that there were no significant differences between the MIs, MWs or GPWs of 
males and females (all p > 0.452).    
A multiple linear regression was performed to determine the most significant covariates 
to use in an ANCOVA analysis.  Within the CDGP group there were no significant 
covariates, but the model using TW3 bone-age, height and weight as independent 
variables was the model with the highest r2 = 0.047 with an F-ratio of 0.341 (p = 0795), 
meaning TW3 bone-age, height and weight only explain 4.7% of the variance in MI 
values.   
 
Table 8.6A 
Covariates for MI CDGP r
2  F-ratio p β p 
TW3 Bone-Age 
0.047 0.342 = 0.795 
-0.289 = 0.366 
Height 0.115 = 0.750 
Weight 0.014 = 0.965 
 
Table 8.6A: Summary of results of the multiple linear regression with MI as the dependent variable 
in the CDGP group. 
 
The results of the ANCOVA analysis for MI using all three variables, despite their 
statistical insignificance, indicated that the common slope was not significantly different 
from zero (p = 0.753) and there was no statistically significant difference between the 
slopes of males and females (p = 0.998).     
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Within the CDGP group, the most significant covariate for the MW was TW3 bone-age, 
meaning that this was the most important predictor for MW.  This model had the highest 
r2 = 0.696 with an F-ratio of 52.550 (p < 0.0001), meaning that TW3 bone-age explained 
69.6% of the variance in MW values.  The positive β value (Table 8.6B) indicated a 
positive relationship between TW3 bone-age and MW; as TW3 bone age increased, MW 
increased.  
  
Table 8.6B 
Covariates for MW CDGP r
2  F-ratio p β p 
TW3 Bone-Age 0.696 52.550 < 0.0001 0.834 < 0.0001 
 
Table 8.6B: Summary of results of the multiple linear regression with MW as the dependent 
variable in the CDGP group. 
 
The results of the ANCOVA analysis for MW indicated that the common slope was 
significantly different from zero (p < 0.0001), but there was no statistically significant 
difference between the regression lines of males and females (p = 0.607).  This means 
that despite the covariates included in the model, the common slope is still rising, but 
there is no statistically significant difference between the slopes of males and females.    
Within the CDGP group, the most significant covariate for GPW was again TW3 bone-
age, meaning that this was the most important predictor for GPW.  This model had the 
highest r2 = 0.746 with an F-ratio of 67.597 (p < 0.0001), meaning that TW3 bone-age 
explained 74.6% of the variance in GPW values.  The positive β value (Table 8.6C) 
indicated a positive relationship between TW3 bone-age and GPW; as TW3 bone age 
increased, GPW increased.   
 
Table 8.6C 
Covariates for GPW CDGP r
2  F-ratio p β p 
TW3 Bone-Age 0.746 67.597 < 0.0001 0.864 < 0.0001 
 
Table 8.6C: Summary of results of the multiple linear regression with GPW as the dependent 
variable in the CDGP group. 
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The results of the ANCOVA analysis for GPW indicated that the common slope was 
significantly different from zero (p < 0.0001), but there was no statistically significant 
difference between the regression lines of males and females (p = 0.550).   
Using an unpaired t-test, neither the TW3 bone-ages of females and males (all baseline 
values) were statistically different (p = 0.507), nor were the means of the MI in CDGP 
females (0.342) and Gymnast males (0.348) (p = 0.218, 95% CI = -0.004 to 0.016).  As 
there were no differences between males and females in the CDGP group, all MI values 
were transformed into Z scores and shown in a combined histogram (Fig 8.6I).  This was 
due to the small number of females (19) in this group.  A Shapiro-Wilk W-test was 
performed to confirm normality; W = 0.983 (p = 0.189), indicating there is no evidence 
of non-normality.  The CDGP group Z scores show a normal distribution around the 
zero mean. 
 
 
Figure 8.6I: MI Z score values for the CDGP group.  These Z scores show a normal distribution 
around the zero mean (approximately). 
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A comparison was made between the means of chronological age compared with TW3 
bone-ages of this group using a paired t-test and plotted using a box and whisker plot 
(Figure 8.6J).  The results indicate the means are significantly different (p < 0.0001); 
specifically the chronological ages of the group are much higher (mean = 12.872) than 
the TW3 bone-ages (mean = 11.056), in part due to their CDGP condition. 
 
 
Figure 8.6J: A box and whisker plot illustrating the difference in means, SD’s, minimum and 
maximum values when chronological age values are compared to TW3 bone-age values in the 
CDGP group (p < 0.0001). 
 
 
Because the skeletal maturity of the CDGP group is not as advanced as their 
chronological age, chronological age would not be an appropriate measure to use.  This 
is illustrated in Figure 8.6K where MI is plotted against TW3 bone-age (A) and MI is 
plotted against chronological age (B).  The figures are both similar but note the x axes in 
both plots; the curve of the regression line and plateau happen earlier in the TW3 bone-
age plot (A) because the TW3 bone-age values are lower than their chronological age 
values. 
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Figure 8.6K: Comparison of two plots – MI vs TW3 bone-age (A) and MI vs chronological age (B).  
Note the x axes and the regression line.  The curve of the regression line and the plateau happen 
earlier in A because the TW3 bone-age values are lower than their chronological age. 
 
 
8.6.1 Longitudinal Analysis 
The results of the simple linear regression of MI values of 15 CDGP group subjects (9 
male) with 2 visits at approximately 18 months apart + 3 months (Fig 8.6.1A) were that r 
= 0.789 (p = 0.0005) with a 95% CI of 0.464 to 0.927.  This indicates a very high 
positive correlation between MI values at visit 1 and visit 2.  When males and females 
were examined separately (Fig 8.6.1B), there was very little difference between the 
slopes, which was confirmed by the statistical output.  The common slope was 
statistically significantly different from zero (p = 0.002), but there was no statistically 
significant difference between the slopes of males and females (p = 0.380). 
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Figure 8.6.1A: A simple linear regression plot comparing MI values of 15 CDGP subjects with visits 
approximately 18 months apart.  This plot shows all values are within the 95% CI.   
   
 
Figure 8.6.1B: A grouped linear regression plot comparing MI values of 15 CDGP subjects (9 male) 
with visits approximately 18 months apart.  This plot appears to show a slight difference between 
the slopes of males and females, but there is no statistically significant difference (p = 0.380). 
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8.7 Comparison of All Groups 
A visual comparison of the means, standard deviations and ranges of the MI, MW and 
GPW of all 4 groups using box and whisker plots was performed (Fig 8.7A*, B*, C*), 
with the means highlighted in Table 8.7A.  The results of the MI means in all 4 groups 
showed the Normal group had the highest mean and the Gymnast group had the lowest. 
 
Table 8.7A:  
Means of Normal, 
Gymnast, NF1 and CDGP 
MI, MW and GPW 
Normal Gymnast NF1 CDGP 
Mean MI 0.346 0.334 0.339 0.342 
Mean MW 15.210 mm 15.339 mm 14.488 mm 14.711 mm 
Mean GPW 21.980 mm 22.988 mm 21.412 mm 21.471 mm 
Difference in Mean 
Heights Adjusted for 
Chronological Age‡ 
compared to Normal 
Group 
 
4.8cm 
shorter than 
Normal 
(p = 0.005) 
5.6cm 
shorter than 
Normal  
(p = 0.009) 
4.9cm 
shorter than 
Normal 
(p = 0.037) 
 
Table 8.7A: Summary table of means for MI, MW and GPW in all 4 groups with highest values in 
red and lowest values in blue.  (‡ The CDGP group was adjusted for TW3 bone-age compared to the 
Normal group).  
 
 
The results of the MW means in all 4 groups showed that the Gymnast group had the 
highest mean and the NF1 group had the lowest mean.  It should be noted that even after 
adjusting for age in each group, there was a statistically significant difference in heights 
between the Normal group and the other groups.  Figure 8.7A* also showed that the 
standard deviations for MW values were smaller across each group than they were for 
the MI means plot.  The results of the GPW means in all 4 groups showed that the 
Gymnast group had the highest mean (22.988 mm) and the NF1 group had the lowest 
mean (21.412 mm), which was only slightly less than the CDGP group mean (21.471 
mm).  All plots showed the standard deviation and ranges overlapping. 
The grouped linear regression plot for MI values (Fig 8.7D) compared with age 
indicated the common slope was not significantly different from zero (p = 0.311) and the 
difference between the regression lines was not significant (p = 0.975). 
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Figure 8.7D: A grouped linear regression plot illustrating MI values compared to age in the Normal, 
Gym, NF1 and CDGP groups using adjusted ages (5.9 – 9.9 years).  Neither the common slope nor 
the differences between slopes were significant (p = 0.311, p = 0.975 respectively). 
 
The Levene statistic = 1.551 (p = 0.203), meaning that there was no evidence for 
heterogeneity of variance.  The ANOVA indicated the F-ratio (between groups) = 3.467 
(p = 0.017) meaning that the experimental group that a subject was in had an effect on 
MI values, and the effect was significant.  Bonferonni’s test, Gabriel’s procedure, the 
Hochberg GT2 test and Dunnett’s t (2-sided) all gave very similar results, therefore this 
section has concentrated on the results of Dunnett’s t (Table 8.7B).  These results 
indicated that the Gymnast group MI was significantly different from the Normal group, 
but the NF1 and CDGP groups were not. 
Each Gymnast baseline subject was matched for height with a control from the Normal 
group and a paired t-test was performed to ensure the heights were not significantly 
different, which they were not (p = 0.210).  The MI was compared between Gymnast 
cases and Normal controls using a paired t-test, which was significant (p = 0.038).  This 
indicates that the significant difference seen when these groups were matched for 
chronological age is not due to the difference in height between the two groups.   
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Table 8.7B – Results of Dunnett’s t (2-sided) Test for MI Comparisons Between 
Groups (Adjusted for Age) 
Group X Group Y r 
Mean  
Difference 
 (X-Y) Std. Error Sig. 
95% CI 
Lower Bound Upper Bound 
Gymnast Normal 0.223 -.011379* .003725 .008 -.02034 -.00242 
NF1 Normal 0.112 -.006709 .004448 .341 -.01741 .00399 
CDGP Normal 0.071 -.003251 .003433 .710 -.01151 .00500 
 
Table 8.7B: Results of Dunnett’s t (2-sided) test for MI compared to age using the Normal group for 
comparison with the other 3 groups.  The results indicate that the Gymnast group has a significant 
difference to Normal, but the other groups do not. 
 
The grouped linear regression plot for MW values (Fig 8.7E) compared with age 
indicated the common slope was significantly different from zero (p < 0.0001), but the 
difference between the regression lines was not significant (p = 0.342).  The Levene 
statistic = 1.109 (p = 0.307), meaning that there was no evidence for heterogeneity of 
variance.  The ANOVA indicated the F-ratio (between groups) = 2.106 (p = 0.101) 
meaning that the experimental group that a subject was in did not have a significant 
effect on MW values.  For reasons mentioned previously, this section has concentrated 
on the results of Dunnett’s t (Table 8.7C).  The results of the Dunnett’s t test indicated 
that no group was significantly different from the Normal group.  
 
Table 8.7C – Results of Dunnett’s t (2-sided) Test for MW Comparisons Between 
Groups (Adjusted for Age) 
Group X Group Y r 
Mean  
Difference 
 (X-Y) Std. Error Sig. 
95% CI 
Lower Bound Upper Bound 
Gymnast Normal 0.030 .128887 .324189 .969 -.65069 .90846 
NF1 Normal 0.139 -.722538 .387120 .275 -1.65344 .20837 
CDGP Normal 0.125 -.499496 .298739 .256 -1.21817 .21858 
 
Table 8.7C: Results of Dunnett’s t (2-sided) test for MW compared to age using the Normal group 
for comparison with the other 3 groups.  The results indicate that none of the 3 groups have a 
significant difference to the Normal group. 
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Figure 8.7E: A grouped linear regression plot illustrating MW values compared to age in the 
Normal, Gym, NF1 and CDGP groups using adjusted ages (5.9 – 9.9 years).  The common slope was 
significantly different from zero (p < 0.0001), but the differences between slopes were not significant 
(p = 0.342). 
 
The grouped linear regression plot for GPW values (Fig 8.7F) compared with age 
indicated the common slope was significantly different from zero (p < 0.0001), but the 
difference between the regression lines was not significant (p = 0.210).  The Levene 
statistic = 1.491 (p = 0.219), meaning that there was no evidence for heterogeneity of 
variance.  The ANOVA indicated the F-ratio (between groups) = 4.268 (p = 0.006), 
meaning that the experimental group that a subject was in had a significant effect on 
GPW values.  For reasons stated previously, this section concentrated on the results of 
Dunnett’s t (Table 8.7D).  The results of the Dunnett’s t test indicated that the Gymnast 
group had a significant difference from the Normal group (p = 0.029), but the other 
groups did not have a significant difference from the Normal group.  Each Gymnast 
baseline subject was matched for height with a control from the Normal group and a 
paired t-test was performed to ensure  the heights were not significantly different, which 
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Figure 8.7F: A grouped linear regression plot illustrating GPW values compared to age in the 
Normal, Gym, NF1 and CDGP groups using adjusted ages (5.9 – 9.9 years).  The common slope was 
significantly different from zero (p < 0.0001), but the differences between slopes were not significant 
(p = 0.210). 
 
 
Table 8.7D – Results of Dunnett’s t (2-sided) Test for GPW Comparisons 
Between Groups (Adjusted for Age) 
Group X Group Y r 
Mean  
Difference 
 (X-Y) Std. Error Sig. 
95% CI 
Lower Bound Upper Bound 
Gymnast Normal 0.191 1.008379 .387446 .029 .07669 1.94007 
NF1 Normal 0.092 -.568048 .462657 .518 -1.68060 .54450 
CDGP Normal 0.106 -.508657 .357030 .319 -1.36720 .34989 
 
Table 8.7D: Results of Dunnett’s t (2-sided) test for GPW compared to age using the Normal group 
for comparison with the other 3 groups.  The results indicate that Gymnasts have a significant 
difference to the Normal group (p = 0.029), but the other groups do not. 
 
they were not (p = 0.210).  The GPW was compared between Gymnast cases and 
Normal controls using a paired t-test, which was significant (p < 0.0001).  This indicates 
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that the significant difference seen when these groups were matched for chronological 
age was not due to the difference in height between the two groups.   
A visual comparison of the distributions of MI Z scores (Fig 8.7G) showed all groups 
are normally distributed.  A combined histogram of Normal males and females (Fig 
8.7G) also showed a normal distribution with the centre around +1 SD.  Separate 
histograms for Normal males (Fig 8.3L) and Normal females (8.3M) are shown in 
section 8.3. 
 
 
 
Figure 8.7G: A visual comparison of the distribution of all MI Z Scores.  A – Normal, B – Gymnast, 
C – NF1, D – CDGP.  These graphs show normal distributions for all groups, but the Normal group 
shows positively skewed result (+1 SD). 
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8.8 Comparison of DXA Images and Radiographs using GP Bone-Age 
Table 8.8A shows the CVs of GP bone-age assessments using radiographs and DXA 
hand images. The CVs in this table indicate that radiographic bone-age assessments have 
 
Table 8.8A: Precision of Bone-Age Assessment  - Comparison of
DXA Images and Radiographs using the GP Method 
CV % 
Radiograph Bone-Age Assessments (GP) 2.68% 
DXA Bone-Age Assessments (GP) 2.95% 
 
Table 8.8A: The CVs of bone-age assessments using the GP methods showing radiographs 
compared to DXA images. 
 
a higher repeatability than the CV of DXA bone-age assessments.  The relation between 
bone-age assessed from radiographs and DXA images is shown in Fig 8.8A, r2 = 0.986 
(p < 0.001).  There was no significant difference between the mean bone ages of the two  
 
 
Figure 8.8A: A plot comparing DXA bone-ages to radiograph bone-ages, which indicates a strong 
positive relationship (p < 0.0001). 
 
methods (p = 0.114) and the upper and lower 95% confidence intervals include zero.  
There was a significant overlap in results (e.g. 5 subjects have a bone-age of 10 years by 
both radiographs and DXA images).  A Bland and Altman plot of the differences 
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between the two bone-age assessments compared to the means of the two ages (Fig 
8.8B) shows 96 of the 98 subjects (98%) had no more than a 1 year difference in bone-
age when comparing assessment from hand radiographs and DXA.  There were two 
subjects outside the 95% prediction interval (Fig 8.8B), one with a +2 year difference 
and one with a -2 year difference between the radiograph and DXA bone-ages.  In the 
first subject (-2 year difference), both the radiograph and DXA bone-ages were within 2 
years of the chronological age.  In the second subject (+2 year difference), the DXA 
bone-age was within 2 years of the chronological age but the radiograph bone-age had a 
>2 year difference.  One further subject also showed a >2 year difference between 
chronological age and radiograph bone-age, but the DXA bone-age was within 2 years 
and both bone-ages were within 2 years of each other.  Fifty-nine subjects (60%) had 
bone-age assessments that were identical as assessed by radiographs and DXA.  Sixty-
seven subjects (68%) had a radiograph bone-age that was within 1 year of their 
chronological age and 68 subjects (69%) had a DXA bone-age that was within 1 year of 
their chronological age.  One subject had a >2 year difference between chronological 
age and both radiograph and DXA bone-age.  However, this was due to the 
methodological issue stated in the GP Bone-Age Method section, as the subject in 
question was a female aged 20.2 years. 
 
 
 
Figure 8.8B: Bland and Altman plot showing the differences in ages between the DXA hand images 
and the hand radiographs plotted against the means of the two ages. 
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9. Discussion 
9.1 Introduction 
This chapter has four parts; the first three correspond with the first three parts in 
Chapters 7 and 8.  The first part is organised into four sections: a discussion of results 
and statistical analyses conducted within the Normal group, within the Gymnast group, 
within the NF1 group and within the CDGP group.  The second part discusses the results 
of the statistical analyses performed in the comparison of the latter three groups to the 
Normal group.  The third part discusses the results of the DXA Bone-age study.  The 
chapter ends with sections discussing the challenges, study limitations, comparisons 
with the literature and potential future work involving examinations of the MI and DXA 
bone-age assessment. 
 
9.2 Precision 
It was not surprising to observe that the manual method of measuring the MW, GPW 
and therefore the MI, was less repeatable than the computer-assisted method.  As 
discussed in section 7.2, the computer-assisted method allowed the user to zoom in on a 
radiograph to many times its normal size, while still maintaining resolution, aiding the 
user to detect the bone edges more accurately, thus its greater repeatability.   
It is also unsurprising to find that the TW3 bone-age assessment method is more 
repeatable than the GP method.  The TW3 method allows the user to examine each 
relevant bone and/or epiphysis for specified size and shape changes.    The GP method 
of examining a whole radiograph with that of standards in an atlas cannot be as accurate 
(if accuracy is measured as obtaining a bone-age similar to the subject’s chronological 
age in a normal subject) or precise as if each bone was examined individually.  Not all 
bones/epiphyses mature at exactly the same rate, therefore it is more desirable to 
examine bones individually to obtain a result that is more likely to be closer to the 
individual’s actual level of skeletal maturity.  Although the GP method is quicker to 
perform for the novice, once an assessor becomes familiar with the TW3 method (as the 
author has during this study), it is possible to perform an assessment in less than 3 
minutes.  Those radiographs that indicate full skeletal maturity in every bone can be 
assessed in less than 30 seconds. 
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9.3 Normal Group 
In the Normal group, the correlation co-efficients (r values) and associated p values 
indicated significant correlations between MI and chronological age, TW3 bone-age, 
height, weight, Tanner stage, arm length, CSMA, pSSI, radius bone area (50%) and 
cortical bone density (50%).  However the highest r value was for Tanner stage; r = 
0.305.  This indicates that although the correlations were significant, a maximum of only 
9.3% of the variation in the MI could be explained by a significantly correlated variable.  
This leaves 90.7% of the variation in MI values to be explained by other variables.  
These results are expected because the MI is a ratio that attempts to measure the same 
area of a bone irrespective of bone size.  Variables like height, weight, Tanner stage, arm 
length, CSMA, pSSI, radius bone area (50%) and cortical bone density (50%) all 
increase with age during the growth period under normal conditions.  Even cortical bone 
density (50%), which is measured in g/cm3, is a volumetric measurement and volume 
correlates with both components of the MI (MW and GPW).  The low r values confirm 
that the MI is successful at eliminating the issue of bone size when measured at the 
distal radius.    
Both plots comparing MI with chronological age and MI with height showed a typical 
growth curve.  Most of the values were within the 95% CI but there were outliers.  In the 
plot that compared MI with chronological age (Fig 8.3A), the outliers occurred from age 
7 to age 19 and, by definition, consisted of those with a high MI (closer to 0.5 
maximum) and those with a low MI (closer to zero).  The fact that MI values had 
outliers in the majority of age groups and on either side of the CI, meant that although 
MI increased with age, younger subjects were not more likely to have an MI outside the 
lower 95% CI and older subjects were not more likely to have an MI outside the higher 
95% CI.  In the plot that compared MI with height (Fig 8.3B), the outliers occurred from 
heights 125 cm to 170 cm.  The fact that MI values had outliers in the majority of height 
groups and on either side of the CI, meant that although MI increased with height, 
shorter subjects were not more likely to have an MI outside the lower 95% CI and taller 
subjects were not more likely to have an MI outside the higher 95% CI.  The plots 
comparing the regression lines of males and females showed no statistically significant 
difference between them when comparing MI with chronological age (Fig 8.3C) and MI 
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with height (Fig 8.3D).  The MI increased slightly as both chronological age and height 
increased but it was not a statistically significant rise.  This indicated that by using the 
MI (a ratio of 0.5MW/ GPW), that the age of the subject and the height of the subject 
(surrogates for bone size) were affecting the results, but not significantly.  This 
combined with the low r values confirmed that MI was not significantly dependent on 
bone size when measured at the distal radius. 
The r values and associated p values indicated significant correlations between MW and 
chronological age, TW3 bone-age, height, weight, Tanner stage, arm length, CSMA, 
pSSI, radius bone area (50%) and cortical bone density (50%).  However, the r values 
ranged from 0.287 to 0.814, indicating that up to 66.3% of the variation in the MW 
could be explained by a single significant variable.  This leaves 33.7% of the variation to 
be explained by other variables.  These r values are much higher than the r values 
obtained using the MI.  This is expected because the MW is a width measurement, 
which will obviously be related to bone size; width increases as bone size increases.  
Variables such as height, weight, Tanner stage, arm length, CSMA, pSSI, radius bone 
area (50%) and cortical bone density (50%) all increase with age during the growth 
period under normal conditions.  Therefore all of the above variables would correlate 
significantly with a bone width measurement.  The high r values confirm that the MW is 
dependent on bone size and correlates well with several variables when measured at the 
distal radius.    
The plots comparing MW with chronological age and height each showed outliers in 
approximately the same areas.  Examination of the outliers revealed that those 
individuals with values below the 95% CI in the chronological age plot were more likely 
to be shorter for their age, and those individuals with values above the 95% CI were 
more likely to be taller for their age.  It is interesting to note that 9 of the 15 females 
aged 18 to 20 years measured from 150cm to 162cm (Fig 9.3A purple), the range of 
which is below the mean height for an adult British female (Nettle, 2002).  In UK 
females aged 18 years, a height of 162cm is below the 50th centile and a height of 150cm 
is below the 3rd centile (Freeman et al., 1995a).  Nine of the 15 females aged 18 to 20 
years in this study group had MW values below 15.0, which is outside the 95% CI.  
However only 5 of the 9 females in question both measured under 162cm and had an 
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MW below 15.0mm.  This indicated that individuals who are short for their age are more 
likely to have a smaller MW.  This trend was confirmed when MW was compared to 
height.  Those individuals with values above the 95% CI were taller for their age, and 
those individuals below the 95% CI were shorter for their age.  The outlier with an MW 
of 26.0mm was a male aged 16 measuring 188.4cm (Fig 9.3A red), which is well above 
the mean height of British males (177.4cm) (Nettle, 2002) and is above the 97th centile 
for UK males aged 16 years (Freeman et al., 1995a).  These results were expected 
because chronological age and height are related; bones increase in length as individuals 
age, therefore the MW will increase in proportion with height and bone length.  Indeed 
MW compared to height showed a smaller 95% CI than MI indicating that MW width 
exhibits less variation when compared to height than age, and is a tightly controlled 
process during growth.  The greatest variation in height was seen from ages 12 to 16 
years when the pubertal growth spurt occurs, although these outliers had a spread of 
Tanner stages ranging from 1 to 3.  Although the outliers exhibited small MWs, none of 
them exhibited abnormal MIs.  
 
   
Figure 9.3A: MW compared to chronological age in the Normal group (baseline values) with 
outliers highlighted.     
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The r values and associated p values indicated significant correlations between GPW 
and chronological age, TW3 bone-age, height, weight, Tanner stage, arm length, CSMA, 
pSSI, radius bone area (50%) and cortical bone density (50%).  However, the r values 
ranged from 0.251 to 0.806, indicating that up to 65.0% of the variation in the GPW 
could be explained by a single significant variable.  This leaves 35.0% of variation left 
to be explained by other variables.  These r values are much higher than the r values 
obtained using the MI.  This is expected because as with the MW, GPW is a width 
measurement, which will be related to bone size; width increases as bone size increases.  
Variables like height, weight, Tanner stage, arm length, CSMA, pSSI, radius bone area 
(50%) and cortical bone density (50%) all increase with age during the growth period 
under normal conditions.  Therefore all of the above variables would correlate 
significantly with a bone width measurement.  The high r values confirm that the GPW 
is dependent on bone size and correlates well with several variables when measured at 
the distal radius.    
The plots comparing GPW with chronological age and height each showed outliers in 
approximately the same areas (Fig 9.3B).  Examination of the outliers revealed that 
those individuals with values below the 95% CI in the chronological age plot were more 
likely to be shorter for their age, and those individuals with values above the 95% CI 
were more likely to be taller for their age.  It is interesting to note that 9 of the 15 
females aged 18 to 20 years measured below 162cm (Fig 9.3B purple), which is below 
the mean height for an adult British female (Nettle, 2002) and 9 of the 15 females aged 
18 to 20 years had GPW values below 20.0, which is outside the 95% CI.  As mentioned 
previously, in UK females aged 18 years, a height of 162cm is below the 50th centile and 
a height of 150cm is below the 3rd centile (Freeman et al., 1995a).  However only 5 of 
the 9 females in question measured both under 162cm and had a GPW below 20.0mm.  
This indicated that individuals who are short for their age are more likely to have a 
smaller GPW.  This trend was confirmed when GPW was compared to height.  Those 
individuals with values above the 95% CI were taller for their age, and those individuals 
below the 95% CI were shorter for their age.  The outlier with a GPW of 39.6mm was a 
male aged 16 years measuring 188.4cm (Fig 9.3B red), which is well above the mean 
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height of British males (177.4 cm) (Nettle, 2002) and is above the 97th centile for UK 
males aged 16 years (Freeman et al., 1995a).  These results were expected because 
chronological age and height are related; bones increase in length as individuals age, 
therefore the width of the GPW will increase in proportion with height and bone length.  
Indeed GPW compared to height showed a smaller 95% CI indicating that GPW width 
exhibits less variation when compared to height than age and is a tightly controlled 
process during growth.  Discounting the purple outliers, the greatest variation in height 
is seen from ages 12  to 16 years when the pubertal growth spurt occurs,  although  these  
 
  
Figure 9.3B: GPW compared to chronological age in the Normal group (baseline values) with 
outliers highlighted.     
 
outliers had a spread of Tanner stages ranging from 1 to 3 (Fig 9.3B blue).  Although the 
blue outliers exhibited small GPWs, none of them exhibited abnormal MIs.   
The Tukey’s HSD test comparing mean MI or MW values between males and females 
revealed no significant differences between MI or MW values, but there was a 
significant difference between the male and female GPWs (males have a larger mean 
GPW than females).  The Normal group is the only group with an age range that extends 
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through puberty and beyond, therefore it is not surprising that GPWs are larger in males 
as adult males generally have larger bones than females (Nieves et al., 2005).  The 
combination of a difference in GPW values in males and females combined with no 
significant difference in MW values in males and females could have produced MI 
values outside the 95% CI but as stated above, this was not the case.  This indicates that 
the proportions of the MW and GPW remain very similar in normal males and females.     
 
It has already been shown that the MI, MW, and GPW increase with age, therefore it 
follows that they all increase with each Tanner stage.  The MW and GPW exhibit the 
same statistically significant differences between Tanner groups indicating that the MW 
and GPW stay in proportion to each other during growth. 
Stepwise multiple linear regressions were performed to discover the most significant 
variables to use in ANCOVA analyses for the MI, MW and GPW.  However growth is 
not a linear process.  As mentioned previously there is a growth spurt around puberty 
and then the increase plateaus in the teenage years.  Linear analyses of growth may thus 
have limited utility.  However non-linear growth analyses are complex requiring major 
statistical input and collaboration, which is beyond the purview of a PhD thesis (Roberts, 
personal communication).  It was considered that multiple linear regressions were the 
most appropriate alternative.   
The results of the MI multiple linear regression showed the most significant variables in 
the model were chronological age and toBMD (4%).  Although MI does increase 
slightly with age, this increase is not significant.  The r2 value and associated F-ratio for 
the MI model is much lower than those of the MW and GPW indicating that although 
the MI model is statistically significant, the MI model does not have the same predictive 
power as the MW and GPW models.  The negative β value of toBMD is signifying that 
metaphyseal bone density at the 4% site decreases, or rather the rate of bone 
mineralisation slows around the pubertal growth spurt when longitudinal bone growth is 
proceeding more quickly than the mineralisation process.  A non-linear growth analysis 
would be helpful in determining the intricacies of this relationship, as it is very probable 
the relationship is not linear.  Therefore after adjusting for all the confounding variables, 
the MI common slope no longer shows as being significantly different from zero, 
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meaning that MI continued to eliminate bone size as a confounder when another variable 
was taken into account. 
The models for MW and GPW were very similar.  The significant variables in both of 
these models were height, chronological age, CSMA, pSSI and toBMD.  The model for 
GPW had an additional significant variable; arm length.  In the MW model, 
chronological age did not have a significant β value, but the other variables did.  The 
model shows the same negative β value for toBMD, indicating a similar relationship as 
discussed previously in the MI model.  In the GPW model, CSMA did not have a 
significant β value, but the other variables did.  Again toBMD has a negative β value, 
but in this model chronological age does also.  This is an interesting result as it has 
already been determined that GPW increases with age.  This result may indicate that 
chronological age has a similar type of relationship to GPW as toBMD; as chronological 
age increases, the GPW expansion rate plateaus, at which point the relationship ceases to 
be linear.  Although chronological age did not have a significant β value in the MW 
model, the fact that the β value was negative indicates the same trend as in the GPW 
model. 
The ANCOVA analysis for MI indicated that once chronological age and toBMD were 
added as covariates, the regression lines for both males and females were neither 
significantly different from flat, nor significantly different from each other.  This is to be 
expected as it has already been confirmed that the MI successfully eliminates the issue 
of bone size.  However, though the ANCOVA analyses for MW and GPW did not show 
a significant difference between the male and female regression lines, the common slope 
showed a significant difference from flat.  This could indicate that even after adjusting 
for the covariates, there is still a significant rise in MW and GPW as height increases or 
it could mean that there are variables that have not been accounted for that are causing 
the slope of the model to rise.  Since the main predictor in each model is height, it is 
more likely that even after adjusting the model using the covariates, there is still a 
significant relationship between MW and height, and GPW and height.  
The histograms illustrating the Z scores of males (Fig 8.3L) and females (Fig 8.3M) both 
showed a normal distribution.  To create Z scores for each chronological age year (5.0 to 
5.9 years, 6.0 to 6.9 years…etc.), would have been the ideal, however when the subjects 
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in the Normal group were divided by sex and chronological age year, there were not 
enough subjects to maintain a normal distribution within each group.  Because Z scores 
require taking means and SD’s, the separate groups from which the data belong must 
also be normally distributed.  When a calculation of Z scores was attempted using this 
method (results not shown), a skewed Z score histogram resulted due to this statistical 
flaw.  This could be remedied by examining more Normal subjects in the future and 
adding them to the dataset.      
 
9.3.1 TW3 Bone-Age Assessments    
MI was plotted against TW3 bone-age and the results showed a similar growth curve to 
that seen when MI was plotted against chronological age.  Although the r value and 
associated p value indicated TW3 bone-age and MI were significantly correlated, TW3 
bone-age was not used in the multiple linear regressions or in the ANCOVA analyses 
because chronological age was a more appropriate variable to use in the Normal group.  
MW and GPW also showed a similar relationship to the plots against chronological age 
(results not shown). 
 
9.3.2 40% and 60% MI and MW 
The 40% MI plotted against chronological age showed a similar growth curve to the MI 
plot, however the 60% MI plotted against chronological age showed an almost flat line 
(Fig 8.3.2B).  This may indicate that the 60% MW, which is a component of the 60% MI 
was not a suitable place to measure in order to see a significant change over time 
because the 60% MW did not change enough with age.  A more in depth study may 
indicate whether larger changes are easier to detect using the 40% MW/MI.  The 40% 
(Fig 8.3.2C*) and 60% (Fig 8.3.2D*) MW plotted against chronological age showed that 
both increased as age increased.  The outlier is the same outlier discussed in section 9.3 
(red circle).  This male measured 188.4 cm in height, therefore it was unsurprising to 
find that his radius was larger as a consequence.  The next three plots showed the MI, 
40% MI and 60% MI plotted against each other (Figs 8.3.2E*, F* and G*).  These plots  
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Figure 9.3.2A: Two radiographs of a distal radius; one showing a large change in bone width 
moving distally from the diaphysis towards the epiphysis (A) and the other showing a smaller 
change in bone width moving distally from the diaphysis towards the epiphysis (B).  The blue dots 
have been placed to highlight the areas in question.    
 
show that subjects with a low or high MI / 40% MI / 60% MI are likely to have low or 
high MI / 40% MI / 60% MI respectively (i.e. all MI’s increase with age).  The outliers 
are those subjects with significantly different indices in the two measurements, which 
indicated a significant shape change in the metaphysis as the measurement proceeded 
distally along the metaphysis (Fig 9.3.2A). 
 
9.3.3 Longitudinal Analyses 
Two plots were constructed plotting subjects with a visit at Tanner stage 3 against their 
visit at Tanner stage 4 (Fig 8.3.3A, B), the latter separating males and females.  These 
plots confirm that subjects with a low/high Tanner stage 3 score were likely to have a 
low/high Tanner stage 4 score, respectively, and there was no statistically significant 
difference between males and females.  However, 6 of the 21 subjects showed a lower 
MI value at Tanner stage 4 than at Tanner stage 3.  Although it is possible that this is 
due to measurement error or a difference in hand positioning in each radiograph, it is 
also possible that the growth process in certain individuals causes the GPW to expand 
more relative to the expansion rate of the MW at near the end of the pubertal growth 
spurt.  This process may then reverse itself by Tanner stage 5, but there are insufficient 
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subjects to examine this hypothesis.  There were also insufficient subjects to construct a 
plot with Tanner stage 2 plotted against Tanner stage 3, or Tanner stage 3 plotted against 
Tanner stage 5.  Although there were sufficient numbers to construct a plot with subjects 
that had a visit at Tanner pubertal stages 1 and 5, the purpose was to examine the effects 
of MI during puberty. 
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9.4 Gymnast Group 
The r values and associated p values indicated only one significant correlation; between 
MI and toBMD (4%); r = -0.383.  This showed that although the correlation was 
significant, a maximum of only 14.7% of the variation in the MI could be explained by 
toBMD (4%).  This result indicates a similar result to that in the Normal group and is 
expected because the MI is a ratio that attempts to measure the same area of a bone 
irrespective of bone size and bone width is a component of BMD (BMD = BMC / bone 
width).  The low r value confirms that the MI is successful at eliminating the issue of 
bone size when measured at the distal radius in the Gymnast group.  The negative r 
value indicates that as MI increases, toBMD (4%) decreases.  As in the Normal group, 
this relationship is describing the decrease in metaphyseal bone density at the 4% site, or 
rather the rate of bone mineralisation slowing around the pubertal growth spurt when 
longitudinal bone growth is proceeding more quickly than the mineralisation process.      
 
Neither the plot comparing MI with chronological age (Fig 8.4A), nor the plot 
comparing MI with height (Fig 8.4B) showed typical growth curves as did the plots in 
the Normal group.  This may be an indication that there were not enough subjects in the 
Gymnast group to illustrate such a curve in graphical form or it may indicate that the 
increased load bearing at the distal radius experienced by gymnasts causes the MI to 
remain stable throughout growth.  The oldest gymnast subjects were aged 12 years at 
baseline, so it was not possible to determine if a change in MI exists beyond age 12 in 
the Gymnast group.  Most of the values in Figs 8.4A and B were within the 95% CI but 
there were outliers.  In the plot that compared MI with chronological age (Fig 9.4A), the 
outliers were both female aged 9.8 years (red) and 11.9 years (blue).  The blue outlier 
was the tallest subject in the Gymnast group by 2.7 cm (144cm).  The red outlier was 
also one of the tallest subjects measuring 139.4cm.  However both of these heights were 
approximate to the 50th centile for their respective ages for UK females (Freeman et al., 
1995a).  As there was a statistically significant difference between the mean height of 
Gymnast group and the mean height of the Normal group adjusting for age (gymnasts 
were shorter), this confirms that shorter subjects are more likely to have a lower MI.   
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Figure 9.4A: MI compared to chronological age in the Gymnast group using baseline values with 
outliers highlighted. 
 
 
Figure 9.4B: MI compared to height (cm) in the Gymnast group using baseline values with outliers 
highlighted. 
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The higher MIs of the outliers indicate that their distal radii are less flared in shape, 
which corresponds more to the shape seen in Figure 9.3.2A, photo B.  In the plot that 
compared MI with height (Fig 9.4B), the blue outlier is now within the 95% CI, but the 
red outlier remains outside the 95% CI.  It is interesting to note that neither of these 
subjects would be outliers if they were included in the Normal plots; they simply have a 
less flared distal radius for their age and height than average for the Gymnast group, but 
not to the point that they show any other abnormalities.  The plots comparing the 
regression lines of males and females showed no statistically significant difference 
between them when comparing MI with chronological age (Fig 8.3C*) and MI with 
height (Fig 8.3D*).  Although the MI increased slightly as both chronological age and 
height increased, it was not a statistically significant rise.  These results were similar to 
those seen in the Normal group and indicated that by using the MI (a ratio of 0.5MW/ 
GPW), that the size of the bone was not significantly affecting the results.  The low r 
value of toBMD (4%) and the fact that no other variables such as height or weight had a 
statistically significant correlation with the MI (which can be seen in the regression 
plots), confirmed that MI was independent of bone size when measured at the distal 
radius in the Gymnast group. 
The r values and associated p values indicated significant correlations between MW and 
chronological age, TW3 bone-age, height, weight, Tanner stage, arm length, CSMA, 
pSSI, radius bone area (50%) and cortical bone density (50%).  Like the Normal group, 
the significant r values were much higher than those seen in the MI correlations and 
ranged from 0.712 to 0.858, indicating that up to 73.6% of the variation in the MW 
could be explained by a single significant variable.  This is expected because the MW is 
a width measurement, which will obviously be related to bone size; width increases as 
bone size increases.  Variables such as height, weight, Tanner stage, arm length, CSMA, 
pSSI, radius bone area (50%) and cortical bone density (50%) all increase with age 
during the growth period under normal conditions.  Therefore all of the above variables 
would correlate significantly with a bone width measurement.  The high r values 
confirm that the MW is dependent on bone size and correlates well with several 
variables during growth when measured at the distal radius in the Gymnast group.    
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The plots comparing MW with chronological age (Fig 8.4E*) and height (Fig 8.4F*) 
showed no significant outliers.  These results were expected for the same reasons they 
were expected in the Normal group, because chronological age and height are related; 
bones increase in length as individuals age, therefore the MW will increase in proportion 
with height/bone length.  Indeed MW compared to height showed a smaller 95% CI 
indicating that MW width exhibits less variation when compared to height than age, and 
is a tightly controlled process during growth in the Gymnast group.   
The r values and associated p values indicated significant correlations between GPW 
and chronological age, TW3 bone-age, height, weight, Tanner stage, arm length, CSMA, 
pSSI, radius bone area (50%) and cortical bone density (50%).  The p value for toBMD 
(p = 0.047) was just below the significance level.  The r values ranged from 0.334 to 
0.866, indicating that up to 75.0% of the variation in the GPW could be explained by a 
single significant variable.  These r values are much higher than the r values obtained 
using the MI.  This is expected because as with the MW, GPW is a width measurement, 
which will be related to bone size; width increases as bone size increases.  Variables like 
height, weight, Tanner stage, arm length, CSMA, pSSI, radius bone area (50%) and 
cortical bone density (50%) all increase with age during the growth period under normal 
conditions.  Therefore all of the above variables would correlate significantly with a 
bone width measurement.  The high r values confirm that the GPW is dependent on bone 
size and remains in proportion with several variables when measured at the distal radius 
in the Gymnast group.    
The plot comparing GPW with chronological age showed no outliers (Fig 8.4G*).  The 
plot comparing GPW with height showed two outliers, highlighted in red and blue (Fig 
9.4C).  An examination of the outliers revealed that the red outlier was one of the oldest 
subjects in the study at age 11.6 years, while the blue outlier was the youngest at age 5.4 
years.  Neither of the outliers exhibited abnormal MIs.  This result was also similar to 
the corresponding result in the Normal group and indicated that individuals who are 
short for their age are more likely to have a smaller GPW.  This was expected because 
chronological age and height are related; bones increase in length as individuals age, 
therefore  the width of  the  GPW will  increase  in  proportion  with  height/bone length.   
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Figure 9.4C: GPW (mm) compared to height in the Gymnast group (baseline values) with outliers 
highlighted. 
 
Indeed GPW compared to height showed a smaller 95% CI indicating that GPW width 
exhibits less variation when compared to height than age and is a tightly controlled 
process during growth.   
The Tukey’s HSD test comparing mean MI, MW and GPW values between males and 
females, revealed no significant differences between MI, MW or GPW values in the 
Gymnast group.  This group does not have an age range that extends through puberty 
and beyond, therefore it is not surprising that there is no significant difference in GPW 
values in this group as there was in the Normal group.  A previous study of the Normal 
group found that toBA (4%) was greater in males at all Tanner pubertal stages (Ashby, 
2007).  This was in contrast to the results of this study, which found that toBA (4%) was 
not significantly different between the sexes at Tanner stages 1, 2 or 3, was borderline 
significant at Tanner stage 4, and highly significantly different at Tanner stage 5.   Using 
the results in this thesis, it is unsurprising that there was no significant difference in 
GPW values (as there was in the Normal group) in the Gymnast group as all baseline 
subjects were confirmed as Tanner stage 1. The difference seen between the Ashby 
study (Ashby, 2007) and this study may be due to the inclusion of over 100 more 
 188
subjects in Ashby’s study than were available for this study.  The results presented in 
this thesis show that the proportions of the MW and GPW remain very similar in 
Gymnast males and females.     
Stepwise multiple linear regressions were performed to discover the most significant 
variables to use in ANCOVA analyses for the MI, MW and GPW.  However growth is 
not a linear process.  As mentioned previously there is a growth spurt around puberty 
and then the increase plateaus in the teenage years.  So once again the use of a linear 
analysis, whilst not ideal, is presented as a pragmatic alternative to more complex non-
linear methods.     
The results of the MI multiple linear regression showed the only significant variable in 
the model was toBMD (4%).  Although MI does increase slightly with age, this increase 
was not significant.  The r2 value and associated F-ratio for the MI model is much lower 
than those of the MW and GPW indicating that although the MI model is statistically 
significant, the MI model does not have the same predictive power of the MW and GPW 
models.  The negative β value of toBMD is signifying that metaphyseal bone density at 
the 4% site decreases, or rather the rate of bone mineralisation slows around the pubertal 
growth spurt when longitudinal bone growth is proceeding more quickly than the 
mineralisation process.  A non-linear growth analysis would be helpful in determining 
the intricacies of this relationship, as it is very probable the relationship is not linear, as 
with the Normal group. 
The models for MW and GPW are very similar.  The significant variables in both of 
these models were height, chronological age, toBMD and pSSI.  In the model for GPW, 
the significant variables were chronological age, arm length and pSSI.  In the MW 
model all of the β values were significant and again toBMD showed a negative β value.  
In the GPW model, arm length did not quite achieve statistical significance, but the other 
variables did, showing that GPW can be predicted using chronological age and pSSI. 
     
The ANCOVA analysis for MI indicated that once chronological age, toBMD and pSSI 
were added as covariates, the regression lines for both males and females were neither 
significantly different from flat, nor significantly different from each other.  This is to be 
expected as it has already been confirmed that the MI successfully eliminates the issue 
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of bone size.  However, though the ANCOVA analyses for MW and GPW did not show 
a significant difference between the male and female regression lines, the common slope 
showed a significant difference from flat.  This could indicate that even after adjusting 
for the covariates, there is still a significant rise in MW and GPW over time or it could 
mean that there are variables that have not been accounted for that are causing the slope 
of the model to rise.  Since the main predictors in each model were chronological age 
and pSSI, it is more likely that even after adjusting the model using the covariates, there 
is still a significant relationship between MW and chronological age/pSSI, and GPW and 
chronological age/pSSI.   
Due to an insufficient number of subjects, it was not possible to calculate separate male 
and female Z scores, but overall the histogram illustrating the Z scores of males and 
females combined (Fig 8.4I) showed a normal distribution centred around the zero 
mean.   
 
9.4.1 Longitudinal Analysis 
Two plots were constructed plotting the first visit of a subject against their second visit 
(Fig 8.4.1A, B), the latter separating males and females.  These plots confirm that those 
with a low/high first visit score were likely to have a low/high second visit score, 
respectively, and there was no statistically significant difference between males and 
females.  However, 16 of the 32 subjects showed a lower MI value at the second visit 
than at the first visit.  Although it is possible that this is due to measurement error or a 
difference in hand positioning in each radiograph, it is also possible that the growth 
process in certain individuals causes the GPW to expand more relative to the expansion 
rate of the MW at near the end of the pubertal growth spurt, especially considering the 
weight-bearing nature of a gymnast’s distal radius.  This process may then reverse itself 
to a certain degree by Tanner stage 5, but all subjects in this group were confirmed as 
Tanner stage 1 at baseline, therefore this hypothesis could not be tested.   
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9.5 NF1 Group 
The r values indicated that none of variables were significantly correlated with MI, 
though the correlation between MI and toBMD (4%) was on the verge of achieving 
statistical significance; r = -0.513 (p = 0.052).  This result is similar to the Gymnast 
group and is expected because the MI is a ratio that attempts to measure the same area of 
a bone irrespective of bone size.  The low r values confirm that the MI is successful at 
eliminating the issue of bone size when measured at the distal radius.  The correlation 
between MI and toBMD (4%) is so close to achieving statistical significance, it may 
indicate that the result could change if more subjects aged 6 to 9 were added to the 
study.  Another explanation is that the oldest subjects in the NF1 study are aged 9.2 and 
were confirmed as Tanner stage 1 by self-assessment before being examined.  Although 
the onset of puberty in these subjects had not yet begun, the negative r value (which 
indicates that as MI increases, toBMD (4%) decreases), may indicate the beginning of 
the decrease in metaphyseal bone density at the 4% site, or rather the rate of bone 
mineralisation slowing around the pubertal growth spurt when longitudinal bone growth 
is proceeding more quickly than the mineralisation process.  Based on the results of 
other groups, statistical significance may have been achieved if older subjects had been 
included in the study. 
Neither the plot comparing MI with chronological age (Fig 8.5A) nor the plot comparing 
MI with height (Fig 8.5B) showed typical growth curves like those in the Normal group.  
Although they both showed a slight rise in MI as age and height increased, the rise was 
not significant.  This may be an indication that there were not enough subjects in the 
NF1 group to illustrate such a curve in graphical form.  Also, the oldest NF1 subjects 
were aged 9.2 years, so it was not possible to determine if a change in MI existed 
beyond this age in the NF1 group, which could also account for the lack of a visible 
growth curve in the plot.  Most of the values in Figs 8.5A and B were within the 95% 
CI, although there was one point that could be considered an outlier on the border of the 
95% CI in Figure 8.5B.   
The plots comparing the regression lines of males and females showed no statistically 
significant difference between them when comparing MI with chronological age (Fig 
8.5C*) and MI with height (Fig 8.5D*).  Although the MI increased slightly as both 
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chronological age and height increased, it was not a statistically significant rise.  These 
results were similar to those seen in the Normal group and indicated that by using the MI 
(a ratio of 0.5MW/ GPW), that the size of the bone was not affecting the results.  
Although the r value of MI and toBMD (4%) was not particularly low, the fact that no 
other variables such as height or weight had a statistically significant correlation with the 
MI (which can be seen in the regression plots), confirms that MI is independent of bone 
size when measured at the distal radius in the NF1 group. 
The r values and associated p values indicated significant correlations between MW and 
height, weight, arm length, CSMA, pSSI and radius bone area (50%).  Like the Normal 
group, the significant r values were much higher than those seen in the MI correlations 
and ranged from 0.678 to 0.842, indicating that up to 70.9% of the variation in the MW 
could be explained by a single significant variable.  This is expected because the MW is 
a width measurement, which will be related to bone size; width increases as bone size 
increases.  Variables such as height, weight, arm length, CSMA, pSSI, radius bone area 
(50%) all increase with age during the growth period under normal conditions.  
Therefore all of the above variables would correlate significantly with a bone width 
measurement.  The high r values confirm that the MW is dependent on bone size when 
measured at the distal radius in the NF1 group.  MW and cortical bone density (50%) 
showed significant correlations in both the Normal and Gymnast groups, but did not in 
this group.  This may indicate that the age range of the NF1 study prohibited a 
correlation and/or the total number of subjects in the study was not sufficient to 
determine a level of correlation. 
The plot comparing MW with chronological age (Fig 8.5E*) showed no significant 
outliers and the plot comparing MW with height (Fig 8.5F*) showed only one outlier, 
which was not significantly outside the 95% CI.  These results were expected for the 
same reasons they were expected in the Normal group, because chronological age and 
height are related; bones increase in length as individuals age, therefore the width of the 
MW will increase in proportion with height/bone length.  Indeed MW compared to 
height showed a smaller 95% CI indicating that MW width exhibits less variation when 
compared to height than age, and is a tightly controlled process during growth in the 
NF1 group.   
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The r values and associated p values indicated significant correlations between GPW 
and height, weight, arm length and radius bone area (50%).  However the p values for 
chronological age, CSMA, pSSI and radius cortical density (50%) were close to 
achieving statistical significance.  The significant r values ranged from 0.590 to 0.677, 
indicating that up to 45.8% of the variation in the GPW could be explained by a single 
significant variable.  These r values are much higher than the r values obtained using the 
MI.  This is expected because as with the MW, GPW is a width measurement, which 
will be related to bone size; width increases as bone size increases.  Variables like 
height, weight, arm length and radius bone area (50%) all increase with age during the 
growth period under normal conditions.  Therefore all of the above variables would 
correlate significantly with a bone width measurement.  Although the CSMA, pSSI and 
radius cortical density also increase during growth, there are too few subjects in this 
group to for these variables to achieve statistical significance, though there are strong 
trends.  The high r values confirm that the GPW is dependent on bone size and remains 
in proportion with several variables when measured at the distal radius in the NF1 group.    
 
The plots comparing GPW with chronological age (8.5G*) and GPW with height 
(8.5H*) showed no outliers, and a significant rise in GPW values as both age and height 
increase.  This result was also similar to the Normal group and indicated that individuals 
who are short for their age are more likely to have a smaller GPW.  This was expected 
because chronological age and height are related; bones increase in length as individuals 
age, therefore the width of the GPW will increase in proportion with height/bone length.  
Again GPW compared to height showed a smaller 95% CI indicating that GPW width 
exhibits less variation when compared to height than age and is a tightly controlled 
process during growth.   
The Tukey’s HSD test comparing mean MI or MW values between males and females, 
revealed no significant differences between MI, MW or GPW values in the NF1 group.  
As seen in the Gymnast group, this group does not have an age range that extends 
through puberty and beyond, therefore it is not surprising that there is no significant 
difference in GPW values in this group as there was in the Normal group.  A previous 
study of the Normal group found that toBA (4%) was greater in males at all Tanner 
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pubertal stages (Ashby, 2007).  This is in contrast to the results presented in this thesis, 
which found that toBA (4%) was not significantly different between the sexes at Tanner 
stages 1, 2 or 3, was borderline significant at Tanner stage 4, and highly significantly 
different at Tanner stage 5.   Using the results obtained in this thesis, it is unsurprising 
that there was no significant difference in GPW values (as there was in the Normal 
group) in the NF1 group as all baseline subjects were confirmed as Tanner stage 1. As 
stated previously, this may be due to the larger number of subjects in the Ashby study 
(Ashby, 2007).  The current results show that that the proportions of the MW and GPW 
remain very similar in NF1 males and females.     
Stepwise multiple linear regressions were performed to discover the most significant 
variables to use in ANCOVA analyses for the MI, MW and GPW; once again their use 
is affected by the pubertal growth spurt, but they provide a practical alternative to more 
complex non-linear models. 
The results of the MI multiple linear regression showed the only significant variable in 
the model was toBMD (4%).  The r2 value, F-ratio and associated p value for the second 
multiple linear regression ANOVA are interesting in that although the r2 value is high 
(0.839) and the F-ratio is > 1 (2.314), the p value (p = 0.218) indicates the model is not 
significant.  Using the df (9,4) and an F-distribution critical values table for significance 
at p ≤ 0.05 (Hill and Lewicki, 2005), the critical F-value for a model exhibiting df = 9,4 
is 5.998.  The F-value of the MI multiple linear regression ANOVA is less than the 
critical value, meaning there is a 21.8% chance of an F-ratio this size happening chance.  
Therefore this model is not a significantly better predictor of NF1 MI values than the 
mean, which again may be a result of too few subjects in the NF1 group.  The negative β 
value of toBMD is signifying that metaphyseal bone density at the 4% site decreases, or 
rather the rate of bone mineralisation slows around the pubertal growth spurt when 
longitudinal bone growth is proceeding more quickly than the mineralisation process.  A 
non-linear growth analysis would be helpful in determining the intricacies of this 
relationship, as it is very probable the relationship is not linear, which is a very similar 
result compared to the Normal group. 
The model for MW showed the significant predictors to be pSSI and radius bone area 
(50%).  The only significant variable in the GPW model was height.  In the MW model 
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both of the β values were significant and both showed positive values, meaning that as 
they increased, the MW increased.  In the GPW model, the β value for height was also 
positive and significant and meaning as height increased, GPW increased.  These results 
show that MW and GPW are more easily predicted than MI in the NF1 group.  The 
results also indicate that in the NF1 group, GPW remains more in proportion to height 
than the MW. 
Section 8.5 stated that two multiple linear regressions were performed; one with toBMD 
(4%) as the only variable and one with toBMD (4%), chronological age, height, weight, 
arm length, CSMA, pSSI, radius bone area (50%) and cortical bone density (50%) as the 
variables.  The ANCOVA analyses for MI indicated that both models produced similar 
results; the regression lines for both males and females were neither significantly 
different from flat, nor significantly different from each other.  This is to be expected as 
it has already been confirmed that the MI successfully eliminates the issue of bone size.  
However, though the ANCOVA analyses for MW and GPW did not show a significant 
difference between the male and female regression lines, the common slope showed a 
significant difference from flat.  This could suggest that even after adjusting for the 
covariates, there is still a significant rise in MW and GPW over time or it could mean 
that there are variables that have not been accounted for that are causing the slope of the 
model to rise.  Since the main predictor in each model differs, therefore it is likely that 
even after adjusting the model using the covariates, there is still a significant relationship 
between MW and pSSI, and GPW and height.   
When the result of the Mann-Whitney U-test comparing MI between NF1 males and 
females, was compared to the results of an unpaired t-test, the results of which were not 
presented in the results section; (p = 0.110) with a 95% CI of -0.005 to 0.041, the 
unpaired t-test indicated that the mean MIs were not significantly different.  The 95% CI 
of the Mann-Whitney U-test was 0 to 0.04.  Note that the zero lower CI was a marginal 
result and it was possible the null hypothesis would not have been accepted if the 
unpaired t-test had been used.  The significant difference between the mean NF1 male 
and female MIs differs from the Normal group result.  Considering that the age range of 
this study did not include pubertal ages, it is likely that this difference is due to an 
insufficient number of subjects.  Because of the limited number of subjects, it was not 
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possible to calculate separate male and female Z scores, but overall the histogram 
illustrating the Z scores of males and females combined (Fig 8.4I) showed a normal 
distribution centred around the zero mean, with no evidence of non-normality.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 196
9.6 CDGP Group 
The r values and associated p values indicated only one significant correlation; between 
MI and TW3 bone-age; r = 0.242 (p = 0.012).  All 108 subjects had baseline bone-age 
assessments, and if applicable bone-age assessments were performed for subsequent 
examinations.  However, only 25 subjects had height and weight values available to the 
author.  The r value for the comparison of MI and TW3 bone-age was not significant 
when only 25 subjects were used (results not shown), which suggests that had there been 
more height and weight values available to the author, significant correlations between 
MI and height and/or MI and weight may have been found.  The r value indicated that 
although the correlation was significant, only 5.9% of the variation in the MI could be 
explained by TW3 bone-age.  This result indicated a similar result to the Normal group 
and was expected because the MI is a ratio that attempts to measure the same area of a 
bone irrespective of bone size.  The low r value confirms that the MI is successful at 
eliminating the issue of bone size when measured at the distal radius in this group.  As 
less than 10 subjects had pQCT data available to the author, the results were not 
analysed, however it would be reasonable to assume that there would be other 
significant correlations in this group, such as a correlation between MI and toBMD 
(4%), which was seen in the other groups (borderline in the NF1 group).   
The plot comparing MI with TW3 bone-age (Fig 8.6A) showed a typical growth curve 
like that seen in the Normal group where MI was compared to chronological age.  There 
were three outliers, but because of the lack of height values for this group, it was not 
possible to determine whether these three subjects were very tall for their age (upper 
outliers) or very short for their age (lower outlier).  The plot comparing MI with height 
(Fig 8.6B) did not show a typical growth curve like those in the Normal group, but this 
is most likely due to an insufficient number of subjects.  Nevertheless the rise was 
borderline significant.  This result is to be expected as the CDGP group is essentially 
normal but for the retardation in growth and the delay of puberty.  It is interesting to 
note that all three outliers would also be outliers if they were included in the Normal 
plots; the upper outliers may simply have a less flared distal radius for their age and 
height than average, and the lower outlier may simply have a more flared distal radius 
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for their age and height than average, but not to the point of significant abnormality.  
Though, as previously stated, height values for the outliers were not available.   
The plots comparing the regression lines of males and females showed no statistically 
significant difference between them when comparing MI with chronological age (Fig 
8.6C*).  However, the plot comparing MI with height (Fig 8.6D*) did show a significant 
difference (p = 0.050), which does not correlate well with the results of the other groups.  
Since this analysis only included 25 subjects, it is likely that the difference is not 
actually significant.  A non-parametric linear regression may have produced a different 
result, especially in a group of this size, but that test does not allow for the selection of 
identifying variables (in this case male and female).  
The r values and associated p values indicated significant correlations between MW and 
chronological age, TW3 bone-age, height and weight.  Like the Normal group, the 
significant r values were much higher than those seen in the MI correlations and ranged 
from 0.630 to 0.785, indicating that up to 61.6% of the variation in the MW could be 
explained by a single significant variable.  This is expected, even in the CDGP group, 
due to reasons discussed in the results of the other groups.  Therefore all of the above 
variables would correlate significantly with a bone width measurement.  The high r 
values confirm that the MW is dependent on bone size and remains in proportion with 
several variables when measured at the distal radius in the CDGP group.    
The plot comparing MW with TW3 bone-age (Fig 8.6E*) showed one outlier.  No 
height or weight values were available for this subject but based on outliers in other 
groups, it is possible the subject is tall for his age.  The outlier showed the largest MW 
of all 108 subjects and was also an outlier in the plot comparing MI with TW3 bone-age 
(Fig 8.6A) with an abnormal MI of 0.396.  This outlier is discussed further in the GPW 
comparisons.  The plot comparing MW with height (Fig 8.6F*) showed no significant 
outliers.  These results were expected for the same reasons they were expected in the 
Normal group, because chronological age and height are related; bones increase in 
length as individuals age, therefore the width of the MW will increase in proportion with 
height/bone length.  Indeed MW compared to height showed a smaller 95% CI 
indicating that MW width exhibits less variation when compared to height than age, and 
is a tightly controlled process during growth in the CDGP group.   
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The r values and associated p values indicated significant correlations between GPW 
and TW3 bone-age, height and weight.  The r values ranged from 0.515 to 0.819, 
indicating that up to 67.1% of the variation in the GPW could be explained by a single 
significant variable.  These r values are much higher than the r values obtained using the 
MI.  This is expected because as with the MW, GPW is a width measurement, which 
will be related to bone size; width increases as bone size increases.  Variables like TW3 
bone-age, height and weight all increase with age during the growth period under normal 
conditions and under CDGP conditions.  Therefore all of the above variables would 
correlate significantly with a bone width measurement.  The high r values confirm that 
the GPW is dependent on bone size and correlates with several variables when measured 
at the distal radius in the CDGP group.    
The plots comparing GPW with TW3 bone-age (Fig 8.6G*) and height (Fig 8.6H*) both 
showed one outlier each.  As mentioned previously, there was no height information for 
most of the subjects in this group, but it possible that the outlier in Fig 8.6G* was tall for 
his age.  The outlier in Figure 8.6H* was the youngest (aged 7.7 years with a TW3 bone-
age of 7 years) of the 25 subjects with height values by 1.5 chronological years.  This 
confirms that outliers are often due to subjects being either very tall or very short for 
their age, which is also seen in the Normal group.  The outlier in Figure 8.6H* did not 
show an abnormal MI but the outlier in Figure 8.6G* did show an abnormal MI and was 
also one of the outliers in the plot comparing TW3 bone-age to MI (Fig 8.6A).  This may 
indicate the presence of another condition that alters the metaphyseal modelling.  
Although individual case notes were not available to the author, some of the 
concomitant diseases in this group included asthma (including subjects not taking and 
taking steroids), Hodgkin’s lymphoma, congestive heart disease and renal dialysis.  
These conditions combined with CDGP and potential bone modelling interference 
caused by medications may be responsible for this outlier.  In other groups, GPW 
compared to height showed smaller 95% CI’s but in this group, the 95% CI for GPW 
compared to height was large.  This is most likely due to fewer numbers of subjects with 
height values available.  
The Tukey’s HSD test comparing mean MI or MW values between males and females, 
revealed no significant differences between MI, MW or GPW values in the CDGP 
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group.  Although this group does not have an age range that extends through puberty, the 
nature of CDGP means that chronological age and Tanner stage do not correlate as they 
would in normal subjects.  A previous study of the Normal group found that toBA (4%) 
was greater in males at all Tanner pubertal stages (Ashby, 2007).  This was in contrast to 
the results of the current study, which found that toBA (4%): was not significantly 
different between the sexes at Tanner stages 1, 2 or 3; was borderline significant at 
Tanner stage 4; and was highly significantly different at Tanner stage 5.  Tanner stages 
for the CDGP group were not available to the author, but it would be reasonable to 
assume that most if not all of the subjects in this group had yet to reach Tanner stage 4 to 
5.  Therefore it is unsurprising that there is no significant difference in GPW values in 
this group as there was in the Normal group.  The difference seen between the Ashby 
study (Ashby, 2007) and the current study may once again be due to the inclusion of  
more Normal subjects in Ashby’s study.  The current results show that that the 
proportions of the MW and GPW remain very similar in CDGP males and females.     
 
Stepwise multiple linear regressions were performed to discover the most significant 
variables to use in ANCOVA analyses for the MI, MW and GPW.  However, once 
again, it is important to note that while linear analyses have their limitations in non-
linear situations such as growth, they have been presented as a pragmatic alternative. 
 
The results of the MI multiple linear regression showed that none of the 3 available 
variables were significant leading to an insignificant overall model.  Again the r2 values 
and associated F-ratio for the MI model were much lower than those of the MW and 
GPW indicating that the MI model does not have the same predictive power of the MW 
and GPW models and is no better than using the mean as a predictor.  However, this 
most likely had to do with the use of only 25 subject values in the model.  Although 
TW3 bone-age had 108 baseline values, height and weight only had 25 values each.  
Therefore during a multiple linear regression, the predictive power of the other 83 TW3 
bone-age values was lost, as it was a significant predictor when all 108 values were used 
in a simple linear regression. 
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The models for MW and GPW are very similar.  The significant variable in both the 
MW and GPW models was TW3 bone-age.  Both models had high r2 values, high F-
ratios and high β values all with highly significant p values.  Although height was often 
a significant predictor for MW and GPW models in other groups, there were only 25 
subjects with height values available in this group, therefore the relationship may be 
even more significant than the borderline result seen in Chapter 8, by obtaining more 
height values for this group.     
The ANCOVA analysis for MI indicated that the common slope was not significantly 
different from zero and the regression lines for both males and females were neither 
significantly different from flat, nor significantly different from each other.  This is to be 
expected as it has already been confirmed that the MI successfully eliminates the issue 
of bone size.  This result agrees with the MI ANCOVAs for all other groups.  Because 
the F-ratio < 1 and the p value is not significant in the multiple linear regression with MI 
as the dependent variable, this model is no better than using the mean as a model.  If the 
question was; what would the MI value be if the TW3 bone-age was x, the simplest 
answer would be to quote the mean MI value.  However, using the mean as a model 
would give the same answer no matter what TW3 bone-age (x) was being used.  
Therefore this is clearly not an ideal model.  However there were no pQCT data 
available for this group to add more independent variables to the model; the use of the 
TW3 bone-age, height and weight in 25 baseline cases was all that was available to the 
author, despite them not contributing to the variation in MI values.  Therefore the ability 
to see any significant differences both in the common slope and between males and 
females using an ANCOVA analysis would be statistically very unlikely.  Indeed that is 
the result of the ANCOVA analysis, which is a similar result to the other groups.  
Although it is likely that in reality the common slope isn’t significantly different from 
zero (due to the nature of the MI), even if it were, it is likely that this dataset would 
probably not have sufficient subject numbers, or the other variables needed, to detect a 
difference. 
However, though the ANCOVA analyses for MW and GPW did not show a significant 
difference between the male and female regression lines, the common slopes of both 
showed a significant difference from zero (a flat line).  This could indicate that even 
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after adjusting for the covariates, there is still a significant rise in MW and GPW over 
time or it could mean that there are variables that have not been accounted for that are 
causing the slope of the model to rise.  Since the main predictor in each model is TW3 
bone-age, it is more likely that even after adjusting the model using the covariates, there 
is still a significant relationship between MW and TW3 bone-age, and GPW and TW3 
bone-age.   
Due to an insufficient number of subjects, it was not possible to calculate separate male 
and female Z scores, but overall the histogram illustrating the Z scores of males and 
females combined (Fig 8.4I) showed a normal distribution centred around the zero 
mean, which was expected and agreed with all other groups.   
 
9.6.1 Longitudinal Analysis 
Two plots were constructed plotting the first visit of a subject against their second visit 
approximately 18 months apart (Fig 8.6.1A, B), the latter separating males and females.  
These plots confirm that those with a low/high first visit score were likely to have a 
low/high second visit score, respectively, and there was no statistically significant 
difference between males and females.  However, 7 of the 15 subjects showed a lower 
MI value at the second visit than at the first visit, which is a very similar proportion to 
the results seen in the Gymnast group.  Although it is possible that this is due to 
measurement error or a difference in hand positioning in each radiograph, it is also 
possible that the growth process in certain individuals causes the GPW to expand more 
relative to the expansion rate of the MW at near the end of the pubertal growth spurt, 
particularly given the extensive list of other diseases present in this group.   The process 
may then reverse itself to a certain degree by Tanner stage 5, but none of the subjects 
had Tanner stages available to the author, so this hypothesis could not be tested.   
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9.7 Comparison of All Groups 
Table 8.7A showed the means of the MI, MW and GPW of all groups.  Although the 
Normal group showed the highest mean MI and the Gymnast group showed the lowest 
mean MI, we must consider whether the difference was significant.  The Gymnast group 
showed the highest mean MW and GPW, while the NF1 group showed the lowest mean 
MW and GPW, but again were these differences significant?  This study is not as 
concerned with the differences between all the groups as it is with the differences of 
each case group compared to Normal.  Therefore the means were compared to the 
Normal group adjusted for chronological age (TW3 bone-age for the CDGP group).  
This required three Dunnett’s t-tests, one for MI, one for MW and one for GPW.  
Although not mentioned in Chapter 7, there were three other tests used to compare the 
groups: Bonferroni’s test, Gabriel’s procedure and Hochberg’s GT2 test.  All three tests 
are used for multiple comparisons of groups, but under different circumstances.  When 
the number of comparisons is small, Bonferroni’s test has more power and also controls 
well for type I errors, but it lacks overall statistical power, and while Gabriels’s 
procedure has greater power when sample sizes are slightly different, Hochberg’s GT2 
test is advised if sample sizes are very different (Field, 2005).  The results of each of 
these tests were very similar to the Dunnett’s t tests, but because Dunnett’s t is the only 
test that compares each group to a chosen control group, this test was the most 
appropriate for the current study and the results of the other tests were not reported.  It is 
interesting to note that despite the fact that each test was designed to be used under 
different circumstances, each result in this case was similar with the Dunnett’s t test for 
that variable.      
There was only one significant MI difference between the groups, and that was between 
the Gymnast and Normal groups.  However, Table 8.7A also illustrates a very important 
consideration; the mean heights of each group are all statistically different (shorter) 
when compared to the Normal group.  Therefore each baseline Gymnast subject was 
matched for height and a paired t-test confirmed there was no statistically significant 
difference between the mean heights of these groups.  However another paired t-test 
confirmed there was still a significant difference between the mean MIs of these groups.  
It was not possible to match the groups for chronological age and height.  The main 
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predictor for the MI models was toBMD (4%).  Therefore it is possible there would still 
be a significant difference in MI between these groups even if they could be matched for 
both chronological age and height.  However there were an insufficient number of 
subjects that could be matched for both chronological age and height for this hypothesis 
to be tested.  This confirmed that the MI is not dependent on height when comparing 
differences between groups.  The grouped linear regression for MI (Fig 8.7D) showed 
that the Gymnast group had the slope with the highest gradient compared to the other 
groups, but the rise was neither significantly different from flat, nor significantly 
different from any of the other groups.  This indicates that although the mean MI of 
Gymnasts was significantly different from Normal, this difference was not significant 
over the age range of 5.9 to 9.9 years.    
The Dunnett’s t-test for MW showed no significant differences between the groups, 
indicating that MW is a tightly controlled area during growth under normal conditions, 
under the abnormal loading conditions of gymnasts and under the disease conditions of 
NF1 and CDGP.  The grouped linear regression (Fig 8.7E) was in agreement as the 
regression showed no significant differences between the groups. 
The Dunnett’s t-test for GPW showed one significant difference; between the Gymnast 
group and the Normal group (Gymnasts with a larger mean GPW).  As with the MI 
comparisons, the same Normal controls and Gymnast cases were used to determine 
whether there would still be a significant difference if the groups were matched for 
height and there was still a significant difference.  This result is expected because as 
stated previously, there was no significant difference in the MW between the Gymnast 
group and the Normal group, therefore the GPW would have to be significantly different 
to produce the significantly different results in the MI between these groups.  The 
grouped linear regression for GPW (Fig 8.7F) showed that the Gymnast group had the 
slope with the highest gradient compared to the other groups, but although the rise was 
significantly different from flat, it was not significantly different from any of the other 
groups.  This indicates that although the mean GPW of Gymnasts was significantly 
different from Normal, this difference was not significant over the adjusted age range.           
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9.8 DXA Bone-Age Study 
The study confirmed good agreement between GP bone-ageing using DXA images and 
radiographs, indicating the two methods are close to being interchangeable in the age 
group of children included in this study.  The r2 value of 0.986 (p < 0.001) is very close 
to the perfect fit value of 1.0, implying that there is very little (<2%) unexplained 
variation in this linear model, which compares the two methods.  There were two 
subjects outside the 95% prediction interval, one showing a +2 year difference in age 
(radiograph bone-age – DXA bone-age) and one showing a -2 year difference.  There 
was no technical or clinical reason for these outliers to be excluded.  On review, the 
explanation for the discrepancies were as follows: in one subject there was partial fusion 
of the epiphyses of the distal phalanges on the radiograph, which was not apparent on 
the DXA image, in which the epiphyses of the phalanges appeared unfused, leading to a 
two year underestimation of bone-age.  In the second case, part of the distal radius 
epiphysis appeared unfused on the radiograph, but completely fused on the DXA image, 
leading to a two year overestimate of bone-age.  Clinically, if there is less than a two 
year difference between chronological age and bone-age, it is still considered within 
normal range because of different rates of maturation.  If the difference is beyond two 
years then further clinical investigation is required.  In both outliers, the bone-age made 
from the DXA image was closer to the chronological age than that made from the 
radiograph.  A limitation of the study is that there is no way of predicting in which DXA 
images the bone-age assessment will fail, however this was only 2% of the total in this 
study.  A pragmatic solution would be that if there was a discrepancy of more than 2 
years between DXA bone-age and chronological age, then a hand radiograph would be 
indicated to confirm bone-age.  With regard to the 2 subjects that had a DXA bone-age 
within 2 years of their chronological age, but a radiograph bone-age >2 years apart from 
their chronological age, further bone-age assessments by another assessor and perhaps 
further clinical investigation are indicated. 
An earlier study, also using DXA images obtained on an Hologic QDR 4500 DXA 
scanner, but with a different software version, found that bone-age assessment using the 
GP method was not reliable in children under 12 years (Ashby et al., 2002b).  This was 
attributed to limited DXA spatial resolution causing partial volume averaging errors in 
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the smaller bones (Ashby et al., 2002b), resulting in the image being of insufficient 
quality for determining bone-age in younger subjects.  In the current study, using 
updated DXA software, the CV of bone-ageing from DXA images was not significantly 
different from radiographs, which is most likely related to improved DXA image 
quality.  The current study encountered no difficulties related to performing bone-age 
assessments on children less than 12 years of age.  There may also be a difference in the 
findings between the current and previous study (Ashby et al., 2002b), due to different 
bone-age assessors performing the measurements.  Another limitation of the current 
study is that there were fewer subjects aged 6-7 years (8 in total) than in the other age 
groups; statistically it would have been preferable if more subjects aged 6-7 years could 
have been recruited.  Although the previous study (Ashby et al., 2002b) and the current 
study were both performed at the same institution, the subject groups were different. 
The current results are in agreement with a previous study of 50 normal children (aged 
5-18 years) and 10 with previous pituitary deficiencies (aged 8-20 years) (Pludowski et 
al., 2004).  The precision errors for duplicate assessment were low; for radiographs 
<1.0% and DXA <0.9%.  There was also good concordance in bone-ages assessed by 
both techniques with the same age being determined in 73.3% and in the remainder the 
discrepancies were no greater than 6 months.  There was a strong correlation between 
bone-age results (r = 0.998; r2 = 0.996; p < 0.001).  However, that study used a GE 
Lunar Expert (Milwaukee, WI, USA) DXA scanner with a spatial resolution of 0.83mm 
(Thorpe and Steel, 1999) and a significantly higher dose of ionising radiation (x10 or 
more) than the current fan beam DXA scanners in common use, such as that used in our 
study, and is no longer manufactured (Steel et al., 1998).  As the resolution of DXA 
scanners improves in the future, it would be informative to conduct more studies of this 
type with the aim of acquiring complete interchangeability between radiographs and 
DXA images for the purposes of bone-ageing.   
In general, the assessor found that determining bone-age using DXA took more time on 
average than when using radiographs due to the reduced spatial resolution of the DXA 
images.  Determining bone-age from the DXA images often required zooming in and out 
to obtain the optimum magnification to view the different maturity markers, whereas the 
maturity markers on the radiographs were for the most part easier to assess due to the 
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higher resolution.  However, there was no one bone or maturity marker that was 
constantly more difficult to assess.  The bones of the younger subjects, including the 
ossification centres, were no more difficult to assess than those of the older subjects. 
 
9.9 Challenges 
The main challenge faced in this thesis was the retrospective nature of the study.  Study 
group sizes and variables were limited to what was available at the time.  In the case of 
the Gymnast group, although there were enough subjects to ensure an overall normal 
distribution, once the groups were subdivided into male and female, this ceased to be 
true.  In the case of the NF1 group, the group as a whole did not have enough subjects to 
ensure an overall normal distribution, which continued to be the case when the group 
was broken down into male and female categories.  Although the CDGP had more than a 
sufficient number of subjects to ensure an overall normal distribution, there was a 
significant majority of male subjects to female subjects (89:19), meaning that the female 
category did not have a sufficient number of subjects to ensure a normal distribution 
outright.  This was a particular challenge when calculating the Z scores.  Z scores rely 
on means and SDs, which by definition requires the variable in question to be normally 
distributed.  Therefore the significance of some of the relationships found in this study is 
in question due to the lack of subjects. 
Another challenge was the method of digitising the films, with a calibration marker, so 
that a computerised MI measurement technique could be used.  This will not be the case 
in future studies using digitally captured images stored using PACS.  Any future study 
using films would benefit by using a flatbed radiograph scanner, which was not 
available for the current study.  Also, the calibration markers used in this thesis are not 
strictly necessary if MI is the only assessment being performed, due to the MI being a 
ratio.  This would allow the MI assessment to be performed directly from a digital image 
with no other equipment needed.  However if the values of the GPWs and MWs are also 
of interest, this would either require the X-ray to be performed with a calibration marker, 
or at a specific focal length and settings of which the calibration had already been set 
and was determined to be repeatable. 
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The third challenge was the use of the computer-assisted measurement technique.  It 
required the images to be at a certain orientation to be analysed.  This eliminated the use 
of the VIDAR radiograph digitiser.  In future studies using digital images, this could be 
overcome in 2 ways: either the computer-assisted measurement technique could be 
adapted to perform the measurements in any orientation, or the orientation of the limb 
being imaged could be taken into account by the radiographer before being taken.  In 
future studies that are retrospective in nature, and are required to use hard-copy films, a 
flatbed scanner, which is a relatively inexpensive piece of equipment, could be used to 
overcome the orientation issue, as films can be placed in scanner at any orientation 
needed. 
In retrospect (discussed briefly in section 6.8.2), one possible explanation for the 
phenomenon of increased file sizes experienced in Adobe Photoshop during image 
rotation, was that Photoshop was creating a background layer around the edges of the 
original image to avoid deleting part of the original image or altering the scale of the 
original image during the rotation process.  Though it was suggested during the image 
analysis phase of the current study that this process could have had undetermined effects 
on the image, that does not appear to be the case.  However, if the image were to be 
distorted in any way, then it is probable that the entire image would be distorted to the 
same degree, meaning the calibration marker in every image would also be distorted to 
the same degree.  Therefore neither the absolute values of the GPW and MW, nor the MI 
(as a ratio), would have been affected.   
The main challenge for the DXA bone-age study was placement of the hand on the bed 
of a full-body DXA scanner.  Scanning of the hand and forearm on a body scanner for 
bone-age assessment is not standard practice.  Some images were unusable and therefore 
excluded from the study due to incorrect placement resulting in the distal phalanges 
being excluded from the resulting image or the radius and ulna being excluded.  Making 
radiographers aware of the requirements for bone-age assessment or having an 
appropriate researcher present while DXA scans are being performed is recommended. 
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9.10 Limitations 
There are two main limitations in this study: its retrospective nature and the subsequent 
restrictions of the statistical analysis, which have been discussed in section 9.9.  
The retrospective nature of this study meant that the author had no control over the 
number of subjects that were recruited for any of the original study groups or the 
methods that were used.  Although the Normal group consisted of hundreds of subjects, 
the Gymnast group only consisted of 36 subjects.  Both the CDGP and NF1 subjects 
were ongoing and although there were over 100 CDGP subjects that had hand 
radiographs at the time of this examination, fewer than 5 subjects had had pQCT scans.  
This meant that during the statistical analysis comparing the Normal and CDGP groups, 
no pQCT measures could be used as covariates.  Also, due to NHS procedures, many of 
the case notes of the CDGP group were held offsite and inaccessible to the author.  
Therefore although height was used as a covariate when comparing the Normal and 
CDGP groups, only 25 of the 108 subjects were used for that analysis because 
information on height, weight and other chronic conditions of the CDGP group were 
held offsite and not accessible to the author.  Of those 25 subjects, some of the chronic 
conditions they were suffering from included several types of cancer, diabetes and 
asthma.  This will no doubt have affected the statistical analysis of this group.  The NF1 
study had 29 subjects recruited at the time of this examination, however only 17 subjects 
were suitable for the MI examination, which is a low number for statistical analysis.  
 
Some of the statistical analysis techniques used in this study, such as multiple linear 
regressions and ANCOVA, have limitations due to their linear nature.  This limitation 
has been discussed at length in previous sections of this chapter.  There is also no doubt, 
as in most experiments, a high amount of variation in the statistical models is due to 
unknown variables and variables that were not measured or able to be taken into 
account. 
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9.11 Comparisons with the Literature 
It has already been shown that stress in the wrist area as a result of athletic activity, such 
as that seen in gymnasts, will result in growth plate widening (Carter et al., 1988, 
Fliegel, 1986, Shih et al., 1995), which confirm the results found in this thesis.  In an 
experiment using rabbits, one study noted an increase in the thickness of the zone of  
cartilage transformation (see Fig 2.5), where chondrocytes hypertophy, using 
histological and microscopy techniques (Trueta and Amato, 1960), which showed 
similarities to patterns seen in metaphyseal fracture (Laor and Jaramillo, 1993).  
Horizontal metaphyseal fractures and bruises in radial metaphyseal bone also indicated 
that these rapidly growing areas are susceptible to trauma (Alexander, 1976, Leveau and 
Bernhardt, 1984).  It has been suggested that metaphyseal injuries may be more 
important with regard to the pathophysiology of a widening growth plate, than any other 
factor (Shih et al., 1995).  The increase in the GPW appears to be the bone’s attempt to 
compensate for the large amount of stress and loading being experienced in gymnastics.  
A lower MI in the distal radius can be found in both certain disease states, as discussed 
in Chapter 4, but also under stress and loading conditions such as gymnastics.  The 
results of this thesis confirm that the resulting lower MI in the Gymnast group is due to a 
widening of GPW and not the reduction of the MW.  However, certain conditions, such 
as many of those discussed in Chapter 4, appear to exhibit both a widening of the GPW 
and a reduction of the MW. 
Therefore in addition to being a tool for monitoring inwaisting, the conclusion that a 
higher MI in long bones is advantageous to a certain degree, seems appropriate.  Where 
MW  has been reduced in addition to a widening of the GPW, a higher MI could be 
advantageous in terms of resisting fracture at the metaphysis/diaphysis junction (thinner 
bones are more likely to fracture), as long as it does not become too high as seen in the 
subject with bisphosphonate induced osteopetrosis (Whyte et al., 2003, Ward et al., 
2005a).  A follow-up case study on the patient from the 2003 Whyte paper (Whyte et al., 
2008) showed that even several years after the intravenous pamidronate therapy was 
halted, the abnormal metaphyses remained.  Figures 9.12A and B show the abnormal 
sclerotic metaphyses of the distal radius and ulna.  Although the author could not 
measure the absolute MW or GPW values for this radiograph due to the lack of a 
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calibration marker, the MI is a proportion and will stay the same despite magnification 
or reduction in size of the image.  The MI for Figure 9.12A is abnormally high (0.433), 
however when pamidronate therapy ceased and normal modelling was allowed to 
resume, the MI for Figure 9.12B reduced to 0.306.   
 
 
Figure 9.12A and B: Progression of abnormal modelling in distal radius and ulna in bisphosphonate 
induced osteopetrosis.  A: Abnormal distal radius and ulna (age 12 years – approximately 6 months 
after pamidronate therapy had ceased); B: longitudinal growth of the distal radius and ulna 
metaphyses showing normal modelling occurring after the cessation of pamidronate, but the 
abnormal sclerotic bone has ‘migrated’ to the diaphyses (age 17 years).  Reproduced with 
permission and copyright © of the JBMR (Whyte et al., 2008). 
 
Both of these MI values are outside the +2 SD range, but it should be noted that the 
skeletal pain and idiopathic thrombocytopenia and hyperphosphatasemia were still 
continuing underlying conditions (Whyte et al., 2008).   
Oral bisphosphonates are regularly, though not exclusively used to treat children now 
and instead of the discrete bands of hypermineralised bone seen at the growth plate, oral 
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bisphosphonates show much a broader and more uniform hypermineralised area 
(DiMeglio and Peacock, 2006).  The MI assessment may be useful in monitoring more 
subtle metaphyseal changes during treatment with bisphosphonates or provide a useful 
monitoring tool for other diseases such as those mentioned in Chapter 4.   
The highest distal radius MI result within the Normal group, including all longitudinal 
results, is 0.406 and the lowest is 0.292 with a mean of 0.351.   This indicates that even 
with increasing age, the MI for normal children at the distal radius does not go beyond a 
range of 0.111, and that the growth and development of the distal radial metaphysis and 
growth plate are highly regulated physiological processes, therefore making any 
abnormalities and/or changes much easier to discover and monitor.    
The distal radius is the most common site of fracture in children (Goulding et al., 1998).  
In their population-based study conducted in the U.S.A., Khosla and colleagues 
observed a peak incidence of distal radius fractures between the ages of 8 and 11 years 
in girls and 11 and 14 years in boys (Khosla et al., 2003).  The graphical representations 
of the TW3 bone-age scores, chronological age and MI calculations seem to indicate that 
at the age when children experience the most fractures of the distal radius, the radius has 
not reached the ultimate shape for resisting fractures, i.e. has not reached the optimum 
MI ratio.  The radius is experiencing a state of active growth and the metaphysis has not 
reached its peak width; the endocortical apposition rate is already very high and it 
appears that it cannot be further increased to the necessary levels in order to keep bone 
strength adapted to mechanical requirements (Rauch et al., 2001a).  This is because 
mineralisation does not occur at the same rate as bone growth in length, therefore the 
increase in mechanical challenges to the distal radius caused by a fall outweighs its 
increase in strength during these age ranges (Rauch et al., 2001a). 
 
9.12 Future Work 
The addition of more subjects to the Normal group database and the examination of 
other groups such as tennis players and other disease groups would improve the power 
of future studies and understanding of the utility of the measure.  Although MI 
examinations lend themselves well to retrospective work, it would be beneficial to 
conduct a prospective study with MI as the main purpose of investigation.  For example, 
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tennis players, particularly those who use one dominant hand to hold the racquet as 
opposed to both hands, would be an ideal cohort to look at how the MI differs under 
stress within an individual.  Both hands could be radiographed and subjects could be 
monitored longitudinally.  Another interesting group for future examination would be an 
OI cohort.  One of the two previous studies to use the MI looked at the distal femora of 
OI subjects (Land et al., 2006).  It would be interesting to compare the results of the MI 
in the distal radius (non-weight-bearing bone) to those in the distal femur (weight-
bearing bone) in an OI cohort.  An attempt to obtain ethics permission to examine 
(retrospectively) the data from two OI cohorts was made in the mid stages of this study.  
This attempt was abandoned however due to both time restrictions and the fact that the 
cohorts would have totalled no more than 20 subjects, which has already been discussed 
as being too few subjects for a normal distribution, making statistical analyses more 
difficult.  A further group worth examining would be subjects with hypophosphatemic 
rickets as the mineral to collagen ratio in these subjects is altered (Glorieux et al., 1980), 
which could cause metaphyseal flaring, and therefore an abnormal MI.  The current 
study examined the MI in a normal group, one athlete group and two disease groups, but 
a comparison of this study’s Normal group (containing only those of white Caucasian 
ancestry) to groups of differing ethnicities may reveal interesting findings.  Bone density 
reference data for non-white Caucasian ethnicities is scarce (Shepherd et al., 2005), but 
future work studying the MI in other ethnicities could reveal novel results and aid in 
creating normal reference data for non-white Caucasian groups.    
  The amount of data collected, the amount of patients recruited, and the fact that there 
are both longitudinal and cross-sectional information, will allow the original database, 
and the MI and bone-age information gathered in the current study to be used for a 
variety of other research topics in the future. Future papers using the information 
collected in this study could benefit from the expertise of a professional statistician to 
perform more in-depth analyses than have been presented here.   
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10.  Conclusion 
This thesis has examined the MI at the distal radius of several groups in a retrospective 
study.  The most commonly performed radiograph in children is that of the hand/forearm 
therefore an examination of the MI at the distal radius lent itself well to retrospective 
study.  Although general studies examining metaphyseal shape have been conducted 
previously, this is the first study to quantify this measure in the distal radius and create a 
range of normal reference values, which could be useful for future work in this area.  A 
review of the aims, objectives and hypotheses is listed below to review key findings and 
results. 
 
The aims and objectives of this PhD were as follows: 
 
1. To describe normal bone growth and development, and how diseases, 
deficiencies, and lifestyle choices may disturb these, with an emphasis on the 
metaphysis of long bones – specifically the distal radius. 
 
An overview of normal growth conditions and various disease, nutrition, exercise and 
medication conditions that affect the metaphysis is located in Chapter 4.  Although the 
two disease groups in this study showed a lower MI than in the Normal group, this was 
not a significant difference.  However an anecdotal examination of hand/forearm 
radiographs of children with OI and rickets would most likely show a significantly lower 
MI compared to normal. 
   
2. To measure the MI, MW and GPW of the distal radius in Normal children, young 
Gymnasts, children with NF1, and children CDGP. 
 
The methods regarding how these measurements were made and subject groups are 
located in Chapters 5 and 6.  Sections 8.7 and 9.7 show the results and discussion 
respectively of all groups compared.  The computer-assisted method allowed the user to 
zoom into the distal radius without losing resolution, meaning more precise and 
repeatable measurements were performed. 
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3. To analyse and compare MI, MW and GPW measurements in the various groups 
of children to determine a normal range of MI, and investigate how the MI in 
disease groups may differ from normal. 
 
The statistical methods, results and discussion of the above measurements are located in 
Chapters 7 through 9.  Although linear analyses were used (e.g. simple and multiple 
linear regressions), they were the most pragmatic alternative to more complex non-linear 
analyses that would have required collaboration with a qualified statistician.  Statistical 
analyses showed that Dunnett’s t test is the most appropriate test to use for a comparison 
of groups such as was performed in this thesis. 
 
4. To perform bone-age assessments in the normal children and CDGP children 
using the TW3 method.  (Chronological age is an inappropriate method by which 
to compare CDGP to normal children due to the nature of CDGP). 
 
TW3 bone-age assessments were conducted for all Normal group subjects and CDGP 
subjects.  In section 8.7, TW3 bone-age was used in place of chronological age when all 
groups were compared.  A comparison of MI to TW3 bone-age using a polynomial 
regression showed similar growth curves to chronological age in both the Normal and 
CDGP groups.  The main difference being that in the CDGP group, the TW3 bone-age 
curve began earlier and started to plateau earlier due to the significant difference in 
chronological age and TW3 bone-age values for this group.  Results of TW3 bone-age 
assessments are located in sections 8.3.1, 8.6, 8.6.1, 9.3.1, 9.6 and 9.6.1. 
 
5. To investigate whether there is any correlation between pQCT measurements of 
the radius (toBMD, CSMA, pSSI, radius cortical area (50%) and cortical bone 
density (50%), with the MI, MW and GPW values using both parametric and 
non-parametric statistical methods. 
 
There were many significant correlations using Spearman’s ranks and Pearson’s ranks.  
However a clearer picture of the MI/MW/GPW variation was obtained using the 
multiple linear regressions.  Although multiple linear regressions have their limits in 
growth studies (growth is not linear), the models allow the most significant predictor 
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variables to be seen.  The results and discussions of the resulting r values and ANOVAs 
for the MI, MW and GPW values are located in Chapters 8 and 9. 
 
6. To assess the MI by altering the original ratio (0.5MW/GPW) to determine 
whether 40% of the MW or 60% of the MW would result in a statistically more 
useful MW site being measured. 
 
The results of the 40% and 60% MW/MI indicated that the 60% MW and therefore the 
60% MI may be too far in the proximal direction to be a suitable place to measure.  The 
MW and 40% MW were similar to each other indicating that both would be suitable 
places to measure.  A more in depth study may indicate whether smaller changes 
become easier to detect using the 40% MW/MI.  The methods, results and discussion of 
the 40% MI and MW and the 60% MI and MW are located in sections 7.3.2, 8.3.2 and 
9.3.2. 
 
7. To compare GP bone-age assessments performed on DXA images of the hand 
(Hologic DXA scanner software version 12.4) to that performed conventionally 
from hand radiographs. 
 
All Normal group subjects with DXA hand images and radiographs of the hand 
performed at the same visit were assessed using GP bone-age.  Results indicate that 
DXA images of the hand are very close to being interchangeable with conventional 
radiographs for the purposes of GP bone-age assessment.  With further improvements in 
spatial resolution, the CV should improve further.  The methods, results and discussion 
are located in sections 3.4, 7.8, 8.8 and 9.8. 
 
In summary, all aims and objectives for this study were met, with some limitations in 
statistical analyses and subject numbers. 
Next we consider the hypotheses set out at the beginning of the thesis and look at key 
findings related to these.  The hypotheses investigated were: 
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10. MI should not be influenced by weight because the distal radius is not a weight 
bearing bone.  The possible exception to this is in the gymnasts, in whom loading 
of the distal radius may present. 
 
Weight was not a significant predictor for MI, MW or GPW in any group, including the 
Gymnast group. 
 
11. MI should be dependent on age: MI is lower in the younger age range (5-6 
years), until it comes to a plateau in mid and late teenage years. 
i) The children with pubertal delay should have a very similar MI development 
pattern to normal children, except that the increase and plateau will occur 
later. 
 
Chronological age is a significant predictor for MI in the Normal group only.  The 
author believes that TW3 bone-age would have been a significant predictor for the 
CDGP group MI model had more subject values been used, because TW3 bone-age was 
a significant predictor when used in a simple linear regression.  Although chronological 
age was not a significant predictor in the Gymnast and NF1 MI models, it is likely this 
was more a result of insufficient subject values and smaller age ranges of the recruited 
subjects.  The growth curve of MI values appeared in the groups with chronological or 
TW3 bone-age ranges extensive enough to support this type of plot (Normal and CDGP 
groups). 
i)  As stated previously, the beginning, rise and plateau (the latter of which is only just 
beginning to occur in Figure 8.6K) differences are evident and between the Normal and 
CDGP groups, as all three occur slightly later in the CDGP group.  
 
12. MI should not be dependent on sex for similar reasons to 3; although the GPW 
and MW of males may be larger than in females, they should be in proportion, 
giving a similar ratio. 
 
Comparisons of both the mean MI values and regression lines of males and females 
reported no statistically significant differences between the sexes.  Although there was a 
significant difference between the mean GPW of males and females in the Normal group 
(this can be explained by the large age range of the Normal group), the mean MI values 
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and regression lines of males and females were not significantly different.  Therefore it 
can be concluded that MI is not dependent on sex. 
 
13. MI should not be dependent on height: bones of different lengths should still be 
in proportion. 
 
Height was a statistically significant predictor in the MW and GPW regression plots, but 
not in the MI regression plots.  Although the plots of MI against height showed typical 
growth curves, the relationship was never significant.  However, extreme outliers (those 
above +2 SD or those below -2SD) in the plots tended to be those who were either very 
short or very tall for their age.  Therefore the usefulness of the MI assessment may break 
down in these cases.  In summary, it is concluded that an MI result be treated with 
scepticism if the subject measures above the 97th centile or below the 3rd centile for 
height with relation to the subject’s age.   
 
14. MI should always be dependent on toBA (4%) because the metaphyseal width is 
part of the MI ratio. 
 
MI, along with MW and GPW values were always highly significantly correlated with 
toBA(4%) (results not shown).  The results were not presented in the current study 
because of their obvious direct relationship and because of this were never used as 
variables in multiple regression analyses or predictors in ANCOVA analyses.  
 
15. Increases in BMD and pSSI should not alter the MI because BMD and pSSI are 
not geometric measurements (i.e. will not influence the shape of the bone). 
 
ToBMD (4%) was a significant predictor for MI in the Normal, Gymnast and NF1 
groups (pQCT scans unavailable for the CDGP group).  pSSI tended to be a more 
significant predictor in the MW and GPW regressions.  This was most likely because 
pSSI is a volumetric measurement, which is related to bone area at the 50% radial 
midshaft.  The hypothesis that toBMD (4%) and pSSI alterations would not change the 
MI could not be assessed directly as both variables tend to increase with age and height.  
To test the hypothesis directly would be difficult as age and height would constantly be 
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increasing.  However, bones can be of different densities, sizes and strengths and still 
maintain the same proportions.  This can be proved by looking at the plots of MI against 
chronological age.  For one chronological age there are many MI values, just as for one 
MI value, there are many densities and many strength-strain indices (results not shown 
but similar curves seen).  Further work would be needed to test this hypothesis over time 
using longitudinal measurements, perhaps in children of the same age being treated for 
conditions exhibiting altered mineral to collagen ratios such as rickets/osteomalacia, 
where the goal is to increase bone density and strength with treatment.  However, it is 
important to note that a correlation does not necessarily imply a causal relationship.   
 
16. MI should be altered in the case of NF1 due to metaphyseal dysplasia being one 
of the possible features of this disease in relation to the distal radius.  However 
the literature concentrates on this dysplasia presenting in the femur and tibia, 
which are weight-bearing bones.  Therefore although a change in the MI is 
possible due to the distal radius not being a weight bearing bone, the change may 
be small.   
   
Although the mean MI was lower in the NF1 subjects, the result was not significantly 
different from the mean MI of the Normal group.  This result may have become 
significantly lower if the NF1 group had had the age range and number of subjects that 
the Normal group had.  Therefore the hypothesis that the change would be small is 
correct, though it most likely is unrelated to the non-weight-bearing status of the distal 
radius. 
 
17. MI should be related to cross-sectional muscle area (CSMA) as muscle causes 
the most stress placed on bone. 
 
MI is significantly correlated to CSMA in the Normal group, but is not significantly 
correlated in any other group (pQCT scans not available for CDGP group).  This may 
have to do with the age range of the Normal group extending 11 years beyond the NF1 
group and 8 years beyond the Gymnast group.  CSMA was not a significant predictor for 
MI in any of the multiple linear regressions for the Normal, Gymnast or NF1 groups, 
meaning that once other more significant predictors were taken into account, CSMA was 
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not as important in the model.  Therefore although CSMA can explain some of the 
variation in MI values, it’s contribution is not significant. 
 
18. MI should not be altered in the case of CDGP as the main feature of this 
condition is a delay in growth (smaller bones) rather than a change in the 
morphology, which should not affect a measurement. 
 
This hypothesis was correct as the MI, MW and GPW in the CDGP group were not 
significantly different from the Normal group. 
 
10.1 Summary 
The main hypothesis for the current study was that metaphyseal inwaisting, and 
therefore the dimensions and resulting index, would be altered at the distal radius as a 
result of various disease states, trauma, drugs or treatments.  In addition, it was proposed 
that metaphyseal inwaisting could be quantified at the distal radius using a technique 
previously used only in the distal femur (the MI).  The MI was indeed altered in the case 
of the Gymnast group exhibiting a significantly lower MI than the Normal group due to 
a widening of GPW values, not a reduction in MW values.  The proportions of MW 
compared to GPW (MI) were maintained throughout growth under Normal, NF1 and 
CDGP conditions, but can be altered in cases of extreme height (short or tall) for 
chronological age.  Significant differences from the Normal group may have appeared in 
the NF1 and CDGP if the age ranges of those groups had extended as far as that of the 
Normal group.    
Furthermore, information such as that gained in the current study could be important in 
understanding how certain diseases/conditions affect skeletal modelling, remodelling 
and specifically metaphyseal inwaisting, as well as how they may increase the 
propensity to fracture.  This information could be of use in terms of a clinical setting, 
e.g. being part of a diagnosis and/or whether drugs or treatments, if any, are needed in 
those children who fall outside the normal values, and provide a mechanism to see 
whether treatments are making an improvement to the skeleton.  Distal radial 
morphology has never been quantified in this way, therefore normal reference data and 
ranges for the distal radius MI are the most important novel outcomes of this thesis. 
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12. Appendices 
 
12.1 Appendix 1 – Abstracts and Posters 
 
 
                                                                                                                                                                
 
Abstract 12.1A: Abstract submitted and accepted to the National Osteoporosis Society Conference, 
Edinburgh 2007. 
ASSESSMENT OF THE METAPHYSEAL INDEX TO STUDY BONE 
DEVELOPMENT OF THE DISTAL RADIUS IN HEALTHY CHILDREN  
 
LC Reddie1, JE Adams1, KA Ward1 
1 Clinical Radiology, Imaging Science and Biomedical Engineering, School of Cancer and Imaging 
Science, University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, UK 
 
The Metaphyseal Index (MI) has been proposed as an outcome to study bone 
development during childhood and studies metaphyseal width in comparison to 
growth plate width. During longitudinal bone growth a rapid reshaping and 
remodelling process occurs known as metaphyseal inwaisting.  In a healthy child, 
metaphyseal inwaisting results in proportional decreases in metaphyseal width and 
increases in growth plate width, thus the MI remains constant.  In situations where 
normal bone growth is impaired, the MI will be altered.  To date, reference values 
for the MI have been calculated and applied to the femur in only one study.  
However, the most commonly taken radiograph in children is that of the hand and 
forearm. 
The aim of this study was to investigate the development of the distal radius MI 
and to compare two methods of measuring MI.   
Postero-Anterior hand radiographs of 67 healthy white Caucasian children (34 
male) aged 5-18 years were taken and digitised using a Vidar radiograph scanner.  
Two methods were used to measure MI: 1) Semi automated computerised method: 
After orientation and magnification of each radiograph, a region of interest was 
defined from the growth plate to the metaphysis (at 0.5 distal radius growth plate 
width (GPW)); a computer program (Leica QWin©) provides automated 
measurements of GPW and 0.5GPW.  2) Manual method: manual calliper 
measurements (Lineartools Electronic Digital Calliper) of the GPW and 0.5GPW 
were made.  20 repeat MI’s were measured for each method.  One-way ANOVA 
was used to calculate precision (co-efficient of variation, CV%).   
The CV’s for the semi-automated method = 0.98% (0.5W), 0.94% (GPW) and 
0.97% (MI).  The CV’s for the manual method = 1.24% (0.5W), 2.73% (GPW) and 
2.90% (MI).  Precision is better using the semi automated method.     
Using a semi-automated computerised method to measure MI in the distal radius in 
children is a quick and precise way to assess bone growth and development.  With 
the creation of a larger reference database, it has the potential to be used in 
assessing metaphyseal inwaisting of children with clinical conditions, or 
undergoing treatments that may affect bone development. 
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Figure 12.1A: Poster displayed at the National Osteoporosis Society Conference, Edinburgh 2007. 
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The Metaphyseal Index for Assessing Development of the Distal Radius  
 
LC Reddie1, KA Ward1,MZ Mughal2, SM Astley1, JE Adams1  
1 Clinical Radiology, Imaging Science and Biomedical Engineering, School of Cancer and Imaging 
Science, University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, United 
Kingdom 
2 St Mary’s Hospital for Women & Children, Department of Paediatric Medicine, Hathersage Road, 
Manchester, M13 0JH, United Kingdom 
 
Introduction 
During skeletal growth and maturation remodelling of the ends of long bones, a process 
occurs known as metaphyseal inwaisting.  In a healthy child, metaphyseal inwaisting 
results in proportional decreases in metaphyseal width (MW) and increases in growth 
plate width (GPW).  The Metaphyseal Index (MI) compares MW to GPW.  MI of the 
distal femur has been examined (Ward et al, 2005; Land et al, 2006). However, the most 
commonly performed radiograph in children is the hand/forearm for bone-ageing. 
Primary Aim: To examine distal radius morphology, measure MI in healthy children 
and compare these reference data to examples from different disease/athlete groups, 
specifically Neurofibromatosis type 1 (NF1) and gymnasts. 
Hypotheses: The gymnast group would show a similar age distribution of MI to the 
normal group but with higher MI values; The NF1 group would show a similar age 
distribution of MI to the normal group but with lower MI values. 
Materials and Methods 
Posterior-anterior hand radiographs of 378 (156 male) healthy white Caucasian children, 
36 (15 male) healthy gymnasts and 17 (6 male) children with NF1, aged between 5 and 
19 years were digitised and semi-automated measurements of GPW and MW were 
obtained using QWin by Leica Microsystems (Milton Keynes, UK).  MI = 0.5MW / 
GPW. 
Results 
The MI increases with age in both sexes and all groups, then levels off in the teenage 
years.  Mean MI results: Normal group: 0.351 (+0.018 SD); Gymnast group: 0.335 
(+0.015 SD); NF1 group: 0.339 (+0.023 SD).    
Discussion 
Unexpectedly, the mean MI of the gymnast group was similar to that of the NF1 group.  
This may be due to small sample size.  Age and gender matching with normal controls is 
in progress and may shed further light on these results. 
References 
1)  Ward, K., Cowell, C.T., & Little, D.G. (2005) Quantification of metaphyseal 
modeling in children treated with bisphosphonates. Bone, 36, 999-1002. 
2) Land, C., Rauch, F. & Glorieux, F.H. (2006) Cyclical intravenous pamidronate 
treatment affects metaphyseal modeling in growing patients with osteogenesis 
imperfecta. J. Bone. Miner. Res. 21, 374-379. 
 
Abstract 12.1B: Abstract submitted and accepted at the Joint Meeting of the Bone Research Society 
and the British Society of Matrix Biology, London 2009. 
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Figure 12.1B: Poster displayed at the Joint Meeting of the Bone Research Society and the British 
Society of Matrix Biology, London 2009. 
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THE METAPHYSEAL INDEX OF THE DISTAL RADIUS: A COMPARISON 
BETWEEN GYMNASTS AND NORMAL CHILDREN 
 
L. Reddie*, K. Ward 1, Z. Mughal 2, S. Astley 1, J. Adams 1  
1ISBE, UNIVERSITY OF MANCHESTER, 2Paediatric Medicine, St Mary's Hospital, Manchester, 
United Kingdom 
 
Introduction 
Metaphyseal inwaisting is a process that occurs during long bone growth & remodelling 
of epiphyses & results in a proportional increase in growth plate width (GPW) and a 
decrease in metaphyseal width (MW).  The Metaphyseal Index (MI) compares GPW to 
MW, usually in the distal femur (Ward et al, 2005; Land et al, 2006).  However, due to 
bone-ageing, the most commonly performed radiograph in children is the hand/forearm.  
Previous work showed that gymnasts have a lower mean MI of the distal radius than 
normal children (Reddie et al, 2009), but that study did not use age & sex-matched 
controls, nor did it compare correlation of MI with pQCT. 
Aims: Examine distal radius morphology of gymnast children (cases) and normal 
children (controls) and investigate whether MI correlates with pQCT parameters: density 
[trabecular (TrD), cortical + subcortical (CSD), total (ToD)], total cross-sectional area 
(ToA), cross-sectional muscle area (CSMA) and polar strength-strain index (pSSI). 
Methods 
Posterior-anterior hand radiographs and pQCT scans of the non-dominant hand were 
taken in 378 (156 male) normal children aged between 5 and 20 years, and 36 (15 male) 
gymnasts aged between 5 and 12 years (mean = 9.1).  GPW and MW measurements 
were obtained using QWin by Leica (Milton Keynes, UK).  Each case had 2 controls 
from the normal group and were matched based on sex and age within 1 year.  Heights 
were within 11cm and weights within 11kg.  MI=0.5MW/GPW. 
Results 
MI of cases & controls were significantly different from each other (mean MI 
case=0.334167, mean MI control=0.345889, P=0.0004).  MI did not correlate with any 
of the aforementioned pQCT parameters (all r2 values<0.15) for either cases or controls. 
Discussion 
The results confirm previous work that the mean distal radius MI of gymnasts is 
significantly lower than in normal children.  Further work is needed to determine the 
reason(s) for this difference.  The results also show that MI does not correlate with 
pQCT parameters.  Future work will involve analysing the MI of children with 
neurofibromatosis & delayed puberty. 
References 
1)  Ward, K et al, (2005) Bone, 36, 999-1002. 
2)  Land, C et al, (2006) J. Bone. Miner. Res. 21, 374-379. 
3)  Reddie, L et al, (2009) Calcif Tissue Int. 85 (2), 181-182. 
 
 
Abstract 12.1C: Abstract submitted and accepted to the Joint Meeting of the Bone Research Society 
and the European Calcified Tissue Society, Glasgow 2010.  
 
*Awarded a BRS Travel Award of £250 for this abstract. 
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Figure 12.1C: Poster displayed at the Joint Meeting of the Bone Research Society and the European 
Calcified Tissue Society, Glasgow 2010. 
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12.2 Appendix 2 – Further Information regarding X-rays 
12.2.1 X-Rays and How They are Generated 
X-rays are generated in a device called an X-ray tube.  These devices have several 
components including a vacuum tube, a tungsten or molybdenum filament, a cathode, an 
anode and a rotor (Fig. 12.2A).  The tungsten filament, which is similar to those used in 
an average light bulb, has an electrical current passing through it that causes the filament 
to heat up.  The cathode is a metal assembly that surrounds the filament.  When the 
filament reaches a sufficiently high temperature, some of the electrons in the filament 
will have enough thermal energy to escape their bonds to the filament’s metal atoms and 
 
 
Figure 12.2A: Construction of an X-Ray tube with a rotating anode, adapted from (Kane, 2003). 
 
will collect in the vacuum tube.  The anode is a piece of metal, again often tungsten or 
molybdenum, located some distance away from the cathode.  The anode is often on a 
rotor rather than being stationary, which aids in dissipating the heat that is a by-product 
of producing X-rays.  When a high electrical voltage, the polarity of which is chosen in 
order to render the cathode negative and the anode positive, is passed between the 
cathode and anode, the positive anode attracts the electrons freed by heating the filament 
and accelerates them towards the anode.  The shape of the cathode is designed in order 
to focus the beam of electrons into striking the anode in a very small area.  When 
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electrons collide with the anode, their kinetic energy is released due to interactions with 
the atoms comprising the metal anode.  Most of the kinetic energy released is in the form 
of heat; less than 1% of the energy contributes to the production of X-rays.  The act of 
the electron changing its velocity (i.e. slowing down when it collides with the atoms in 
the anode), will cause it to emit radiation.  Low-energy X-rays are produced by glancing 
collisions, while high-energy X-rays are produced when a collision results in all of the 
electron’s original energy being converted into a photon.  After traversing the gap 
between the anode and cathode, each electron has the equivalent energy in kilo electron-
Volts (keV) to the voltage in kilovolts, (kV) being passed between the anode and the 
cathode.  Therefore, if the peak kiloVoltage (kVp) is 100 kV, then the kinetic energy of 
the electrons will be equal to 100 keV just prior to striking the anode.   
Both molybdenum and tungsten produce a broad spectrum of radiation, but because the 
X-ray sources are operated at different voltages, the maximum emitted X-ray energy 
differs: molybdenum has a kVp of 30 volts (equal to 30 keV), whereas tungsten has a 
kVp of 100 volts (equal to 100 keV).  The lower atomic number of molybdenum, 42, 
compared to tungsten, 74, means that molybdenum is not as effective at accelerating the 
electron beam and therefore produces less X-rays under the same operating conditions.  
This is one reason molybdenum is most commonly used in mammography and tungsten 
is used for full chest or body imaging (Kane, 2005).  Another advantage of these 
substances is that both tungsten and molybdenum have thermal properties which make 
them good at dissipating heat.   
 
12.2.2 X-Rays and Their Interaction with Tissue 
The Photoelectric Effect states: An inner-orbital electron of an atom within the body 
becomes excited when an X-ray photon interacts with it.  The X-ray photon is absorbed 
entirely, while the resulting photoelectron is free to travel. 
The Compton Effect states: When an incoming X-ray photon collides with an outer-
orbital electron, it will lead to that electron being ejected and the X-ray photon will 
scatter in a different direction.   
The Compton Effect requires less energy to occur than the Photoelectric Effect and is 
therefore more likely to occur in soft tissues such as fat and skin (Kane, 2005).  The 
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likelihood of the Photoelectric Effect occurring increases as the cube of the atomic 
number (Z3) increases.  It is for this reason that calcium (i.e. present in the skeleton) and 
heavy metals such as lead (used to line rooms and vests in order to protect from 
radiation exposure), are good absorbers.   
Different structures in the body have different attenuation co-efficients (μ), which 
depend on Z and electron density.  The higher the value of μ, the more readily a material 
will attenuate X-rays of a certain energy.  Bone, with its high calcium content, is more 
radiodense than other tissues, meaning it is not transparent to radiation and appears 
white on a radiograph.  Whereas the more radiolucent something is, the darker it will 
appear on a radiograph, i.e. air.  Fat also appears radiolucent (black) and other soft 
tissues appear in varying shades of grey.   
Table 12.2.2A shows the μ for various tissues and substances at 60 keV (Kane, 2005).  
Only 37% of X-rays remain after passing through a thickness of a substance equal to 
1/μ, which is the range of travel for X-rays.  The keV may need to be raised when 
imaging thicker parts of the body or individuals with a large girth (Kane, 2005).   
 
Table 12.2.2A: Attenuation Co-Efficients at 60 keV & Density for Tissues and 
Substances Important to Medical Imaging 
Absorbing Material Attenuation Co-Efficient at 60 keV 
μ (cm-1) 
Density ρ (g/cm-3) 
Fat 0.1788 0.90 
Soft tissues other 
than fat (muscle, 
bodily fluids) 
0.2045 1.00 
Water 0.2055 1.00 
Air ~3 X 10-4 0.00129 
Bone 0.466 – 0.548 1.65 – 2.00 
 
Table 12.2.2A: Attenuation Co-Efficients at 60 keV & Density for Tissues and Substances Important 
to Medical Imaging, adapted from (Kane, 2005). 
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12.3 Appendix 3 - Tanner Pubertal Stage Self-Assessment Sheets 
 
 
 
Figure 12.3A: Tanner pubertal stage self-assessment form for male pubic area. 
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Figure 12.3B: Tanner pubertal stage self-assessment form for male testicular volume. 
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Figure 12.3C: Tanner pubertal stage self-assessment form for female pubic area. 
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Figure 12.3D: Tanner pubertal stage self-assessment form for female breast development. 
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12.4 Appendix 4 - Figures from Chapter 8 Results 
 
 
Figure 8.3I: MI in Tanner stages 1 through 5 in the Normal group (baseline values).  This box and 
whisker plot illustrates that the MI increases as puberty develops. 
 
 
Figure 8.3J: MW in Tanner stages 1 through 5 in the Normal group (baseline values).  This box and 
whisker plot illustrates that the MW increases as puberty develops. 
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Figure 8.3K: GPW in Tanner stages 1 through 5 in the Normal group (baseline values).  This box 
and whisker plot illustrates that the GPW increases as puberty develops. 
 
   
 
Figure 8.3.2C: 40% MW vs chronological age (years) using 25 males and 25 females from the 
Normal group (baseline values).   This plot illustrates that the 40% MW increases with age.   
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Figure 8.3.2D: 60% MW vs chronological age (years) using 25 males and 25 females from the 
Normal group (baseline values).   This plot illustrates that the 60% MW increases with age.  
 
 
Figure 8.3.2E: MI compared to 40% MI in 25 normal males and 25 normal females.  This plot 
illustrates a good correlation between the MI and 40% MI. 
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Figure 8.3.2F: MI compared to 60% MI in 25 normal males and 25 normal females.  This plot 
illustrates a good correlation between the MI and 60% MI. 
 
 
 
Figure 8.3.2G: 40% MI compared to 60% MI in 25 normal males and 25 normal females.  This plot 
illustrates a good correlation between the 40% and 60% MI. 
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Figure 8.4C: MI compared to chronological age in Gymnast males and females.  The regression 
lines show a slight difference in the slopes for males and females, but it is not significant (p = 0.502).  
 
 
Figure 8.4D: MI compared to height (cm) in Gymnast males and females.  The regression lines show 
the slopes for males and females are almost parallel, but the vertical distance between the lines is 
not significant (p = 0.959). 
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Figure 8.4E: MW (mm) vs chronological age in the Normal group (baseline values).  This cross-
sectional plot illustrates that the MW increases with age. 
 
 
 
Figure 8.4F: MW (mm) vs height (cm) in the Normal group (baseline values).  This cross-sectional 
plot illustrates that the MW increases as height increases. 
 
 263
 
 
Figure 8.4G: GPW (mm) vs chronological age in the Gymnast group (baseline values).  This cross-
sectional plot illustrates a similar result to the MW plot - that the GPW increases with age. 
 
 
Figure 8.4H: GPW (mm) compared to height in the Gymnast group (baseline values).  This plot 
illustrates a similar result to the MW plot - that the GPW increases as height increases. 
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Figure 8.5C: MI compared to chronological age in NF1 males and females.  The regression lines 
appear to show a large difference between the slopes, but it is not significant (p = 0.882).  
 
 
Figure 8.5D: MI compared to height in NF1 males and females.  The regression lines show the two 
slopes are almost parallel, but the vertical distance between them is not significant (p = 0.840). 
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Figure 8.5E: MW (mm) vs chronological age in the NF1 group.  This cross-sectional plot appears to 
show the MW increasing with age, but the regression is not significant (p = 0.159). 
 
 
 
Figure 8.5F: MW (mm) vs height (cm) in the NF1 group.  This cross-sectional plot illustrates that 
the MW increases as height increases (p = 0.003). 
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Figure 8.5G: GPW (mm) vs chronological age in the NF1 group.  This cross-sectional plot appears 
to show an increase in GPW as subjects age, but the relationship is not significant (p = 0.082). 
 
 
Figure 8.5H: GPW (mm) vs height in the NF1 group.  This cross-sectional plot illustrates a similar 
result to the MW plot - that the GPW increases as height increases (p = 0.013). 
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Figure 8.6C: MI compared to TW3 bone-age in CDGP males and females.  The regression lines 
show a slight difference in the slopes for males and females, but this is not significant (p = 0.550).  
 
 
 
Figure 8.6D: MI compared to height (cm) in CDGP males and females.  The regression lines appear 
to show a large difference between the slopes of males and females, but the vertical distance between 
the lines is not significant (p = 0.812). 
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Figure 8.6E: MW (mm) vs chronological age in the CDGP group using all baseline values.  This 
cross-sectional plot illustrates that the MW increases with age. 
 
 
 
 
Figure 8.6F: MW (mm) vs height (cm) in the CDGP group using 25 baseline values.  This cross-
sectional plot illustrates that the MW increases as height increases. 
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Figure 8.6G: GPW (mm) compared to TW3 bone-age in the CDGP group (all baseline values).  This 
cross-sectional plot illustrates a similar result to the MW plot - that the GPW increases with age. 
 
 
 
Figure 8.6H: GPW (mm) compared to height in the CDGP group (25 baseline values).  This cross-
sectional plot illustrates a similar result to the MW plot - that the GPW increases as height 
increases. 
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Figure 8.7A: Box and whisker plot illustrating the MI means, standard deviations and ranges of the 
Normal, Gymnast, NF1 and CDGP groups. 
 
 
Figure 8.7B: Box and whisker plot illustrating the MW means, standard deviations and ranges of 
the Normal, Gymnast, NF1 and CDGP groups. 
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Figure 8.7C: Box and whisker plot illustrating the GPW means, standard deviations and ranges of 
the Normal, Gymnast, NF1 and CDGP groups. 
 
 
 
 
